{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 28207, "items": [{"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T12:45:56Z", "timestamp": 1575290756967}, "reference-count": 35, "publisher": "Oxford University Press (OUP)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2014, 3]]}, "DOI": "10.1093/carcin/bgt338", "type": "journal-article", "created": {"date-parts": [[2013, 10, 16]], "date-time": "2013-10-16T04:45:11Z", "timestamp": 1381898711000}, "page": "624-634", "source": "Crossref", "is-referenced-by-count": 13, "title": ["SH3RF2 functions as an oncogene by mediating PAK4 protein stability"], "prefix": "10.1093", "volume": "35", "author": [{"given": "Tae Woo", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Yun Kyung", "family": "Kang", "sequence": "additional", "affiliation": []}, {"given": "Zee Yong", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Young-Ho", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Seong Woo", "family": "Hong", "sequence": "additional", "affiliation": []}, {"given": "Su Jin", "family": "Oh", "sequence": "additional", "affiliation": []}, {"given": "Hyun Ahm", "family": "Sohn", "sequence": "additional", "affiliation": []}, {"given": "Suk-Jin", "family": "Yang", "sequence": "additional", "affiliation": []}, {"given": "Ye Jin", "family": "Jang", "sequence": "additional", "affiliation": []}, {"given": "Dong Chul", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Se-yong", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Hyang-Sook", "family": "Yoo", "sequence": "additional", "affiliation": []}, {"given": "Eunhee", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Young Il", "family": "Yeom", "sequence": "additional", "affiliation": []}, {"given": "Kyung Chan", "family": "Park", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2013, 10, 15]]}, "reference": [{"key": "key\n\t\t\t\t20170521002948_CIT0001", "doi-asserted-by": "crossref", "first-page": "2763", "DOI": "10.4049/jimmunol.178.5.2763", "article-title": "Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage", "volume": "178", "author": "Perrot", "year": "(2007)", "journal-title": "J. Immunol."}, {"key": "key\n\t\t\t\t20170521002948_CIT0002", "doi-asserted-by": "crossref", "first-page": "2159", "DOI": "10.1056/NEJMoa041869", "article-title": "Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells", "volume": "351", "author": "Dave", "year": "(2004)", "journal-title": "N. Engl. J. Med."}, {"key": "key\n\t\t\t\t20170521002948_CIT0003", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1038/nrc2628", "article-title": "Tumour necrosis factor and cancer", "volume": "9", "author": "Balkwill", "year": "(2009)", "journal-title": "Nat. Rev. Cancer"}, {"key": "key\n\t\t\t\t20170521002948_CIT0004", "first-page": "371854", "article-title": "Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy", "volume": "2013", "author": "Bremer", "year": "(2013)", "journal-title": "ISRN Oncol."}, {"key": "key\n\t\t\t\t20170521002948_CIT0005", "doi-asserted-by": "crossref", "first-page": "745", "DOI": "10.1038/nri1184", "article-title": "Signalling pathways of the TNF superfamily: a double-edged sword", "volume": "3", "author": "Aggarwal", "year": "(2003)", "journal-title": "Nat. Rev. Immunol."}, {"key": "key\n\t\t\t\t20170521002948_CIT0006", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1016/S0092-8674(03)00521-X", "article-title": "Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes", "volume": "114", "author": "Micheau", "year": "(2003)", "journal-title": "Cell"}, {"key": "key\n\t\t\t\t20170521002948_CIT0007", "doi-asserted-by": "crossref", "first-page": "1297", "DOI": "10.1016/j.cellsig.2012.02.006", "article-title": "Signal transduction by tumor necrosis factor receptors", "volume": "24", "author": "Cabal-Hierro", "year": "(2012)", "journal-title": "Cell. Signal."}, {"key": "key\n\t\t\t\t20170521002948_CIT0008", "doi-asserted-by": "crossref", "first-page": "2975", "DOI": "10.3390/molecules13122975", "article-title": "Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells", "volume": "13", "author": "Kim", "year": "(2008)", "journal-title": "Molecules"}, {"key": "key\n\t\t\t\t20170521002948_CIT0009", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1016/j.lungcan.2003.11.017", "article-title": "Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma", "volume": "44", "author": "Sanlioglu", "year": "(2004)", "journal-title": "Lung Cancer"}, {"key": "key\n\t\t\t\t20170521002948_CIT0010", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1016/S1673-8527(09)60080-1", "article-title": "POSH is involved in Eiger-Basket (TNF-JNK) signaling and embryogenesis in Drosophila", "volume": "37", "author": "Zhang", "year": "(2010)", "journal-title": "J. Genet. Genomics"}, {"key": "key\n\t\t\t\t20170521002948_CIT0011", "doi-asserted-by": "crossref", "first-page": "4689", "DOI": "10.1016/j.febslet.2010.10.048", "article-title": "POSH promotes cell survival in Drosophila and in human RASF cells", "volume": "584", "author": "Tsuda", "year": "(2010)", "journal-title": "FEBS Lett."}, {"key": "key\n\t\t\t\t20170521002948_CIT0012", "doi-asserted-by": "crossref", "first-page": "4700", "DOI": "10.1158/0008-5472.CAN-06-4645", "article-title": "Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells", "volume": "67", "author": "Wang", "year": "(2007)", "journal-title": "Cancer Res."}, {"key": "key\n\t\t\t\t20170521002948_CIT0013", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1159/000105476", "article-title": "Identification of POSH2, a novel homologue of the c-Jun N-terminal kinase scaffold protein POSH", "volume": "29", "author": "Wilhelm", "year": "(2007)", "journal-title": "Dev. Neurosci."}, {"key": "key\n\t\t\t\t20170521002948_CIT0014", "doi-asserted-by": "crossref", "first-page": "2247", "DOI": "10.1074/jbc.M111.269431", "article-title": "Sh3rf2/POSHER protein promotes cell survival by RING-mediated proteasomal degradation of the c-Jun N-terminal kinase scaffold POSH (Plenty of SH3s) protein", "volume": "287", "author": "Wilhelm", "year": "(2012)", "journal-title": "J. Biol. Chem."}, {"key": "key\n\t\t\t\t20170521002948_CIT0015", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1038/367040a0", "article-title": "A brain serine/threonine protein kinase activated by Cdc42 and Rac1", "volume": "367", "author": "Manser", "year": "(1994)", "journal-title": "Nature"}, {"key": "key\n\t\t\t\t20170521002948_CIT0016", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1038/nrc1892", "article-title": "p21-activated kinases in cancer", "volume": "6", "author": "Kumar", "year": "(2006)", "journal-title": "Nat. Rev. Cancer"}, {"key": "key\n\t\t\t\t20170521002948_CIT0017", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1007/s10555-008-9181-4", "article-title": "Targeting group II PAKs in cancer and metastasis", "volume": "28", "author": "Eswaran", "year": "(2009)", "journal-title": "Cancer Metastasis Rev."}, {"key": "key\n\t\t\t\t20170521002948_CIT0018", "doi-asserted-by": "crossref", "first-page": "41192", "DOI": "10.1074/jbc.M506884200", "article-title": "PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor", "volume": "280", "author": "Li", "year": "(2005)", "journal-title": "J. Biol. Chem."}, {"key": "key\n\t\t\t\t20170521002948_CIT0019", "doi-asserted-by": "crossref", "first-page": "1560", "DOI": "10.1038/onc.2012.170", "article-title": "Roles of 14-3-3eta in mitotic progression and its potential use as a therapeutic target for cancers", "volume": "32", "author": "Lee", "year": "(2012)", "journal-title": "Oncogene."}, {"key": "key\n\t\t\t\t20170521002948_CIT0020", "doi-asserted-by": "crossref", "first-page": "1340", "DOI": "10.1016/j.humpath.2004.07.021", "article-title": "Overexpression of clusterin in human hepatocellular carcinoma", "volume": "35", "author": "Kang", "year": "(2004)", "journal-title": "Hum. Pathol."}, {"key": "key\n\t\t\t\t20170521002948_CIT0021", "doi-asserted-by": "crossref", "first-page": "35283", "DOI": "10.1074/jbc.M805590200", "article-title": "A novel germ cell-specific protein, SHIP1, forms a complex with chromatin remodeling activity during spermatogenesis", "volume": "283", "author": "Choi", "year": "(2008)", "journal-title": "J. Biol. Chem."}, {"key": "key\n\t\t\t\t20170521002948_CIT0022", "doi-asserted-by": "crossref", "first-page": "2608", "DOI": "10.1002/cncr.25841", "article-title": "Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer", "volume": "117", "author": "Kim", "year": "(2011)", "journal-title": "Cancer"}, {"key": "key\n\t\t\t\t20170521002948_CIT0023", "doi-asserted-by": "crossref", "first-page": "550", "DOI": "10.1074/jbc.M105732200", "article-title": "Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines", "volume": "277", "author": "Callow", "year": "2002", "journal-title": "J. Biol. Chem."}, {"key": "key\n\t\t\t\t20170521002948_CIT0024", "doi-asserted-by": "crossref", "first-page": "1215", "DOI": "10.1158/1541-7786.MCR-08-0087", "article-title": "The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice", "volume": "6", "author": "Liu", "year": "(2008)", "journal-title": "Mol. Cancer Res."}, {"key": "key\n\t\t\t\t20170521002948_CIT0025", "doi-asserted-by": "crossref", "first-page": "1793", "DOI": "10.4161/cbt.7.11.6840", "article-title": "Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification", "volume": "7", "author": "Chen", "year": "(2008)", "journal-title": "Cancer Biol. Ther."}, {"key": "key\n\t\t\t\t20170521002948_CIT0026", "doi-asserted-by": "crossref", "first-page": "5883", "DOI": "10.1038/onc.2010.329", "article-title": "The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis", "volume": "29", "author": "Liu", "year": "(2010)", "journal-title": "Oncogene"}, {"key": "key\n\t\t\t\t20170521002948_CIT0027", "doi-asserted-by": "crossref", "first-page": "1908", "DOI": "10.1111/j.1349-7006.2009.01252.x", "article-title": "Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma", "volume": "100", "author": "Begum", "year": "(2009)", "journal-title": "Cancer Sci."}, {"key": "key\n\t\t\t\t20170521002948_CIT0028", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1038/nrm2430", "article-title": "Regulation of TNFR1 and CD95 signalling by receptor compartmentalization", "volume": "9", "author": "Sch\u00fctze", "year": "(2008)", "journal-title": "Nat. Rev. Mol. Cell Biol."}, {"key": "key\n\t\t\t\t20170521002948_CIT0029", "doi-asserted-by": "crossref", "first-page": "3964", "DOI": "10.1128/MCB.21.12.3964-3973.2001", "article-title": "NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling", "volume": "21", "author": "Kreuz", "year": "(2001)", "journal-title": "Mol. Cell. Biol."}, {"key": "key\n\t\t\t\t20170521002948_CIT0030", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1016/j.bbamcr.2011.11.013", "article-title": "Nucleo-cytoplasmic shuttling of PAK4 modulates \u03b2-catenin intracellular translocation and signaling", "volume": "1823", "author": "Li", "year": "(2012)", "journal-title": "Biochim. Biophys. Acta"}, {"key": "key\n\t\t\t\t20170521002948_CIT0031", "doi-asserted-by": "crossref", "first-page": "1795", "DOI": "10.1002/jcb.23092", "article-title": "PAK4 is required for regulation of the cell-cycle regulatory protein p21, and for control of cell-cycle progression", "volume": "112", "author": "Nekrasova", "year": "(2011)", "journal-title": "J. Cell. Biochem."}, {"key": "key\n\t\t\t\t20170521002948_CIT0032", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1083/jcb.200912056", "article-title": "Subgroup II PAK-mediated phosphorylation regulates Ran activity during mitosis", "volume": "190", "author": "Bompard", "year": "(2010)", "journal-title": "J. Cell Biol."}, {"key": "key\n\t\t\t\t20170521002948_CIT0033", "doi-asserted-by": "crossref", "first-page": "2264", "DOI": "10.1002/ijc.24720", "article-title": "Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences", "volume": "125", "author": "Nakagawa", "year": "(2009)", "journal-title": "Int. J. Cancer"}, {"key": "key\n\t\t\t\t20170521002948_CIT0034", "doi-asserted-by": "crossref", "first-page": "2766", "DOI": "10.1002/ijc.24281", "article-title": "High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B", "volume": "124", "author": "Wong", "year": "(2009)", "journal-title": "Int. J. Cancer"}, {"key": "key\n\t\t\t\t20170521002948_CIT0035", "doi-asserted-by": "crossref", "first-page": "27429", "DOI": "10.1074/jbc.M110.142752", "article-title": "Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells", "volume": "285", "author": "Liu", "year": "(2010)", "journal-title": "J. Biol. Chem."}], "container-title": ["Carcinogenesis"], "language": "en", "link": [{"URL": "http://academic.oup.com/carcin/article-pdf/35/3/624/17293105/bgt338.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T13:17:32Z", "timestamp": 1503580652000}, "score": 41.14928, "issued": {"date-parts": [[2013, 10, 15]]}, "references-count": 35, "journal-issue": {"published-online": {"date-parts": [[2013, 10, 15]]}, "published-print": {"date-parts": [[2014, 3]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1093/carcin/bgt338", "relation": {"cites": []}, "ISSN": ["1460-2180", "0143-3334"], "issn-type": [{"value": "0143-3334", "type": "print"}, {"value": "1460-2180", "type": "electronic"}], "subject": ["Cancer Research", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:39:17Z", "timestamp": 1574113157900}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "12", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1998, 3, 1]], "date-time": "1998-03-01T00:00:00Z", "timestamp": 888710400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[1998, 3]]}, "DOI": "10.1038/sj.onc.1201671", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T19:06:37Z", "timestamp": 1031166397000}, "page": "1625-1631", "source": "Crossref", "is-referenced-by-count": 29, "title": ["The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly"], "prefix": "10.1038", "volume": "16", "author": [{"given": "Shu", "family": "Pan", "sequence": "first", "affiliation": []}, {"given": "Koh Yee", "family": "Ming", "sequence": "additional", "affiliation": []}, {"given": "Theresa A", "family": "Dunn", "sequence": "additional", "affiliation": []}, {"given": "Kim KC", "family": "Li", "sequence": "additional", "affiliation": []}, {"given": "Kevin AW", "family": "Lee", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[1998, 4, 1]]}, "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1201671.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1201671", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1201671.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T01:41:29Z", "timestamp": 1552873289000}, "score": 23.274511, "issued": {"date-parts": [[1998, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 3]]}, "issue": "12"}, "alternative-id": ["BF1201671"], "URL": "http://dx.doi.org/10.1038/sj.onc.1201671", "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:06:50Z", "timestamp": 1574114810594}, "reference-count": 47, "publisher": "Springer Science and Business Media LLC", "issue": "21", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 3, 15]], "date-time": "2004-03-15T00:00:00Z", "timestamp": 1079308800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2004, 5]]}, "DOI": "10.1038/sj.onc.1207492", "type": "journal-article", "created": {"date-parts": [[2004, 3, 15]], "date-time": "2004-03-15T11:51:18Z", "timestamp": 1079351478000}, "page": "3863-3871", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Multiple cell-type-specific elements regulate Myc protein stability"], "prefix": "10.1038", "volume": "23", "author": [{"given": "Andreas", "family": "Herbst", "sequence": "first", "affiliation": []}, {"given": "Simone E", "family": "Salghetti", "sequence": "additional", "affiliation": []}, {"given": "So Young", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "William P", "family": "Tansey", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2004, 3, 15]]}, "reference": [{"key": "BF1207492_CR1", "unstructured": "Atchley WR and Fitch WM . (1995). Proc. Natl. Acad. Sci. USA, 92, 10217\u201310221."}, {"key": "BF1207492_CR2", "unstructured": "Bahram F, von der Lehr N, Cetinkaya C and Larsson LG . (2000). Blood, 95, 2104\u20132110."}, {"key": "BF1207492_CR3", "unstructured": "Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW and Elledge SJ . (1996). Cell, 86, 263\u2013274."}, {"key": "BF1207492_CR4", "unstructured": "Bello-Fernandez C, Packham G and Cleveland JL . (1993). Proc. Natl. Acad. Sci. USA, 90, 7804\u20137808."}, {"key": "BF1207492_CR5", "unstructured": "Bloom J, Amador V, Bartolini F, DeMartino G and Pagano M . (2003). Cell, 115, 71\u201382."}, {"key": "BF1207492_CR6", "unstructured": "Bres V, Kiernan RE, Linares LK, Chable-Bessia C, Plechakova O, Treand C, Emiliani S, Peloponese JM, Jeang KT, Coux O, Scheffner M and Benkirane M . (2003). Nat. Cell Biol., 5, 754\u2013761."}, {"key": "BF1207492_CR7", "unstructured": "Chen L, Smith L, Accavitti-Loper MA, Omura S and Bingham Smith J . (2000). Arch. Biochem. Biophys., 374, 306\u2013312."}, {"key": "BF1207492_CR8", "unstructured": "Cole MD and McMahon SB . (1999). Oncogene, 18, 2916\u20132924."}, {"key": "BF1207492_CR9", "unstructured": "Conklin DS, Kung C and Culbertson MR . (1993). Mol. Cell. Biol., 13, 2041\u20132049."}, {"key": "BF1207492_CR10", "unstructured": "Conzen SD, Gottlob K, Kandel ES, Khanduri P, Wagner AJ, O'Leary M and Hay N . (2000). Mol. Cell. Biol., 20, 6008\u20136018."}, {"key": "BF1207492_CR11", "unstructured": "Dotto GP, Gilman MZ, Maruyama M and Weinberg RA . (1986). EMBO J., 5, 2853\u20132857."}, {"key": "BF1207492_CR12", "unstructured": "Eilers M, Picard D, Yamamoto KR and Bishop JM . (1989). Nature, 340, 66\u201368."}, {"key": "BF1207492_CR13", "unstructured": "Flinn EM, Busch CMC and Wright APH . (1998). Mol. Cell. Biol., 18, 5961\u20135969."}, {"key": "BF1207492_CR14", "unstructured": "Grandori C, Cowley SM, James LP and Eisenman RN . (2000). Annu. Rev. Cell Dev. Biol., 16, 653\u2013699."}, {"key": "BF1207492_CR15", "unstructured": "Greer SF, Zika E, Conti B, Zhu XS and Ting JP . (2003). Nat. Immunol., 4, 1074\u20131082."}, {"key": "BF1207492_CR16", "unstructured": "Gregory MA and Hann SR . (2000). Mol. Cell. Biol., 20, 2423\u20132435."}, {"key": "BF1207492_CR17", "unstructured": "Gross-Mesilaty S, Reinstein E, Bercovich B, Tobias KE, Schwartz AL, Kahana C and Ciechanover A . (1998). Proc. Natl. Acad. Sci. USA, 95, 8058\u20138063."}, {"key": "BF1207492_CR18", "unstructured": "Hann SR and Eisenman RN . (1984). Mol. Cell. Biol., 4, 2486\u20132497."}, {"key": "BF1207492_CR19", "unstructured": "Hannon GJ, Sun P, Carnero A, Xie LY, Maestro R, Conklin DS and Beach D . (1999). Science, 283, 1129\u20131130."}, {"key": "BF1207492_CR20", "unstructured": "Henriksson M and Luscher B . (1996). Adv. Cancer Res., 68, 109\u2013182."}, {"key": "BF1207492_CR21", "unstructured": "Herbst A and Tansey WP . (2000). Mol. Biol. Rep., 27, 203\u2013208."}, {"key": "BF1207492_CR22", "unstructured": "Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B and Kinzler KW . (2000). Proc. Natl. Acad. Sci. USA, 97, 2229\u20132234."}, {"key": "BF1207492_CR23", "unstructured": "Kim SY, Herbst A, Tworkowski KA, Salghetti SE and Tansey WP . (2003). Mol. Cell, 11, 1177\u20131188."}, {"key": "BF1207492_CR24", "unstructured": "Kunkel TA, Roberts JD and Zakour RA . (1987). Methods Enzymol., 154, 367\u2013382."}, {"key": "BF1207492_CR25", "unstructured": "Land H, Parada LF and Weinberg RA . (1983). Nature, 304, 596\u2013602."}, {"key": "BF1207492_CR26", "unstructured": "Logan J, Nicolas JC, Topp WC, Girard M, Shenk T and Levine AJ . (1981). Virology, 115, 419\u2013422."}, {"key": "BF1207492_CR27", "unstructured": "Mortimer RK and Johnston JR . (1986). Genetics, 113, 35\u201343."}, {"key": "BF1207492_CR28", "unstructured": "Mumberg D, Muller R and Funk M . (1995). Gene, 156, 119\u2013122."}, {"key": "BF1207492_CR29", "unstructured": "Muratani M and Tansey WP . (2003). Nat. Rev. Mol. Cell. Biol., 4, 192\u2013201."}, {"key": "BF1207492_CR30", "unstructured": "Oster SK, Mao DY, Kennedy J and Penn LZ . (2003). Oncogene, 22, 1998\u20132010."}, {"key": "BF1207492_CR31", "unstructured": "Prasad I, Zouzias D and Basilico C . (1976). J. Virol., 18, 436\u2013444."}, {"key": "BF1207492_CR32", "unstructured": "Rogers S, Wells R and Rechsteiner M . (1986). Science, 234, 364\u2013368."}, {"key": "BF1207492_CR33", "unstructured": "Rudolph C, Adam G and Simm A . (1999). Anal. Biochem., 269, 66\u201371."}, {"key": "BF1207492_CR34", "unstructured": "Ryan KM and Birnie GD . (1996). Biochem. J., 314, 713\u2013721."}, {"key": "BF1207492_CR35", "unstructured": "Sakamuro D and Prendergast GC . (1999). Oncogene, 18, 2942\u20132954."}, {"key": "BF1207492_CR36", "unstructured": "Salghetti SE, Caudy AA, Chenoweth JG and Tansey WP . (2001). Science, 293, 1651\u20131653."}, {"key": "BF1207492_CR37", "unstructured": "Salghetti SE, Kim SY and Tansey WP . (1999). EMBO J., 18, 717\u2013726."}, {"key": "BF1207492_CR38", "unstructured": "Sarid J, Halazonetis TD, Murphy W and Leder P . (1987). Proc. Natl. Acad. Sci. USA, 84, 170\u2013173."}, {"key": "BF1207492_CR39", "author": "F Sherman", "year": "1986", "unstructured": "Sherman F, Fink GR and Hicks JB . (1986). Methods in Yeast Genetics: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.", "volume-title": "Methods in Yeast Genetics: A Laboratory Manual"}, {"key": "BF1207492_CR40", "unstructured": "Spencer CA and Groudine M . (1991). Adv. Cancer Res., 56, 1\u201348."}, {"key": "BF1207492_CR41", "unstructured": "Spotts GD, Patel SV, Xiao Q and Hann SR . (1997). Mol. Cell. Biol., 17, 1459\u20131468."}, {"key": "BF1207492_CR42", "unstructured": "Tanaka M . (1996). Proc. Natl. Acad. Sci. USA, 93, 4311\u20134315."}, {"key": "BF1207492_CR43", "unstructured": "Thompson JD, Higgins DG and Gibson TJ . (1994). Nucleic Acids Res., 22, 4673\u20134680."}, {"key": "BF1207492_CR44", "unstructured": "Treier M, Staszewski LM and Bohmann D . (1994). Cell, 78, 787\u2013798."}, {"key": "BF1207492_CR45", "unstructured": "Tworkowski KA, Salghetti SE and Tansey WP . (2002). Oncogene, 21, 8515\u20138520."}, {"key": "BF1207492_CR46", "unstructured": "Varshavsky A . (1997). Trends Biochem. Sci., 22, 383\u2013387."}, {"key": "BF1207492_CR47", "unstructured": "Xie Y and Varshavsky A . (2002). Nat Cell Biol., 4, 1003\u20131007."}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1207492.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1207492", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1207492.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T16:48:46Z", "timestamp": 1552754926000}, "score": 23.02186, "issued": {"date-parts": [[2004, 3, 15]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2004, 5]]}, "issue": "21"}, "alternative-id": ["BF1207492"], "URL": "http://dx.doi.org/10.1038/sj.onc.1207492", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:53:27Z", "timestamp": 1574157207076}, "update-to": [{"updated": {"date-parts": [[2004, 12, 16]], "date-time": "2004-12-16T00:00:00Z", "timestamp": 1103155200000}, "DOI": "10.1038/sj.onc.1207492", "type": "erratum", "label": "Erratum"}], "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "58", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 12, 1]], "date-time": "2004-12-01T00:00:00Z", "timestamp": 1101859200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2004, 12]]}, "DOI": "10.1038/sj.onc.1208362", "type": "journal-article", "created": {"date-parts": [[2004, 12, 16]], "date-time": "2004-12-16T09:04:07Z", "timestamp": 1103187847000}, "page": "9448-9448", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Erratum: Multiple cell-type-specific elements regulate Myc protein stability"], "prefix": "10.1038", "volume": "23", "author": [{"given": "Andreas", "family": "Herbst", "sequence": "first", "affiliation": []}, {"given": "Simone E", "family": "Salghetti", "sequence": "additional", "affiliation": []}, {"given": "So Young", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "William P", "family": "Tansey", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2004, 12, 16]]}, "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1208362.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1208362", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1208362.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T15:23:50Z", "timestamp": 1555341830000}, "score": 23.02186, "issued": {"date-parts": [[2004, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 12]]}, "issue": "58"}, "alternative-id": ["BF1208362"], "URL": "http://dx.doi.org/10.1038/sj.onc.1208362", "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}], "assertion": [{"value": "16 December 2004", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T16:06:33Z", "timestamp": 1574265993887}, "publisher-location": "100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959", "reference-count": 0, "publisher": "ASTM International", "isbn-type": [{"value": "9780803102255", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1520/stp34247s", "type": "book-chapter", "created": {"date-parts": [[2008, 12, 4]], "date-time": "2008-12-04T22:04:54Z", "timestamp": 1228428294000}, "page": "95-95-11", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Wide-Range Weight Functions for the Strip with a Single Edge Crack"], "prefix": "10.1520", "author": [{"given": "TW", "family": "Orange", "sequence": "first", "affiliation": []}], "member": "381", "container-title": ["Fracture Mechanics: Sixteenth Symposium"], "deposited": {"date-parts": [[2015, 4, 7]], "date-time": "2015-04-07T19:50:19Z", "timestamp": 1428436219000}, "score": 21.281525, "issued": {"date-parts": [[null]]}, "ISBN": ["9780803102255"], "references-count": 0, "URL": "http://dx.doi.org/10.1520/stp34247s"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:55:15Z", "timestamp": 1574492115042}, "reference-count": 45, "publisher": "Springer Science and Business Media LLC", "issue": "19", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2011, 1, 31]], "date-time": "2011-01-31T00:00:00Z", "timestamp": 1296432000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2011, 5]]}, "DOI": "10.1038/onc.2010.604", "type": "journal-article", "created": {"date-parts": [[2011, 1, 31]], "date-time": "2011-01-31T11:19:04Z", "timestamp": 1296472744000}, "page": "2264-2274", "source": "Crossref", "is-referenced-by-count": 32, "title": ["Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src"], "prefix": "10.1038", "volume": "30", "author": [{"given": "J", "family": "Jung", "sequence": "first", "affiliation": []}, {"given": "H Y", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Sohn", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Lee", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 1, 31]]}, "reference": [{"key": "BFonc2010604_CR1", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1074/jbc.272.1.217", "volume": "272", "author": "YS Bae", "year": "1997", "unstructured": "Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB et al. (1997). Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217\u2013221.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010604_CR2", "doi-asserted-by": "publisher", "first-page": "1082", "DOI": "10.1091/mbc.e04-05-0427", "volume": "16", "author": "SP Barwe", "year": "2005", "unstructured": "Barwe SP, Anilkumar G, Moon SY, Zheng Y, Whitelegge JP, Rajasekaran SA et al. (2005). Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol Cell 16: 1082\u20131094.", "journal-title": "Mol Biol Cell"}, {"key": "BFonc2010604_CR3", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1186/bcr55", "volume": "2", "author": "JS Biscardi", "year": "2000", "unstructured": "Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ . (2000). Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res 2: 203\u2013210.", "journal-title": "Breast Cancer Res"}, {"key": "BFonc2010604_CR4", "doi-asserted-by": "publisher", "first-page": "550", "DOI": "10.1126/science.1068999", "volume": "296", "author": "TR Brummelkamp", "year": "2002", "unstructured": "Brummelkamp TR, Bernards R, Agami R . (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550\u2013553.", "journal-title": "Science"}, {"key": "BFonc2010604_CR5", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1007/s10549-005-9053-3", "volume": "96", "author": "JQ Chen", "year": "2006", "unstructured": "Chen JQ, Contreras RG, Wang R, Fernandez SV, Shoshani L, Russo IH et al. (2006). Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: a new paradigm for development of anti- breast cancer drugs? Breast Cancer Res Treat 96: 1\u201315.", "journal-title": "Breast Cancer Res Treat"}, {"key": "BFonc2010604_CR6", "doi-asserted-by": "publisher", "first-page": "1091", "DOI": "10.1002/bmc.1029", "volume": "22", "author": "MS Cheon", "year": "2008", "unstructured": "Cheon MS, Suh JK, Kim MJ, Kim SH, Lee K . (2008). Identification of differentially expressed proteins in the heart of translationally controlled tumor protein over-expressing transgenic mice. Biomed Chromatogr 22: 1091\u20131099.", "journal-title": "Biomed Chromatogr"}, {"key": "BFonc2010604_CR7", "doi-asserted-by": "publisher", "first-page": "1051", "DOI": "10.1016/0092-8674(93)90634-3", "volume": "73", "author": "JA Cooper", "year": "1993", "unstructured": "Cooper JA, Howell B . (1993). The when and how of Src regulation. Cell 73: 1051\u20131054.", "journal-title": "Cell"}, {"key": "BFonc2010604_CR8", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1016/j.ccr.2006.12.013", "volume": "11", "author": "I Dolado", "year": "2007", "unstructured": "Dolado I, Swat A, Ajenjo N, De Vita G, Cuadrado A, Nebreda AR . (2007). p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11: 191\u2013205.", "journal-title": "Cancer Cell"}, {"key": "BFonc2010604_CR9", "doi-asserted-by": "publisher", "first-page": "4079", "DOI": "10.1074/jbc.272.7.4079", "volume": "272", "author": "DR Emlet", "year": "1997", "unstructured": "Emlet DR, Moscatello DK, Ludlow LB, Wong AJ . (1997). Subsets of epidermal growth factor receptors during activation and endocytosis. J Biol Chem 272: 4079\u20134086.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010604_CR10", "doi-asserted-by": "publisher", "first-page": "1859", "DOI": "10.1002/cncr.11267", "volume": "97", "author": "C Espineda", "year": "2003", "unstructured": "Espineda C, Seligson DB, James Ball Jr W, Rao J, Palotie A, Horvath S et al. (2003). Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer 97: 1859\u20131868.", "journal-title": "Cancer"}, {"key": "BFonc2010604_CR11", "doi-asserted-by": "publisher", "first-page": "1533", "DOI": "10.1007/s00436-007-0671-z", "volume": "101", "author": "M Gnanasekar", "year": "2007", "unstructured": "Gnanasekar M, Ramaswamy K . (2007). Translationally controlled tumor protein of Brugia malayi functions as an antioxidant protein. Parasitol Res 101: 1533\u20131540.", "journal-title": "Parasitol Res"}, {"key": "BFonc2010604_CR12", "doi-asserted-by": "publisher", "first-page": "18694", "DOI": "10.1074/jbc.M111357200", "volume": "277", "author": "M Haas", "year": "2002", "unstructured": "Haas M, Wang H, Tian J, Xie Z . (2002). Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem 277: 18694\u201318702.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010604_CR13", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1054/mehy.1999.0985", "volume": "53", "author": "J Haux", "year": "1999", "unstructured": "Haux J . (1999). Digitoxin is a potential anticancer agent for several types of cancer. Med Hypotheses 53: 543\u2013548.", "journal-title": "Med Hypotheses"}, {"key": "BFonc2010604_CR14", "doi-asserted-by": "publisher", "first-page": "720", "DOI": "10.1111/j.1365-2133.2005.06447.x", "volume": "152", "author": "U Impola", "year": "2005", "unstructured": "Impola U, Jeskanen L, Ravanti L, Syrj\u00e4nen S, Baldursson B, K\u00e4h\u00e4ri VM et al. (2005). Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds. Br J Dermatol 152: 720\u2013726.", "journal-title": "Br J Dermatol"}, {"key": "BFonc2010604_CR15", "doi-asserted-by": "publisher", "first-page": "5636", "DOI": "10.1038/sj.onc.1203912", "volume": "19", "author": "RB Irby", "year": "2000", "unstructured": "Irby RB, Yeatman TJ . (2000). Role of Src expression and activation in human cancer. Oncogene 19: 5636\u20135642.", "journal-title": "Oncogene"}, {"key": "BFonc2010604_CR16", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1016/j.ccr.2004.09.001", "volume": "6", "author": "R Ishizawar", "year": "2004", "unstructured": "Ishizawar R, Parsons SJ . (2004). c-Src and cooperating partners in human cancer. Cancer Cell 6: 209\u2013214.", "journal-title": "Cancer Cell"}, {"key": "BFonc2010604_CR17", "doi-asserted-by": "publisher", "first-page": "2033", "DOI": "10.1016/j.cellsig.2006.03.014", "volume": "18", "author": "J Jung", "year": "2006", "unstructured": "Jung J, Kim M, Choi S, Kim MJ, Suh JK, Choi EC et al. (2006). Molecular mechanism of cofilin dephosphorylation by ouabain. Cell Signal 18: 2033\u20132040.", "journal-title": "Cell Signal"}, {"key": "BFonc2010604_CR18", "doi-asserted-by": "publisher", "first-page": "49868", "DOI": "10.1074/jbc.M400895200", "volume": "279", "author": "J Jung", "year": "2004", "unstructured": "Jung J, Kim M, Kim MJ, Kim J, Moon J, Lim JS et al. (2004). Translationally controlled tumor protein interacts with the third cytoplasmic domain of Na,K-ATPase alpha subunit and inhibits the pump activity in HeLa cells. J Biol Chem 279: 49868\u201349875.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010604_CR19", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1016/j.abb.2009.02.002", "volume": "485", "author": "M Kim", "year": "2009", "unstructured": "Kim M, Jung J, Lee K . (2009). Roles of ERK, PI3 kinase, and PLC-gamma pathways induced by overexpression of translationally controlled tumor protein in HeLa cells. Arch Biochem Biophys 485: 82\u201387.", "journal-title": "Arch Biochem Biophys"}, {"key": "BFonc2010604_CR20", "doi-asserted-by": "publisher", "first-page": "929", "DOI": "10.1124/mol.104.007302", "volume": "67", "author": "P Kometiani", "year": "2005", "unstructured": "Kometiani P, Liu L, Askari A . (2005). Digitalis-induced signaling by Na+/K+-ATPase in human breast cancer cells. Mol Pharmacol 67: 929\u2013936.", "journal-title": "Mol Pharmacol"}, {"key": "BFonc2010604_CR21", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1038/nrc1892", "volume": "6", "author": "R Kumar", "year": "2006", "unstructured": "Kumar R, Gururaj AE, Barnes CJ . (2006). p21-activated kinases in cancer. Nat Rev Cancer 6: 459\u2013471.", "journal-title": "Nat Rev Cancer"}, {"key": "BFonc2010604_CR22", "first-page": "27838", "volume": "275", "author": "J Liu", "year": "2000", "unstructured": "Liu J, Tian J, Haas M, Shapiro JI, Askari A, Xie Z . (2000). Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem 275: 27838\u201327844.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010604_CR23", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1007/s10549-005-9011-0", "volume": "95", "author": "HW Lo", "year": "2006", "unstructured": "Lo HW, Hsu SC, Hung MC . (2006). EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 95: 211\u2013218.", "journal-title": "Breast Cancer Res Treat"}, {"key": "BFonc2010604_CR24", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1002/jcp.10119", "volume": "192", "author": "JL Martindale", "year": "2002", "unstructured": "Martindale JL, Holbrook NJ . (2002). Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1\u201315.", "journal-title": "J Cell Physiol"}, {"key": "BFonc2010604_CR25", "doi-asserted-by": "publisher", "first-page": "7464", "DOI": "10.1158/0008-5472.CAN-04-1725", "volume": "64", "author": "K Mori", "year": "2004", "unstructured": "Mori K, Shibanuma M, Nose K . (2004). Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 64: 7464\u20137472.", "journal-title": "Cancer Res"}, {"key": "BFonc2010604_CR26", "doi-asserted-by": "publisher", "first-page": "1363", "DOI": "10.1016/j.febslet.2009.03.045", "volume": "583", "author": "M Nagano-Ito", "year": "2009", "unstructured": "Nagano-Ito M, Banba A, Ichikawa S . (2009). Functional cloning of genes that suppress oxidative stress-induced cell death: TCTP prevents hydrogen peroxide-induced cell death. FEBS Lett 583: 1363\u20131367.", "journal-title": "FEBS Lett"}, {"key": "BFonc2010604_CR27", "doi-asserted-by": "publisher", "first-page": "642", "DOI": "10.1111/j.1398-9995.1998.tb03950.x", "volume": "53", "author": "HV Nielsen", "year": "1998", "unstructured": "Nielsen HV, Johnsen AH, Sanchez JC, Hochstrasser DF, Schiotz PO . (1998). Identification of a basophil leukocyte interleukin-3-regulated protein that is identical to IgE-dependent histamine-releasing factor. Allergy 53: 642\u2013652.", "journal-title": "Allergy"}, {"key": "BFonc2010604_CR28", "doi-asserted-by": "publisher", "first-page": "984", "DOI": "10.1006/bbrc.2001.6302", "volume": "290", "author": "K Oikawa", "year": "2002", "unstructured": "Oikawa K, Ohbayashi T, Mimura J, Fujii-Kuriyama Y, Teshima S, Rokutan K et al. (2002). Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor. Biochem Biophys Res Commun 290: 984\u2013987.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BFonc2010604_CR29", "doi-asserted-by": "publisher", "first-page": "4384", "DOI": "10.1128/MCB.24.10.4384-4394.2004", "volume": "24", "author": "HS Park", "year": "2004", "unstructured": "Park HS, Lee SH, Park D, Lee JS, Ryu SH, Lee WJ et al. (2004). Sequential activation of phosphatidylinositol 3-kinase, beta Pix, Rac1, and Nox1 in growth factor-induced production of H2O2. Mol Cell Biol 24: 4384\u20134394.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2010604_CR30", "doi-asserted-by": "publisher", "first-page": "3717", "DOI": "10.1091/mbc.12.12.3717", "volume": "12", "author": "SA Rajasekaran", "year": "2001", "unstructured": "Rajasekaran SA, Palmer LG, Moon SY, Peralta Soler A, Apodaca GL, Harper JF et al. (2001a). Na,K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Mol Biol Cell 12: 3717\u20133732.", "journal-title": "Mol Biol Cell"}, {"key": "BFonc2010604_CR31", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1091/mbc.12.2.279", "volume": "12", "author": "SA Rajasekaran", "year": "2001", "unstructured": "Rajasekaran SA, Palmer LG, Quan K, Harper JF, Ball Jr WJ, Bander NH et al. (2001b). Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Biol Cell 12: 279\u2013295.", "journal-title": "Mol Biol Cell"}, {"key": "BFonc2010604_CR32", "doi-asserted-by": "publisher", "first-page": "560", "DOI": "10.1016/j.tcb.2008.08.007", "volume": "18", "author": "RG Rowe", "year": "2008", "unstructured": "Rowe RG, Weiss SJ . (2008). Breaching the basement membrane: who, when and how? Trends Cell Biol 18: 560\u2013574.", "journal-title": "Trends Cell Biol"}, {"key": "BFonc2010604_CR33", "doi-asserted-by": "publisher", "first-page": "14675", "DOI": "10.1074/jbc.M411625200", "volume": "280", "author": "I Shin", "year": "2005", "unstructured": "Shin I, Kim S, Song H, Kim HR, Moon A . (2005). H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem 280: 14675\u201314683.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010604_CR34", "doi-asserted-by": "publisher", "first-page": "10487", "DOI": "10.1158/0008-5472.CAN-06-1461", "volume": "66", "author": "H Song", "year": "2006", "unstructured": "Song H, Ki SH, Kim SG, Moon A . (2006). Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res 66: 10487\u201310496.", "journal-title": "Cancer Res"}, {"key": "BFonc2010604_CR35", "doi-asserted-by": "publisher", "first-page": "1102", "DOI": "10.1038/sj.onc.1203347", "volume": "19", "author": "MD Sternlicht", "year": "2000", "unstructured": "Sternlicht MD, Bissell MJ, Werb Z . (2000). The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19: 1102\u20131113.", "journal-title": "Oncogene"}, {"key": "BFonc2010604_CR36", "first-page": "794", "volume": "51", "author": "TP Szatrowski", "year": "1991", "unstructured": "Szatrowski TP, Nathan CF . (1991). Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794\u2013798.", "journal-title": "Cancer Res"}, {"key": "BFonc2010604_CR37", "first-page": "6356", "volume": "161", "author": "S Teshima", "year": "1998", "unstructured": "Teshima S, Rokutan K, Nikawa T, Kishi K . (1998). Macrophage colony-stimulating factor stimulates synthesis and secretion of a mouse homolog of a human IgE-dependent histamine-releasing factor by macrophages in vitro and in vivo. J Immunol 161: 6356\u20136366.", "journal-title": "J Immunol"}, {"key": "BFonc2010604_CR38", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1091/mbc.e05-08-0735", "volume": "17", "author": "J Tian", "year": "2006", "unstructured": "Tian J, Cai T, Yuan Z, Wang H, Liu L, Haas M et al. (2006). Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol Biol Cell 17: 317\u2013326.", "journal-title": "Mol Biol Cell"}, {"key": "BFonc2010604_CR39", "doi-asserted-by": "publisher", "first-page": "1415", "DOI": "10.1073/pnas.96.4.1415", "volume": "96", "author": "DA Tice", "year": "1999", "unstructured": "Tice DA, Biscardi JS, Nickles AL, Parsons SJ . (1999). Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Pro Natl Acad Sci USA 96: 1415\u20131420.", "journal-title": "Pro Natl Acad Sci USA"}, {"key": "BFonc2010604_CR40", "doi-asserted-by": "publisher", "first-page": "15364", "DOI": "10.1073/pnas.0406776101", "volume": "101", "author": "M Tuynder", "year": "2004", "unstructured": "Tuynder M, Fiucci G, Prieur S, Lespagnol A, G\u00e9ant A, Beaucourt S et al. (2004). Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci USA 101: 15364\u201315369.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2010604_CR41", "doi-asserted-by": "publisher", "first-page": "14976", "DOI": "10.1073/pnas.222470799", "volume": "99", "author": "M Tuynder", "year": "2002", "unstructured": "Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R et al. (2002). Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Proc Natl Acad Sci USA 99: 14976\u201314981.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2010604_CR42", "doi-asserted-by": "publisher", "first-page": "497", "DOI": "10.1111/j.1749-6632.2003.tb07234.x", "volume": "986", "author": "Z Xie", "year": "2003", "unstructured": "Xie Z . (2003). Molecular mechanisms of Na/K-ATPase-mediated signal transduction. Ann N Y Acad Sci 986: 497\u2013503.", "journal-title": "Ann N Y Acad Sci"}, {"key": "BFonc2010604_CR43", "doi-asserted-by": "publisher", "first-page": "470", "DOI": "10.1038/nrc1366", "volume": "4", "author": "TJ Yeatman", "year": "2004", "unstructured": "Yeatman TJ . (2004). A renaissance for SRC. Nat Rev Cancer 4: 470\u2013480.", "journal-title": "Nat Rev Cancer"}, {"key": "BFonc2010604_CR44", "doi-asserted-by": "publisher", "first-page": "6556", "DOI": "10.1073/pnas.100128297", "volume": "97", "author": "GA Yudowski", "year": "2000", "unstructured": "Yudowski GA, Efendiev R, Pedemonte CH, Katz AI, Berggren PO, Bertorello AM . (2000). Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking. Proc Natl Acad Sci USA 97: 6556\u20136561.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2010604_CR45", "doi-asserted-by": "publisher", "first-page": "408", "DOI": "10.1016/S0165-6147(99)01373-5", "volume": "20", "author": "E Zwick", "year": "1999", "unstructured": "Zwick E, Hackel PO, Prenzel N, Ullrich A . (1999). The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci 20: 408\u2013412.", "journal-title": "Trends Pharmacol Sci"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc2010604.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2010604", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2010604.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T14:09:08Z", "timestamp": 1555596548000}, "score": 20.4752, "issued": {"date-parts": [[2011, 1, 31]]}, "references-count": 45, "journal-issue": {"published-print": {"date-parts": [[2011, 5]]}, "issue": "19"}, "alternative-id": ["BFonc2010604"], "URL": "http://dx.doi.org/10.1038/onc.2010.604", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T19:37:59Z", "timestamp": 1574710679985}, "reference-count": 49, "publisher": "Springer Science and Business Media LLC", "issue": "14", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2015, 7, 13]], "date-time": "2015-07-13T00:00:00Z", "timestamp": 1436745600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2016, 4]]}, "DOI": "10.1038/onc.2015.251", "type": "journal-article", "created": {"date-parts": [[2015, 7, 13]], "date-time": "2015-07-13T10:03:32Z", "timestamp": 1436781812000}, "page": "1857-1867", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Hepatitis B virus X protein enhances Myc stability by inhibiting SCFSkp2 ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis"], "prefix": "10.1038", "volume": "35", "author": [{"given": "S", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "W", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Ko", "sequence": "additional", "affiliation": []}, {"given": "W-S", "family": "Ryu", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 7, 13]]}, "reference": [{"key": "BFonc2015251_CR1", "doi-asserted-by": "publisher", "first-page": "e1261", "DOI": "10.1053/j.gastro.2012.03.007", "volume": "142", "author": "HB El-Serag", "year": "2012", "unstructured": "El-Serag HB . Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: e1261.", "journal-title": "Gastroenterology"}, {"key": "BFonc2015251_CR2", "doi-asserted-by": "publisher", "first-page": "594", "DOI": "10.1016/j.jhep.2009.10.033", "volume": "52", "author": "C Neuveut", "year": "2010", "unstructured": "Neuveut C, Wei Y, Buendia MA . Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 2010; 52: 594\u2013604.", "journal-title": "J Hepatol"}, {"key": "BFonc2015251_CR3", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1016/S0065-230X(09)03004-8", "volume": "103", "author": "S Benhenda", "year": "2009", "unstructured": "Benhenda S, Cougot D, Buendia MA, Neuveut C . Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 2009; 103: 75\u2013109.", "journal-title": "Adv Cancer Res"}, {"key": "BFonc2015251_CR4", "doi-asserted-by": "publisher", "first-page": "974", "DOI": "10.1007/s00535-011-0415-9", "volume": "46", "author": "SA Ng", "year": "2011", "unstructured": "Ng SA, Lee C . Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol 2011; 46: 974\u2013990.", "journal-title": "J Gastroenterol"}, {"key": "BFonc2015251_CR5", "doi-asserted-by": "publisher", "first-page": "651", "DOI": "10.1007/s005350170027", "volume": "36", "author": "S Murakami", "year": "2001", "unstructured": "Murakami S . Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001; 36: 651\u2013660.", "journal-title": "J Gastroenterol"}, {"key": "BFonc2015251_CR6", "doi-asserted-by": "publisher", "first-page": "12725", "DOI": "10.1128/JVI.78.23.12725-12734.2004", "volume": "78", "author": "MJ Bouchard", "year": "2004", "unstructured": "Bouchard MJ, Schneider RJ . The enigmatic X gene of hepatitis B virus. J Virol 2004; 78: 12725\u201312734.", "journal-title": "J Virol"}, {"key": "BFonc2015251_CR7", "doi-asserted-by": "publisher", "first-page": "1416", "DOI": "10.1002/hep.27360", "volume": "61", "author": "BL Slagle", "year": "2015", "unstructured": "Slagle BL, Andrisani OM, Bouchard MJ, Lee CG, Ou JH, Siddiqui A . Technical standards for hepatitis B virus X protein (HBx) research. Hepatology 2015; 61: 1416\u20131424.", "journal-title": "Hepatology"}, {"key": "BFonc2015251_CR8", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1038/351317a0", "volume": "351", "author": "CM Kim", "year": "1991", "unstructured": "Kim CM, Koike K, Saito I, Miyamura T, Jay G . HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317\u2013320.", "journal-title": "Nature"}, {"key": "BFonc2015251_CR9", "first-page": "5939", "volume": "64", "author": "TH Lee", "year": "1990", "unstructured": "Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SL, Butel JS . Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 1990; 64: 5939\u20135947.", "journal-title": "J Virol"}, {"key": "BFonc2015251_CR10", "doi-asserted-by": "publisher", "first-page": "119", "DOI": "10.1016/S0168-8278(97)80018-9", "volume": "26", "author": "K Reifenberg", "year": "1997", "unstructured": "Reifenberg K, Lohler J, Pudollek HP, Schmitteckert E, Spindler G, Kock J et al. Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice. J Hepatol 1997; 26: 119\u2013130.", "journal-title": "J Hepatol"}, {"key": "BFonc2015251_CR11", "doi-asserted-by": "publisher", "first-page": "3851", "DOI": "10.1128/JVI.75.8.3851-3858.2001", "volume": "75", "author": "CR Madden", "year": "2001", "unstructured": "Madden CR, Finegold MJ, Slagle BL . Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol 2001; 75: 3851\u20133858.", "journal-title": "J Virol"}, {"key": "BFonc2015251_CR12", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1002/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J", "volume": "15", "author": "BL Slagle", "year": "1996", "unstructured": "Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS . Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 1996; 15: 261\u2013269.", "journal-title": "Mol Carcinog"}, {"key": "BFonc2015251_CR13", "doi-asserted-by": "publisher", "first-page": "395", "DOI": "10.1038/sj.onc.1200850", "volume": "14", "author": "O Terradillos", "year": "1997", "unstructured": "Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P et al. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997; 14: 395\u2013404.", "journal-title": "Oncogene"}, {"key": "BFonc2015251_CR14", "doi-asserted-by": "publisher", "first-page": "80", "DOI": "10.1046/j.1440-1746.2003.02902.x", "volume": "18", "author": "R Lakhtakia", "year": "2003", "unstructured": "Lakhtakia R, Kumar V, Reddi H, Mathur M, Dattagupta S, Panda SK . Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: a sequential pathological evaluation. J Gastroenterol Hepatol 2003; 18: 80\u201391.", "journal-title": "J Gastroenterol Hepatol"}, {"key": "BFonc2015251_CR15", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1038/sj.onc.1203840", "volume": "20", "author": "YC Kim", "year": "2001", "unstructured": "Kim YC, Song KS, Yoon G, Nam MJ, Ryu WS . Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. Oncogene 2001; 20: 16\u201323.", "journal-title": "Oncogene"}, {"key": "BFonc2015251_CR16", "doi-asserted-by": "publisher", "first-page": "1540", "DOI": "10.1111/j.1349-7006.2007.00579.x", "volume": "98", "author": "N Oishi", "year": "2007", "unstructured": "Oishi N, Shilagardi K, Nakamoto Y, Honda M, Kaneko S, Murakami S . Hepatitis B virus X protein overcomes oncogenic RAS-induced senescence in human immortalized cells. Cancer Sci 2007; 98: 1540\u20131548.", "journal-title": "Cancer Sci"}, {"key": "BFonc2015251_CR17", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1038/nrm1547", "volume": "6", "author": "MD Petroski", "year": "2005", "unstructured": "Petroski MD, Deshaies RJ . Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6: 9\u201320.", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "BFonc2015251_CR18", "doi-asserted-by": "publisher", "first-page": "5961", "DOI": "10.1128/MCB.18.10.5961", "volume": "18", "author": "EM Flinn", "year": "1998", "unstructured": "Flinn EM, Busch CM, Wright AP . myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol Cell Biol 1998; 18: 5961\u20135969.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2015251_CR19", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1093/emboj/18.3.717", "volume": "18", "author": "SE Salghetti", "year": "1999", "unstructured": "Salghetti SE, Kim SY, Tansey WP . Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 1999; 18: 717\u2013726.", "journal-title": "EMBO J"}, {"key": "BFonc2015251_CR20", "doi-asserted-by": "publisher", "first-page": "1177", "DOI": "10.1016/S1097-2765(03)00173-4", "volume": "11", "author": "SY Kim", "year": "2003", "unstructured": "Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP . Skp2 regulates Myc protein stability and activity. Mol Cell 2003; 11: 1177\u20131188.", "journal-title": "Mol Cell"}, {"key": "BFonc2015251_CR21", "doi-asserted-by": "publisher", "first-page": "1189", "DOI": "10.1016/S1097-2765(03)00193-X", "volume": "11", "author": "N von der Lehr", "year": "2003", "unstructured": "von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 2003; 11: 1189\u20131200.", "journal-title": "Mol Cell"}, {"key": "BFonc2015251_CR22", "doi-asserted-by": "publisher", "first-page": "9085", "DOI": "10.1073/pnas.0402770101", "volume": "101", "author": "M Welcker", "year": "2004", "unstructured": "Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 2004; 101: 9085\u20139090.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2015251_CR23", "doi-asserted-by": "publisher", "first-page": "1236", "DOI": "10.1101/gad.1920310", "volume": "24", "author": "SH Choi", "year": "2010", "unstructured": "Choi SH, Wright JB, Gerber SA, Cole MD . Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev 2010; 24: 1236\u20131241.", "journal-title": "Genes Dev"}, {"key": "BFonc2015251_CR24", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1038/nsmb.1719", "volume": "17", "author": "T Li", "year": "2010", "unstructured": "Li T, Robert EI, van Breugel PC, Strubin M, Zheng N . A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat Struct Mol Biol 2010; 17: 105\u2013111.", "journal-title": "Nat Struct Mol Biol"}, {"key": "BFonc2015251_CR25", "doi-asserted-by": "publisher", "first-page": "431", "DOI": "10.1016/j.febslet.2005.12.034", "volume": "580", "author": "N Kalra", "year": "2006", "unstructured": "Kalra N, Kumar V . The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc. FEBS Lett 2006; 580: 431\u2013436.", "journal-title": "FEBS Lett"}, {"key": "BFonc2015251_CR26", "first-page": "7231", "volume": "73", "author": "Z Hu", "year": "1999", "unstructured": "Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, Liang TJ . Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol 1999; 73: 7231\u20137240.", "journal-title": "J Virol"}, {"key": "BFonc2015251_CR27", "doi-asserted-by": "publisher", "first-page": "978", "DOI": "10.1099/vir.0.009928-0", "volume": "90", "author": "MY Cha", "year": "2009", "unstructured": "Cha MY, Ryu DK, Jung HS, Chang HE, Ryu WS . Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression. J Gen Virol 2009; 90: 978\u2013986.", "journal-title": "J Gen Virol"}, {"key": "BFonc2015251_CR28", "doi-asserted-by": "publisher", "first-page": "1714", "DOI": "10.1128/JVI.01863-06", "volume": "81", "author": "S Kim", "year": "2007", "unstructured": "Kim S, Kim HY, Lee S, Kim SW, Sohn S, Kim K et al. Hepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and dynein-dependent manners. J Virol 2007; 81: 1714\u20131726.", "journal-title": "J Virol"}, {"key": "BFonc2015251_CR29", "first-page": "7803", "volume": "61", "author": "H Tu", "year": "2001", "unstructured": "Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M et al. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 2001; 61: 7803\u20137810.", "journal-title": "Cancer Res"}, {"key": "BFonc2015251_CR30", "doi-asserted-by": "publisher", "first-page": "5061", "DOI": "10.1158/1078-0432.CCR-07-5082", "volume": "14", "author": "NF Ma", "year": "2008", "unstructured": "Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J et al. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res 2008; 14: 5061\u20135068.", "journal-title": "Clin Cancer Res"}, {"key": "BFonc2015251_CR31", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1002/hep.25979", "volume": "57", "author": "KM Sze", "year": "2013", "unstructured": "Sze KM, Chu GK, Lee JM, Ng IO . C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 2013; 57: 131\u2013139.", "journal-title": "Hepatology"}, {"key": "BFonc2015251_CR32", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/B978-0-12-386469-7.00004-9", "volume": "110", "author": "LR Thomas", "year": "2011", "unstructured": "Thomas LR, Tansey WP . Proteolytic control of the oncoprotein transcription factor Myc. Adv Cancer Res 2011; 110: 77\u2013106.", "journal-title": "Adv Cancer Res"}, {"key": "BFonc2015251_CR33", "doi-asserted-by": "crossref", "first-page": "674", "DOI": "10.1038/nrc1934", "volume": "6", "author": "PA Farazi", "year": "2006", "unstructured": "Farazi PA, DePinho RA . Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674\u2013687.", "journal-title": "Nat Rev Cancer"}, {"key": "BFonc2015251_CR34", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1038/ng0802-339", "volume": "31", "author": "SS Thorgeirsson", "year": "2002", "unstructured": "Thorgeirsson SS, Grisham JW . Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339\u2013346.", "journal-title": "Nat Genet"}, {"key": "BFonc2015251_CR35", "doi-asserted-by": "publisher", "first-page": "2775", "DOI": "10.1158/0008-5472.CAN-08-3357", "volume": "69", "author": "P Kaposi-Novak", "year": "2009", "unstructured": "Kaposi-Novak P, Libbrecht L, Woo HG, Lee YH, Sears NC, Coulouarn C et al. Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. Cancer Res 2009; 69: 2775\u20132782.", "journal-title": "Cancer Res"}, {"key": "BFonc2015251_CR36", "doi-asserted-by": "publisher", "first-page": "18471", "DOI": "10.1073/pnas.1204668109", "volume": "109", "author": "X Geng", "year": "2012", "unstructured": "Geng X, Huang C, Qin Y, McCombs JE, Yuan Q, Harry BL et al. Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction. Proc Natl Acad Sci USA 2012; 109: 18471\u201318476.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2015251_CR37", "doi-asserted-by": "publisher", "first-page": "741", "DOI": "10.1016/j.bbrc.2014.06.042", "volume": "450", "author": "H Kusunoki", "year": "2014", "unstructured": "Kusunoki H, Tanaka T, Kohno T, Wakamatsu K, Hamaguchi I . Structural characterization of the BH3-like motif of hepatitis B virus X protein. Biochem Biophys Res Commun 2014; 450: 741\u2013745.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BFonc2015251_CR38", "first-page": "pe21", "volume": "2006", "author": "M Barry", "year": "2006", "unstructured": "Barry M, Fruh K . Viral modulators of cullin RING ubiquitin ligases: culling the host defense. Sci STKE 2006; 2006: pe21.", "journal-title": "Sci STKE"}, {"key": "BFonc2015251_CR39", "doi-asserted-by": "publisher", "first-page": "4082", "DOI": "10.1128/JVI.02500-07", "volume": "82", "author": "BG Bajaj", "year": "2008", "unstructured": "Bajaj BG, Murakami M, Cai Q, Verma SC, Lan K, Robertson ES . Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein. J Virol 2008; 82: 4082\u20134090.", "journal-title": "J Virol"}, {"key": "BFonc2015251_CR40", "doi-asserted-by": "publisher", "first-page": "16199", "DOI": "10.1074/jbc.M111.335216", "volume": "287", "author": "P Baresova", "year": "2012", "unstructured": "Baresova P, Pitha PM, Lubyova B . Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability. J Biol Chem 2012; 287: 16199\u201316208.", "journal-title": "J Biol Chem"}, {"key": "BFonc2015251_CR41", "doi-asserted-by": "publisher", "first-page": "1112", "DOI": "10.1038/nature03043", "volume": "431", "author": "CM Shachaf", "year": "2004", "unstructured": "Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004; 431: 1112\u20131117.", "journal-title": "Nature"}, {"key": "BFonc2015251_CR42", "doi-asserted-by": "publisher", "first-page": "13689", "DOI": "10.1128/JVI.02035-14", "volume": "88", "author": "C Ko", "year": "2014", "unstructured": "Ko C, Lee S, Windisch MP, Ryu WS . DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level. J Virol 2014; 88: 13689\u201313698.", "journal-title": "J Virol"}, {"key": "BFonc2015251_CR43", "doi-asserted-by": "publisher", "first-page": "5815", "DOI": "10.1128/JVI.00011-09", "volume": "83", "author": "H Wang", "year": "2009", "unstructured": "Wang H, Kim S, Ryu WS . DDX3 DEAD-box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids. J Virol 2009; 83: 5815\u20135824.", "journal-title": "J Virol"}, {"key": "BFonc2015251_CR44", "doi-asserted-by": "publisher", "first-page": "312", "DOI": "10.1039/b603229j", "volume": "2", "author": "Y Utku", "year": "2006", "unstructured": "Utku Y, Dehan E, Ouerfelli O, Piano F, Zuckermann RN, Pagano M et al. A peptidomimetic siRNA transfection reagent for highly effective gene silencing. Mol Biosyst 2006; 2: 312\u2013317.", "journal-title": "Mol Biosyst"}, {"key": "BFonc2015251_CR45", "doi-asserted-by": "publisher", "first-page": "52", "DOI": "10.1128/JVI.01232-09", "volume": "84", "author": "S Kim", "year": "2010", "unstructured": "Kim S, Wang H, Ryu WS . Incorporation of eukaryotic translation initiation factor eIF4E into viral nucleocapsids via interaction with hepatitis B virus polymerase. J Virol 2010; 84: 52\u201358.", "journal-title": "J Virol"}, {"key": "BFonc2015251_CR46", "doi-asserted-by": "publisher", "first-page": "e1000986", "DOI": "10.1371/journal.ppat.1000986", "volume": "6", "author": "H Wang", "year": "2010", "unstructured": "Wang H, Ryu WS . Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 2010; 6: e1000986.", "journal-title": "PLoS Pathog"}, {"key": "BFonc2015251_CR47", "doi-asserted-by": "publisher", "first-page": "2423", "DOI": "10.1128/MCB.20.7.2423-2435.2000", "volume": "20", "author": "MA Gregory", "year": "2000", "unstructured": "Gregory MA, Hann SR . c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 2000; 20: 2423\u20132435.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2015251_CR48", "doi-asserted-by": "publisher", "first-page": "765", "DOI": "10.1038/ncb1601", "volume": "9", "author": "N Popov", "year": "2007", "unstructured": "Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R et al. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol 2007; 9: 765\u2013774.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2015251_CR49", "doi-asserted-by": "publisher", "first-page": "1072", "DOI": "10.1038/ncomms2074", "volume": "3", "author": "HS Cho", "year": "2012", "unstructured": "Cho HS, Shimazu T, Toyokawa G, Daigo Y, Maehara Y, Hayami S et al. Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of aurora kinase B. Nat Commun 2012; 3: 1072.", "journal-title": "Nat Commun"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc2015251.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2015251", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2015251.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T21:02:47Z", "timestamp": 1555621367000}, "score": 20.194027, "issued": {"date-parts": [[2015, 7, 13]]}, "references-count": 49, "journal-issue": {"published-print": {"date-parts": [[2016, 4]]}, "issue": "14"}, "alternative-id": ["BFonc2015251"], "URL": "http://dx.doi.org/10.1038/onc.2015.251", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}], "assertion": [{"value": "30 June 2014", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "5 May 2015", "order": 2, "name": "revised", "label": "Revised", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "22 May 2015", "order": 3, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "13 July 2015", "order": 4, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no conflict of interest.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:15:21Z", "timestamp": 1574489721844}, "reference-count": 51, "publisher": "Springer Science and Business Media LLC", "issue": "20", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2011, 1, 17]], "date-time": "2011-01-17T00:00:00Z", "timestamp": 1295222400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2011, 5]]}, "DOI": "10.1038/onc.2010.610", "type": "journal-article", "created": {"date-parts": [[2011, 1, 18]], "date-time": "2011-01-18T06:27:45Z", "timestamp": 1295332065000}, "page": "2379-2389", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling"], "prefix": "10.1038", "volume": "30", "author": [{"given": "B", "family": "Cha", "sequence": "first", "affiliation": []}, {"given": "W", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Y K", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "B N", "family": "Hwang", "sequence": "additional", "affiliation": []}, {"given": "S Y", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "J W", "family": "Yoon", "sequence": "additional", "affiliation": []}, {"given": "W S", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "J W", "family": "Cho", "sequence": "additional", "affiliation": []}, {"given": "M T", "family": "Bedford", "sequence": "additional", "affiliation": []}, {"given": "E-h", "family": "Jho", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 1, 17]]}, "reference": [{"key": "BFonc2010610_CR1", "doi-asserted-by": "publisher", "first-page": "4243", "DOI": "10.1242/jcs.019885", "volume": "120", "author": "MT Bedford", "year": "2007", "unstructured": "Bedford MT . (2007). Arginine methylation at a glance. J Cell Sci 120: 4243\u20134246.", "journal-title": "J Cell Sci"}, {"key": "BFonc2010610_CR2", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.molcel.2008.12.013", "volume": "33", "author": "MT Bedford", "year": "2009", "unstructured": "Bedford MT, Clarke SG . (2009). Protein arginine methylation in mammals: who, what, and why. Mol Cell 33: 1\u201313.", "journal-title": "Mol Cell"}, {"key": "BFonc2010610_CR3", "doi-asserted-by": "publisher", "first-page": "16030", "DOI": "10.1074/jbc.M909368199", "volume": "275", "author": "MT Bedford", "year": "2000", "unstructured": "Bedford MT, Frankel A, Yaffe MB, Clarke S, Leder P, Richard S . (2000). Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J Biol Chem 275: 16030\u201316036.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010610_CR4", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/j.molcel.2005.04.003", "volume": "18", "author": "MT Bedford", "year": "2005", "unstructured": "Bedford MT, Richard S . (2005). Arginine methylation an emerging regulator of protein function. Mol Cell 18: 263\u2013272.", "journal-title": "Mol Cell"}, {"key": "BFonc2010610_CR5", "doi-asserted-by": "publisher", "first-page": "311", "DOI": "10.1016/S0092-8674(00)00122-7", "volume": "103", "author": "M Bienz", "year": "2000", "unstructured": "Bienz M, Clevers H . (2000). Linking colorectal cancer to Wnt signaling. Cell 103: 311\u2013320.", "journal-title": "Cell"}, {"key": "BFonc2010610_CR6", "first-page": "re2", "volume": "2005", "author": "FM Boisvert", "year": "2005", "unstructured": "Boisvert FM, Chenard CA, Richard S . (2005). Protein interfaces in signaling regulated by arginine methylation. Sci STKE 2005: re2.", "journal-title": "Sci STKE"}, {"key": "BFonc2010610_CR7", "doi-asserted-by": "publisher", "first-page": "3286", "DOI": "10.1101/gad.11.24.3286", "volume": "11", "author": "KM Cadigan", "year": "1997", "unstructured": "Cadigan KM, Nusse R . (1997). Wnt signaling: a common theme in animal development. Genes Dev 11: 3286\u20133305.", "journal-title": "Genes Dev"}, {"key": "BFonc2010610_CR8", "doi-asserted-by": "publisher", "first-page": "5103", "DOI": "10.1242/dev.01318", "volume": "131", "author": "F Cong", "year": "2004", "unstructured": "Cong F, Schweizer L, Varmus H . (2004). Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development 131: 5103\u20135115.", "journal-title": "Development"}, {"key": "BFonc2010610_CR9", "doi-asserted-by": "publisher", "first-page": "494", "DOI": "10.1093/emboj/cdg068", "volume": "22", "author": "R Dajani", "year": "2003", "unstructured": "Dajani R, Fraser E, Roe SM, Yeo M, Good VM, Thompson V et al. (2003). Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. EMBO J 22: 494\u2013501.", "journal-title": "EMBO J"}, {"key": "BFonc2010610_CR10", "doi-asserted-by": "publisher", "first-page": "867", "DOI": "10.1038/nature04170", "volume": "438", "author": "G Davidson", "year": "2005", "unstructured": "Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P et al. (2005). Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438: 867\u2013872.", "journal-title": "Nature"}, {"key": "BFonc2010610_CR11", "doi-asserted-by": "publisher", "first-page": "741", "DOI": "10.1083/jcb.145.4.741", "volume": "145", "author": "F Fagotto", "year": "1999", "unstructured": "Fagotto F, Jho E, Zeng L, Kurth T, Joos T, Kaufmann C et al. (1999). Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol 145: 741\u2013756.", "journal-title": "J Cell Biol"}, {"key": "BFonc2010610_CR12", "doi-asserted-by": "publisher", "first-page": "33009", "DOI": "10.1074/jbc.M704349200", "volume": "282", "author": "I Goulet", "year": "2007", "unstructured": "Goulet I, Gauvin G, Boisvenue S, Cote J . (2007). Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate specificity, and subcellular localization. J Biol Chem 282: 33009\u201333021.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010610_CR13", "doi-asserted-by": "publisher", "first-page": "e2658", "DOI": "10.1371/journal.pone.0002658", "volume": "3", "author": "P Gupta", "year": "2008", "unstructured": "Gupta P, Ho PC, Huq MD, Khan AA, Tsai NP, Wei LN . (2008). PKCepsilon stimulated arginine methylation of RIP140 for its nuclear-cytoplasmic export in adipocyte differentiation. PLoS One 3: e2658.", "journal-title": "PLoS One"}, {"key": "BFonc2010610_CR14", "doi-asserted-by": "publisher", "first-page": "614", "DOI": "10.1038/nature08356", "volume": "461", "author": "SM Huang", "year": "2009", "unstructured": "Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA et al. (2009). Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614\u2013620.", "journal-title": "Nature"}, {"key": "BFonc2010610_CR15", "doi-asserted-by": "publisher", "first-page": "ra37", "DOI": "10.1126/scisignal.2000647", "volume": "3", "author": "KK Jernigan", "year": "2010", "unstructured": "Jernigan KK, Cselenyi CS, Thorne CA, Hanson AJ, Tahinci E, Hajicek N et al. (2010). Gbetagamma activates GSK3 to promote LRP6-mediated beta-catenin transcriptional activity. Sci Signal 3: ra37.", "journal-title": "Sci Signal"}, {"key": "BFonc2010610_CR16", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1006/bbrc.1999.1760", "volume": "266", "author": "E Jho", "year": "1999", "unstructured": "Jho E, Lomvardas S, Costantini F . (1999). A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression. Biochem Biophys Res Commun 266: 28\u201335.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BFonc2010610_CR17", "doi-asserted-by": "publisher", "first-page": "695", "DOI": "10.3858/emm.2009.41.10.076", "volume": "41", "author": "H Jung", "year": "2009", "unstructured": "Jung H, Kim HJ, Lee SK, Kim R, Kopachik W, Han JK et al. (2009). Negative feedback regulation of Wnt signaling by Gbetagamma-mediated reduction of Dishevelled. Exp Mol Med 41: 695\u2013706.", "journal-title": "Exp Mol Med"}, {"key": "BFonc2010610_CR18", "doi-asserted-by": "publisher", "first-page": "3785", "DOI": "10.1096/fj.08-113910", "volume": "22", "author": "MJ Kim", "year": "2008", "unstructured": "Kim MJ, Chia IV, Costantini F . (2008). SUMOylation target sites at the C terminus protect Axin from ubiquitination and confer protein stability. FASEB J 22: 3785\u20133794.", "journal-title": "FASEB J"}, {"key": "BFonc2010610_CR19", "doi-asserted-by": "publisher", "first-page": "36420", "DOI": "10.1074/jbc.M110.137471", "volume": "285", "author": "S Kim", "year": "2010", "unstructured": "Kim S, Jho EH . (2010). The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2). J Biol Chem 285: 36420\u201336426.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010610_CR20", "doi-asserted-by": "publisher", "first-page": "7482", "DOI": "10.1038/sj.onc.1210055", "volume": "25", "author": "D Kimelman", "year": "2006", "unstructured": "Kimelman D, Xu W . (2006). beta-Catenin destruction complex: insights and questions from a structural perspective. Oncogene 25: 7482\u20137491.", "journal-title": "Oncogene"}, {"key": "BFonc2010610_CR21", "doi-asserted-by": "publisher", "first-page": "849", "DOI": "10.1038/sj.onc.1202653", "volume": "18", "author": "E Latres", "year": "1999", "unstructured": "Latres E, Chiaur DS, Pagano M . (1999). The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene 18: 849\u2013854.", "journal-title": "Oncogene"}, {"key": "BFonc2010610_CR22", "doi-asserted-by": "publisher", "first-page": "E10", "DOI": "10.1371/journal.pbio.0000010", "volume": "1", "author": "E Lee", "year": "2003", "unstructured": "Lee E, Salic A, Kruger R, Heinrich R, Kirschner MW . (2003). The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol 1: E10.", "journal-title": "PLoS Biol"}, {"key": "BFonc2010610_CR23", "doi-asserted-by": "publisher", "first-page": "837", "DOI": "10.1016/S0092-8674(02)00685-2", "volume": "108", "author": "C Liu", "year": "2002", "unstructured": "Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y et al. (2002). Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837\u2013847.", "journal-title": "Cell"}, {"key": "BFonc2010610_CR24", "doi-asserted-by": "publisher", "first-page": "781", "DOI": "10.1146/annurev.cellbio.20.010403.113126", "volume": "20", "author": "CY Logan", "year": "2004", "unstructured": "Logan CY, Nusse R . (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781\u2013810.", "journal-title": "Annu Rev Cell Dev Biol"}, {"key": "BFonc2010610_CR25", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1159/000076563", "volume": "13", "author": "W Luo", "year": "2004", "unstructured": "Luo W, Lin SC . (2004). Axin: a master scaffold for multiple signaling pathways. Neurosignals 13: 99\u2013113.", "journal-title": "Neurosignals"}, {"key": "BFonc2010610_CR26", "doi-asserted-by": "publisher", "first-page": "1511", "DOI": "10.1038/sj.emboj.7601607", "volume": "26", "author": "W Luo", "year": "2007", "unstructured": "Luo W, Peterson A, Garcia BA, Coombs G, Kofahl B, Heinrich R et al. (2007). Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. EMBO J 26: 1511\u20131521.", "journal-title": "EMBO J"}, {"key": "BFonc2010610_CR27", "doi-asserted-by": "publisher", "first-page": "773", "DOI": "10.1016/j.devcel.2008.10.004", "volume": "15", "author": "J Lyu", "year": "2008", "unstructured": "Lyu J, Yamamoto V, Lu W . (2008). Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neurogenesis. Dev Cell 15: 773\u2013780.", "journal-title": "Dev Cell"}, {"key": "BFonc2010610_CR28", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/j.devcel.2009.06.016", "volume": "17", "author": "BT MacDonald", "year": "2009", "unstructured": "MacDonald BT, Tamai K, He X . (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9\u201326.", "journal-title": "Dev Cell"}, {"key": "BFonc2010610_CR29", "doi-asserted-by": "publisher", "first-page": "3128", "DOI": "10.1074/jbc.275.5.3128", "volume": "275", "author": "AE McBride", "year": "2000", "unstructured": "McBride AE, Weiss VH, Kim HK, Hogle JM, Silver PA . (2000). Analysis of the yeast arginine methyltransferase Hmt1p/Rmt1p and its in vivo function. Cofactor binding and substrate interactions. J Biol Chem 275: 3128\u20133136.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010610_CR30", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.1016/S0092-8674(01)00423-8", "volume": "106", "author": "AE McBride", "year": "2001", "unstructured": "McBride AE, Silver PA . (2001). State of the arg: protein methylation at arginine comes of age. Cell 106: 5\u20138.", "journal-title": "Cell"}, {"key": "BFonc2010610_CR31", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1016/S0168-9525(97)01093-7", "volume": "13", "author": "RT Moon", "year": "1997", "unstructured": "Moon RT, Brown JD, Torres M . (1997). WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 13: 157\u2013162.", "journal-title": "Trends Genet"}, {"key": "BFonc2010610_CR32", "doi-asserted-by": "publisher", "first-page": "731", "DOI": "10.1016/S0092-8674(01)00269-0", "volume": "104", "author": "KA Mowen", "year": "2001", "unstructured": "Mowen KA, Tang J, Zhu W, Schurter BT, Shuai K, Herschman HR et al. (2001). Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104: 731\u2013741.", "journal-title": "Cell"}, {"key": "BFonc2010610_CR33", "doi-asserted-by": "publisher", "first-page": "466", "DOI": "10.1016/j.phrs.2009.07.006", "volume": "60", "author": "TB Nicholson", "year": "2009", "unstructured": "Nicholson TB, Chen T, Richard S . (2009). The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharmacol Res 60: 466\u2013474.", "journal-title": "Pharmacol Res"}, {"key": "BFonc2010610_CR34", "doi-asserted-by": "publisher", "first-page": "4859", "DOI": "10.1128/MCB.20.13.4859-4869.2000", "volume": "20", "author": "MR Pawlak", "year": "2000", "unstructured": "Pawlak MR, Scherer CA, Chen J, Roshon MJ, Ruley HE . (2000). Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol Cell Biol 20: 4859\u20134869.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2010610_CR35", "first-page": "1837", "volume": "14", "author": "P Polakis", "year": "2000", "unstructured": "Polakis P . (2000). Wnt signaling and cancer. Genes Dev 14: 1837\u20131851.", "journal-title": "Genes Dev"}, {"key": "BFonc2010610_CR36", "doi-asserted-by": "publisher", "first-page": "42981", "DOI": "10.1074/jbc.M208099200", "volume": "277", "author": "HL Rui", "year": "2002", "unstructured": "Rui HL, Fan E, Zhou HM, Xu Z, Zhang Y, Lin SC . (2002). SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. J Biol Chem 277: 42981\u201342986.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010610_CR37", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1136/jcp.2003.009506", "volume": "58", "author": "S Salahshor", "year": "2005", "unstructured": "Salahshor S, Woodgett JR . (2005). The links between axin and carcinogenesis. J Clin Pathol 58: 225\u2013236.", "journal-title": "J Clin Pathol"}, {"key": "BFonc2010610_CR38", "doi-asserted-by": "publisher", "first-page": "523", "DOI": "10.1016/S1097-2765(00)80446-3", "volume": "5", "author": "A Salic", "year": "2000", "unstructured": "Salic A, Lee E, Mayer L, Kirschner MW . (2000). Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell 5: 523\u2013532.", "journal-title": "Mol Cell"}, {"key": "BFonc2010610_CR39", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1038/73448", "volume": "24", "author": "S Satoh", "year": "2000", "unstructured": "Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T et al. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245\u2013250.", "journal-title": "Nat Genet"}, {"key": "BFonc2010610_CR40", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1002/gcc.1226", "volume": "33", "author": "Y Shimizu", "year": "2002", "unstructured": "Shimizu Y, Ikeda S, Fujimori M, Kodama S, Nakahara M, Okajima M et al. (2002). Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 33: 73\u201381.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BFonc2010610_CR41", "doi-asserted-by": "publisher", "first-page": "7723", "DOI": "10.1074/jbc.275.11.7723", "volume": "275", "author": "J Tang", "year": "2000", "unstructured": "Tang J, Frankel A, Cook RJ, Kim S, Paik WK, Williams KR et al. (2000). PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem 275: 7723\u20137730.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010610_CR42", "doi-asserted-by": "publisher", "first-page": "1466", "DOI": "10.1101/gad.1295005", "volume": "19", "author": "C Teyssier", "year": "2005", "unstructured": "Teyssier C, Ma H, Emter R, Kralli A, Stallcup MR . (2005). Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation. Genes Dev 19: 1466\u20131473.", "journal-title": "Genes Dev"}, {"key": "BFonc2010610_CR43", "doi-asserted-by": "publisher", "first-page": "177", "DOI": "10.1016/j.tig.2004.02.003", "volume": "20", "author": "NS Tolwinski", "year": "2004", "unstructured": "Tolwinski NS, Wieschaus E . (2004). Rethinking WNT signaling. Trends Genet 20: 177\u2013181.", "journal-title": "Trends Genet"}, {"key": "BFonc2010610_CR44", "doi-asserted-by": "publisher", "first-page": "1394", "DOI": "10.1101/gad.1424006", "volume": "20", "author": "K Willert", "year": "2006", "unstructured": "Willert K, Jones KA . (2006). Wnt signaling: is the party in the nucleus? Genes Dev 20: 1394\u20131404.", "journal-title": "Genes Dev"}, {"key": "BFonc2010610_CR45", "doi-asserted-by": "publisher", "first-page": "1768", "DOI": "10.1101/gad.13.14.1768", "volume": "13", "author": "K Willert", "year": "1999", "unstructured": "Willert K, Shibamoto S, Nusse R . (1999). Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex. Genes Dev 13: 1768\u20131773.", "journal-title": "Genes Dev"}, {"key": "BFonc2010610_CR46", "doi-asserted-by": "publisher", "first-page": "270", "DOI": "10.1101/gad.13.3.270", "volume": "13", "author": "JT Winston", "year": "1999", "unstructured": "Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW . (1999). The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 13: 270\u2013283.", "journal-title": "Genes Dev"}, {"key": "BFonc2010610_CR47", "doi-asserted-by": "publisher", "first-page": "10681", "DOI": "10.1074/jbc.274.16.10681", "volume": "274", "author": "H Yamamoto", "year": "1999", "unstructured": "Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A . (1999). Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J Biol Chem 274: 10681\u201310684.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010610_CR48", "doi-asserted-by": "publisher", "first-page": "2982", "DOI": "10.1128/MCB.00042-09", "volume": "29", "author": "Z Yu", "year": "2009", "unstructured": "Yu Z, Chen T, Hebert J, Li E, Richard S . (2009). A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol Cell Biol 29: 2982\u20132996.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2010610_CR49", "doi-asserted-by": "publisher", "first-page": "367", "DOI": "10.1242/dev.013540", "volume": "135", "author": "X Zeng", "year": "2008", "unstructured": "Zeng X, Huang H, Tamai K, Zhang X, Harada Y, Yokota C et al. (2008). Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development 135: 367\u2013375.", "journal-title": "Development"}, {"key": "BFonc2010610_CR50", "doi-asserted-by": "publisher", "first-page": "873", "DOI": "10.1038/nature04185", "volume": "438", "author": "X Zeng", "year": "2005", "unstructured": "Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R et al. (2005). A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438: 873\u2013877.", "journal-title": "Nature"}, {"key": "BFonc2010610_CR51", "doi-asserted-by": "publisher", "first-page": "640", "DOI": "10.1101/gad.1632608", "volume": "22", "author": "X Zhao", "year": "2008", "unstructured": "Zhao X, Jankovic V, Gural A, Huang G, Pardanani A, Menendez S et al. (2008). Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev 22: 640\u2013653.", "journal-title": "Genes Dev"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc2010610.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2010610", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2010610.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T11:14:40Z", "timestamp": 1555586080000}, "score": 19.771128, "issued": {"date-parts": [[2011, 1, 17]]}, "references-count": 51, "journal-issue": {"published-print": {"date-parts": [[2011, 5]]}, "issue": "20"}, "alternative-id": ["BFonc2010610"], "URL": "http://dx.doi.org/10.1038/onc.2010.610", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T18:23:23Z", "timestamp": 1576779803578}, "reference-count": 47, "publisher": "Springer Science and Business Media LLC", "issue": "27", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 4, 9]], "date-time": "2018-04-09T00:00:00Z", "timestamp": 1523232000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2018, 7]]}, "DOI": "10.1038/s41388-018-0225-0", "type": "journal-article", "created": {"date-parts": [[2018, 4, 11]], "date-time": "2018-04-11T13:58:48Z", "timestamp": 1523455128000}, "page": "3715-3728", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3\u03b2 and F-box and WD repeat domain-containing 7"], "prefix": "10.1038", "volume": "37", "author": [{"given": "Ji Hoon", "family": "Jung", "sequence": "first", "affiliation": []}, {"given": "Deok-Beom", "family": "Jung", "sequence": "additional", "affiliation": []}, {"given": "Hyunseok", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Hyemin", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Shi-Eun", "family": "Kang", "sequence": "additional", "affiliation": []}, {"given": "Sanjay K.", "family": "Srivastava", "sequence": "additional", "affiliation": []}, {"given": "Miyong", "family": "Yun", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0003-2423-1973", "authenticated-orcid": false, "given": "Sung-Hoon", "family": "Kim", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 4, 9]]}, "reference": [{"key": "225_CR1", "doi-asserted-by": "publisher", "first-page": "1688", "DOI": "10.1158/1055-9965.EPI-09-0090", "volume": "18", "author": "MM Center", "year": "2009", "unstructured": "Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomark Prev. 2009;18:1688\u201394.", "journal-title": "Cancer Epidemiol Biomark Prev"}, {"key": "225_CR2", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1016/j.ccr.2007.04.015", "volume": "11", "author": "GT Bommer", "year": "2007", "unstructured": "Bommer GT, Fearon ER. Role of c-Myc in Apc mutant intestinal phenotype: case closed or time for a new beginning? Cancer Cell. 2007;11:391\u20134.", "journal-title": "Cancer Cell"}, {"key": "225_CR3", "doi-asserted-by": "publisher", "first-page": "1509", "DOI": "10.1126/science.281.5382.1509", "volume": "281", "author": "TC He", "year": "1998", "unstructured": "He TC, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509\u201312.", "journal-title": "Science"}, {"key": "225_CR4", "doi-asserted-by": "publisher", "first-page": "947", "DOI": "10.1002/mc.20451", "volume": "47", "author": "UK Roy", "year": "2008", "unstructured": "Roy UK, et al. Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc. Mol Carcinog. 2008;47:947\u201355.", "journal-title": "Mol Carcinog"}, {"key": "225_CR5", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1016/S0092-8674(02)01014-0", "volume": "111", "author": "M Wetering van de", "year": "2002", "unstructured": "van de Wetering M, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111:241\u201350.", "journal-title": "Cell"}, {"key": "225_CR6", "first-page": "435", "volume": "4", "author": "SJ Garte", "year": "1993", "unstructured": "Garte SJ. The c-myc oncogene in tumor progression. Crit Rev Oncog. 1993;4:435\u201349.", "journal-title": "Crit Rev Oncog"}, {"key": "225_CR7", "doi-asserted-by": "publisher", "first-page": "152", "DOI": "10.1002/ssu.2980030305", "volume": "3", "author": "PG Rothberg", "year": "1987", "unstructured": "Rothberg PG. The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli. Semin Surg Oncol. 1987;3:152\u20138.", "journal-title": "Semin Surg Oncol"}, {"key": "225_CR8", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1146/annurev.iy.04.040186.001533", "volume": "4", "author": "K Kelly", "year": "1986", "unstructured": "Kelly K, Siebenlist U. The regulation and expression of c-myc in normal and malignant cells. Annu Rev Immunol. 1986;4:317\u201338.", "journal-title": "Annu Rev Immunol"}, {"key": "225_CR9", "first-page": "955", "volume": "4", "author": "D Morello", "year": "1989", "unstructured": "Morello D, Asselin C, Lavenu A, Marcu KB, Babinet C. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice. Oncogene. 1989;4:955\u201361.", "journal-title": "Oncogene"}, {"key": "225_CR10", "doi-asserted-by": "publisher", "first-page": "938", "DOI": "10.1101/gad.1.9.938", "volume": "1", "author": "A Nepveu", "year": "1987", "unstructured": "Nepveu A, Marcu KB, Skoultchi AI, Lachman HM. Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells. Genes Dev. 1987;1:938\u201345.", "journal-title": "Genes Dev"}, {"key": "225_CR11", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0065-230X(08)60476-5", "volume": "56", "author": "CA Spencer", "year": "1991", "unstructured": "Spencer CA, Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res. 1991;56:1\u201348.", "journal-title": "Adv Cancer Res"}, {"key": "225_CR12", "doi-asserted-by": "publisher", "first-page": "51606", "DOI": "10.1074/jbc.M310722200", "volume": "278", "author": "MA Gregory", "year": "2003", "unstructured": "Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem. 2003;278:51606\u201312.", "journal-title": "J Biol Chem"}, {"key": "225_CR13", "doi-asserted-by": "publisher", "first-page": "2881", "DOI": "10.18632/oncotarget.2037", "volume": "5", "author": "JA McCubrey", "year": "2014", "unstructured": "McCubrey JA, et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 2014;5:2881\u2013911.", "journal-title": "Oncotarget"}, {"key": "225_CR14", "doi-asserted-by": "publisher", "first-page": "2930", "DOI": "10.1128/MCB.01455-12", "volume": "33", "author": "AS Farrell", "year": "2013", "unstructured": "Farrell AS, et al. Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis. Mol Cell Biol. 2013;33:2930\u201349.", "journal-title": "Mol Cell Biol"}, {"key": "225_CR15", "doi-asserted-by": "publisher", "first-page": "973", "DOI": "10.1038/ncb2104", "volume": "12", "author": "N Popov", "year": "2010", "unstructured": "Popov N, Schulein C, Jaenicke LA, Eilers M. Ubiquitylation of the amino terminus of Myc by SCF(beta-TrCP) antagonizes SCF(Fbw7)-mediated turnover. Nat Cell Biol. 2010;12:973\u201381.", "journal-title": "Nat Cell Biol"}, {"key": "225_CR16", "doi-asserted-by": "publisher", "first-page": "689", "DOI": "10.1016/j.cell.2011.02.010", "volume": "144", "author": "JH Shin", "year": "2011", "unstructured": "Shin JH, et al. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson\u2019s disease. Cell. 2011;144:689\u2013702.", "journal-title": "Cell"}, {"key": "225_CR17", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1038/ng.491", "volume": "42", "author": "S Veeriah", "year": "2010", "unstructured": "Veeriah S, et al. Somatic mutations of the Parkinson\u2019s disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet. 2010;42:77\u201382.", "journal-title": "Nat Genet"}, {"key": "225_CR18", "doi-asserted-by": "publisher", "first-page": "15145", "DOI": "10.1073/pnas.1009941107", "volume": "107", "author": "G Poulogiannis", "year": "2010", "unstructured": "Poulogiannis G, et al. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci USA. 2010;107:15145\u201350.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "225_CR19", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.3892/or.2013.2801", "volume": "31", "author": "B Kim", "year": "2014", "unstructured": "Kim B, et al. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells. Oncol Rep. 2014;31:73\u201378.", "journal-title": "Oncol Rep"}, {"key": "225_CR20", "author": "SS Karuppagounder", "volume": "4", "year": "2014", "unstructured": "Karuppagounder SS, et al. The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson\u2019s disease. Sci Rep. 2014;4:4874.", "journal-title": "Sci Rep", "DOI": "10.1038/srep04874", "doi-asserted-by": "publisher"}, {"key": "225_CR21", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.tiv.2015.11.002", "volume": "31", "author": "TC Chen", "year": "2016", "unstructured": "Chen TC, et al. Nilotinib reduced the viability of human ovarian cancer cells via mitochondria-dependent apoptosis, independent of JNK activation. Toxicol Vitr. 2016;31:1\u201311.", "journal-title": "Toxicol Vitr"}, {"key": "225_CR22", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1016/j.ajpath.2014.10.014", "volume": "185", "author": "R Yuge", "year": "2015", "unstructured": "Yuge R, et al. mTOR and PDGF pathway blockade inhibits liver metastasis of colorectal cancer by modulating the tumor microenvironment. Am J Pathol. 2015;185:399\u2013408.", "journal-title": "Am J Pathol"}, {"key": "225_CR23", "doi-asserted-by": "publisher", "first-page": "669", "DOI": "10.1002/ptr.3616", "volume": "26", "author": "SH Won", "year": "2012", "unstructured": "Won SH, Lee HJ, Jeong SJ, Lu J, Kim SH. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells. Phytother Res PTR. 2012;26:669\u201374.", "journal-title": "Phytother Res PTR"}, {"key": "225_CR24", "doi-asserted-by": "publisher", "first-page": "596", "DOI": "10.1038/nature09454", "volume": "467", "author": "G Bollag", "year": "2010", "unstructured": "Bollag G, et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature. 2010;467:596\u20139.", "journal-title": "Nature"}, {"key": "225_CR25", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1007/978-1-4939-4035-6_1", "volume": "1468", "author": "T Conrad", "year": "2017", "unstructured": "Conrad T, Orom UA. Cellular fractionation and isolation of chromatin-associated RNA. Methods Mol Biol. 2017;1468:1\u20139.", "journal-title": "Methods Mol Biol"}, {"key": "225_CR26", "doi-asserted-by": "publisher", "first-page": "1279", "DOI": "10.1007/s13277-015-3878-0", "volume": "37", "author": "SP Gao", "year": "2016", "unstructured": "Gao SP, et al. Loss of TIM50 suppresses proliferation and induces apoptosis in breast cancer. Tumour Biol. 2016;37:1279\u201387.", "journal-title": "Tumour Biol"}, {"key": "225_CR27", "doi-asserted-by": "publisher", "first-page": "116", "DOI": "10.1007/s10120-015-0467-2", "volume": "19", "author": "X Wang", "year": "2016", "unstructured": "Wang X, et al. Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer. Gastric Cancer. 2016;19:116\u201327.", "journal-title": "Gastric Cancer"}, {"key": "225_CR28", "doi-asserted-by": "publisher", "first-page": "497", "DOI": "10.1016/j.molcel.2009.04.011", "volume": "34", "author": "JE Aslan", "year": "2009", "unstructured": "Aslan JE, et al. Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis. Mol Cell. 2009;34:497\u2013509.", "journal-title": "Mol Cell"}, {"key": "225_CR29", "doi-asserted-by": "publisher", "first-page": "2116", "DOI": "10.1038/sj.emboj.7600217", "volume": "23", "author": "M Yada", "year": "2004", "unstructured": "Yada M, et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 2004;23:2116\u201325.", "journal-title": "EMBO J"}, {"key": "225_CR30", "doi-asserted-by": "publisher", "first-page": "1161", "DOI": "10.3233/JAD-150423", "volume": "49", "author": "J Geng", "year": "2016", "unstructured": "Geng J, Xia L, Li W, Zhao C, Dou F. Cycloheximide treatment causes a ZVAD-sensitive protease-dependent cleavage of human Tau in drosophila cells. J Alzheimers Dis. 2016;49:1161\u20138.", "journal-title": "J Alzheimers Dis"}, {"key": "225_CR31", "doi-asserted-by": "publisher", "first-page": "710", "DOI": "10.1007/s12094-011-0720-z", "volume": "13", "author": "GV Koukourakis", "year": "2011", "unstructured": "Koukourakis GV, Sotiropoulou-Lontou A. Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer. Clin Transl Oncol. 2011;13:710\u20134.", "journal-title": "Clin Transl Oncol"}, {"key": "225_CR32", "first-page": "220", "volume": "83", "author": "M Kumar", "year": "2012", "unstructured": "Kumar M, et al. Targeted cancer therapies: the future of cancer treatment. Acta Biomed. 2012;83:220\u201333.", "journal-title": "Acta Biomed"}, {"key": "225_CR33", "first-page": "1124", "volume": "7", "author": "L Ji", "year": "2014", "unstructured": "Ji L, Wei Y, Jiang T, Wang S. Correlation of Nrf2, NQO1, MRP1, cmyc, and p53 in colorectal cancer and their relationships to clinicopathologic features and survival. Int J Clin Exp Pathol. 2014;7:1124\u201331.", "journal-title": "Int J Clin Exp Pathol"}, {"key": "225_CR34", "doi-asserted-by": "publisher", "first-page": "6315", "DOI": "10.3748/wjg.v19.i38.6315", "volume": "19", "author": "RA Mello de", "year": "2013", "unstructured": "de Mello RA, Marques AM, Araujo A. Epidermal growth factor receptor and metastatic colorectal cancer: insights into target therapies. World J Gastroenterol. 2013;19:6315\u20138.", "journal-title": "World J Gastroenterol"}, {"key": "225_CR35", "doi-asserted-by": "crossref", "first-page": "1019", "DOI": "10.1684/bdc.2011.1380", "volume": "98", "author": "L Mansi", "year": "2011", "unstructured": "Mansi L, Viel E, Curtit E, Medioni J, Le Tourneau C. Targeting the RAS signalling pathway in cancer. Bull Cancer. 2011;98:1019\u201328.", "journal-title": "Bull Cancer"}, {"key": "225_CR36", "doi-asserted-by": "publisher", "first-page": "946", "DOI": "10.1245/s10434-013-3386-7", "volume": "21", "author": "T Schweiger", "year": "2014", "unstructured": "Schweiger T, et al. EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study. Ann Surg Oncol. 2014;21:946\u201354.", "journal-title": "Ann Surg Oncol"}, {"key": "225_CR37", "doi-asserted-by": "publisher", "first-page": "1084", "DOI": "10.7150/ijbs.10190", "volume": "10", "author": "BJ Chen", "year": "2014", "unstructured": "Chen BJ, Wu YL, Tanaka Y, Zhang W. Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics. Int J Biol Sci. 2014;10:1084\u201396.", "journal-title": "Int J Biol Sci"}, {"key": "225_CR38", "doi-asserted-by": "publisher", "first-page": "6543", "DOI": "10.2174/1381612820666140826153203", "volume": "20", "author": "H Huang", "year": "2014", "unstructured": "Huang H, Weng H, Zhou H, Qu L. Attacking c-Myc: targeted and combined therapies for cancer. Curr Pharm Des. 2014;20:6543\u201354.", "journal-title": "Curr Pharm Des"}, {"key": "225_CR39", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1586/14737140.4.2.289", "volume": "4", "author": "EV Prochownik", "year": "2004", "unstructured": "Prochownik EV. c-Myc as a therapeutic target in cancer. Expert Rev Anticancer Ther. 2004;4:289\u2013302.", "journal-title": "Expert Rev Anticancer Ther"}, {"key": "225_CR40", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.2174/157489206778776934", "volume": "1", "author": "S Robson", "year": "2006", "unstructured": "Robson S, Pelengaris S, Khan M. c-Myc and downstream targets in the pathogenesis and treatment of cancer. Recent Pat Anticancer Drug Discov. 2006;1:305\u201326.", "journal-title": "Recent Pat Anticancer Drug Discov"}, {"key": "225_CR41", "doi-asserted-by": "publisher", "first-page": "1236", "DOI": "10.1101/gad.1920310", "volume": "24", "author": "SH Choi", "year": "2010", "unstructured": "Choi SH, Wright JB, Gerber SA, Cole MD. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev. 2010;24:1236\u201341.", "journal-title": "Genes Dev"}, {"key": "225_CR42", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.4161/cc.6.2.3742", "volume": "6", "author": "HB Koch", "year": "2007", "unstructured": "Koch HB, et al. Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle. 2007;6:205\u201317.", "journal-title": "Cell Cycle"}, {"key": "225_CR43", "doi-asserted-by": "publisher", "first-page": "503", "DOI": "10.1038/cdd.2012.147", "volume": "20", "author": "PY Liu", "year": "2013", "unstructured": "Liu PY, et al. The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death Differ. 2013;20:503\u201314.", "journal-title": "Cell Death Differ"}, {"key": "225_CR44", "doi-asserted-by": "publisher", "first-page": "1284", "DOI": "10.1038/onc.2012.144", "volume": "32", "author": "I Paul", "year": "2013", "unstructured": "Paul I, Ahmed SF, Bhowmik A, Deb S, Ghosh MK. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity. Oncogene. 2013;32:1284\u201395.", "journal-title": "Oncogene"}, {"key": "225_CR45", "doi-asserted-by": "publisher", "first-page": "913", "DOI": "10.1016/j.cell.2008.12.024", "volume": "136", "author": "JC Schwamborn", "year": "2009", "unstructured": "Schwamborn JC, Berezikov E, Knoblich JA. The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell. 2009;136:913\u201325.", "journal-title": "Cell"}, {"key": "225_CR46", "doi-asserted-by": "publisher", "first-page": "1627", "DOI": "10.3892/or.2017.5432", "volume": "37", "author": "M Li", "year": "2017", "unstructured": "Li M, et al. E3 ubiquitin ligase FBW7alpha inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E. Oncol Rep. 2017;37:1627\u201336.", "journal-title": "Oncol Rep"}, {"key": "225_CR47", "author": "M Welcker", "volume": "2", "year": "2007", "unstructured": "Welcker M, Clurman BE. Fbw7/hCDC4 dimerization regulates its substrate interactions. Cell Div. 2007;2:7.", "journal-title": "Cell Div", "DOI": "10.1186/1747-1028-2-7", "doi-asserted-by": "publisher"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/s41388-018-0225-0", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41388-018-0225-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41388-018-0225-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 15]], "date-time": "2019-10-15T03:42:50Z", "timestamp": 1571110970000}, "score": 19.771128, "issued": {"date-parts": [[2018, 4, 9]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2018, 7]]}, "issue": "27"}, "alternative-id": ["225"], "URL": "http://dx.doi.org/10.1038/s41388-018-0225-0", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}], "subject": ["Genetics", "Cancer Research", "Molecular Biology"], "assertion": [{"value": "12 December 2017", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "30 January 2018", "order": 2, "name": "revised", "label": "Revised", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "13 February 2018", "order": 3, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "9 April 2018", "order": 4, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with ethical standards"}}, {"value": "The authors declare that they have no conflict of interest.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of interest"}}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T19:05:45Z", "timestamp": 1575399945961}, "reference-count": 107, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2019, 2, 1]], "date-time": "2019-02-01T00:00:00Z", "timestamp": 1548979200000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/501100003725", "name": "National Research Foundation of Korea", "doi-asserted-by": "publisher", "award": ["2017M3A9D8063627", "2017R1A2B4002661", "2017R1A2B3005714"]}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Exp Mol Med"], "published-print": {"date-parts": [[2019, 2]]}, "DOI": "10.1038/s12276-018-0204-0", "type": "journal-article", "created": {"date-parts": [[2019, 2, 12]], "date-time": "2019-02-12T07:03:19Z", "timestamp": 1549954999000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["PAK4 signaling in health and disease: defining the PAK4\u2013CREB axis"], "prefix": "10.1038", "volume": "51", "author": [{"given": "So-Yoon", "family": "Won", "sequence": "first", "affiliation": []}, {"given": "Jung-Jin", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Eun-Young", "family": "Shin", "sequence": "additional", "affiliation": []}, {"given": "Eung-Gook", "family": "Kim", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 2, 12]]}, "reference": [{"key": "204_CR1", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1038/367040a0", "volume": "367", "author": "E Manser", "year": "1994", "unstructured": "Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S. & Lim, L. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40\u201346 (1994).", "journal-title": "Nature"}, {"key": "204_CR2", "doi-asserted-by": "crossref", "first-page": "1235", "DOI": "10.1083/jcb.144.6.1235", "volume": "144", "author": "CD Nobes", "year": "1999", "unstructured": "Nobes, C. D. & Hall, A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144, 1235\u20131244 (1999).", "journal-title": "J. Cell Biol."}, {"key": "204_CR3", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1007/978-3-642-58591-3_6", "volume": "22", "author": "E Manser", "year": "1999", "unstructured": "Manser, E. & Lim, L. Roles of PAK family kinases. Prog. Mol. Subcell. Biol. 22, 115\u2013133 (1999).", "journal-title": "Prog. Mol. Subcell. Biol."}, {"key": "204_CR4", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1042/BC20070109", "volume": "100", "author": "LE Arias-Romero", "year": "2008", "unstructured": "Arias-Romero, L. E. & Chernoff, J. A tale of two Paks. Biol. Cell 100, 97\u2013108 (2008).", "journal-title": "Biol. Cell"}, {"key": "204_CR5", "doi-asserted-by": "crossref", "first-page": "3108", "DOI": "10.1091/mbc.e05-09-0896", "volume": "17", "author": "EJ Chenette", "year": "2006", "unstructured": "Chenette, E. J., Mitin, N. Y. & Der, C. J. Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity. Mol. Biol. Cell 17, 3108\u20133121 (2006).", "journal-title": "Mol. Biol. Cell"}, {"key": "204_CR6", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1073/pnas.1717437115", "volume": "115", "author": "BH Ha", "year": "2018", "unstructured": "Ha, B. H. & Boggon, T. J. CDC42 binds PAK4 via an extended GTPase-effector interface. Proc. Natl Acad. Sci. USA 115, 531\u2013536 (2018).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "204_CR7", "doi-asserted-by": "crossref", "first-page": "32377", "DOI": "10.1074/jbc.273.49.32377", "volume": "273", "author": "K Du", "year": "1998", "unstructured": "Du, K. & Montminy, M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273, 32377\u201332379 (1998).", "journal-title": "J. Biol. Chem."}, {"key": "204_CR8", "first-page": "pe1", "volume": "2001", "author": "S Finkbeiner", "year": "2001", "unstructured": "Finkbeiner, S. New roles for introns: sites of combinatorial regulation of Ca2\u2009+\u2009- and cyclic AMP-dependent gene transcription. Sci. STKE 2001, pe1 (2001).", "journal-title": "Sci. STKE"}, {"key": "204_CR9", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1038/35085068", "volume": "2", "author": "B Mayr", "year": "2001", "unstructured": "Mayr, B. & Montminy, M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599\u2013609 (2001).", "journal-title": "Nat. Rev. Mol. Cell Biol."}, {"key": "204_CR10", "doi-asserted-by": "crossref", "first-page": "6413", "DOI": "10.4049/jimmunol.1001829", "volume": "185", "author": "AY Wen", "year": "2010", "unstructured": "Wen, A. Y., Sakamoto, K. M. & Miller, L. S. The role of the transcription factor CREB in immune function. J. Immunol. 185, 6413\u20136419 (2010).", "journal-title": "J. Immunol."}, {"key": "204_CR11", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1146/annurev.biochem.68.1.821", "volume": "68", "author": "AJ Shaywitz", "year": "1999", "unstructured": "Shaywitz, A. J. & Greenberg, M. E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68, 821\u2013861 (1999).", "journal-title": "Annu. Rev. Biochem."}, {"key": "204_CR12", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1016/j.neuron.2014.08.049", "volume": "84", "author": "M Nonaka", "year": "2014", "unstructured": "Nonaka, M. et al. Region-specific activation of CRTC1-CREB signaling mediates long-term fear memory. Neuron 84, 92\u2013106 (2014).", "journal-title": "Neuron"}, {"key": "204_CR13", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1016/j.cell.2011.02.013", "volume": "144", "author": "D Hanahan", "year": "2011", "unstructured": "Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).", "journal-title": "Cell"}, {"key": "204_CR14", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1158/1541-7786.MCR-12-0466", "volume": "11", "author": "H Tabusa", "year": "2013", "unstructured": "Tabusa, H., Brooks, T. & Massey, A. J. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling. Mol. Cancer Res. 11, 109\u2013121 (2013).", "journal-title": "Mol. Cancer Res."}, {"key": "204_CR15", "doi-asserted-by": "crossref", "first-page": "3947", "DOI": "10.1242/jcs.00080", "volume": "115", "author": "CM Wells", "year": "2002", "unstructured": "Wells, C. M., Abo, A. & Ridley, A. J. PAK4 is activated via PI3K in HGF-stimulated epithelial cells. J. Cell Sci. 115, 3947\u20133956 (2002).", "journal-title": "J. Cell Sci."}, {"key": "204_CR16", "unstructured": "Fu, X. et al. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways. Biosci. Rep. 34, e00094 (2014).", "DOI": "10.1042/BSR20130102", "doi-asserted-by": "crossref"}, {"key": "204_CR17", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.1038/onc.2011.294", "volume": "31", "author": "G Zhu", "year": "2012", "unstructured": "Zhu, G. et al. A Rac1/PAK1 cascade controls beta-catenin activation in colon cancer cells. Oncogene 31, 1001\u20131012 (2012).", "journal-title": "Oncogene"}, {"key": "204_CR18", "doi-asserted-by": "crossref", "first-page": "6786", "DOI": "10.1074/jbc.M115.697292", "volume": "291", "author": "Z Vershinin", "year": "2016", "unstructured": "Vershinin, Z., Feldman, M., Chen, A. & Levy, D. PAK4 methylation by SETD6 promotes the activation of the Wnt/beta-catenin pathway. J. Biol. Chem. 291, 6786\u20136795 (2016).", "journal-title": "J. Biol. Chem."}, {"key": "204_CR19", "author": "LE Wong", "volume": "2", "year": "2013", "unstructured": "Wong, L. E., Chen, N., Karantza, V. & Minden, A. The Pak4 protein kinase is required for oncogenic transformation of MDA-MB-231 breast cancer cells. Oncogenesis 2, e50 (2013).", "journal-title": "Oncogenesis"}, {"key": "204_CR20", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1593/tlo.11145", "volume": "4", "author": "HK Ahn", "year": "2011", "unstructured": "Ahn, H. K. et al. P21-activated kinase 4 overexpression in metastatic gastric cancer patients. Transl. Oncol. 4, 345\u2013349 (2011).", "journal-title": "Transl. Oncol."}, {"key": "204_CR21", "doi-asserted-by": "crossref", "first-page": "2475", "DOI": "10.1038/onc.2012.255", "volume": "32", "author": "MH Park", "year": "2013", "unstructured": "Park, M. H. et al. p21-Activated kinase 4 promotes prostate cancer progression through CREB. Oncogene 32, 2475\u20132482 (2013).", "journal-title": "Oncogene"}, {"key": "204_CR22", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1186/s13046-015-0165-2", "volume": "34", "author": "S Cai", "year": "2015", "unstructured": "Cai, S. et al. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion. J. Exp. Clin. Cancer Res. 34, 48 (2015).", "journal-title": "J. Exp. Clin. Cancer Res."}, {"key": "204_CR23", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1159/000132570", "volume": "29", "author": "JH Kim", "year": "2008", "unstructured": "Kim, J. H. et al. Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis. Tumour Biol. 29, 41\u201349 (2008).", "journal-title": "Tumour Biol."}, {"key": "204_CR24", "doi-asserted-by": "crossref", "first-page": "1495", "DOI": "10.1158/1535-7163.MCT-15-0039", "volume": "14", "author": "SJ Davis", "year": "2015", "unstructured": "Davis, S. J. et al. Enhanced GAB2 expression is associated with improved survival in high-grade serous ovarian cancer and sensitivity to PI3K inhibition. Mol. Cancer Ther. 14, 1495\u20131503 (2015).", "journal-title": "Mol. Cancer Ther."}, {"key": "204_CR25", "doi-asserted-by": "crossref", "first-page": "1793", "DOI": "10.4161/cbt.7.11.6840", "volume": "7", "author": "S Chen", "year": "2008", "unstructured": "Chen, S. et al. Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification. Cancer Biol. Ther. 7, 1793\u20131802 (2008).", "journal-title": "Cancer Biol. Ther."}, {"key": "204_CR26", "doi-asserted-by": "crossref", "first-page": "1411", "DOI": "10.1158/1078-0432.CCR-12-3433", "volume": "19", "author": "SJ Davis", "year": "2013", "unstructured": "Davis, S. J. et al. Functional analysis of genes in regions commonly amplified in high-grade serous and endometrioid ovarian cancer. Clin. Cancer Res. 19, 1411\u20131421 (2013).", "journal-title": "Clin. Cancer Res."}, {"key": "204_CR27", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1016/j.cancergencyto.2009.03.017", "volume": "193", "author": "W Yu", "year": "2009", "unstructured": "Yu, W., Kanaan, Y., Bae, Y. K. & Gabrielson, E. Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genet. Cytogenet. 193, 29\u201337 (2009).", "journal-title": "Cancer Genet. Cytogenet."}, {"key": "204_CR28", "doi-asserted-by": "crossref", "first-page": "1908", "DOI": "10.1111/j.1349-7006.2009.01252.x", "volume": "100", "author": "A Begum", "year": "2009", "unstructured": "Begum, A. et al. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma. Cancer Sci. 100, 1908\u20131916 (2009).", "journal-title": "Cancer Sci."}, {"key": "204_CR29", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1097/MPA.0000000000000276", "volume": "44", "author": "D Yeo", "year": "2015", "unstructured": "Yeo, D., He, H., Baldwin, G. S. & Nikfarjam, M. The role of p21-activated kinases in pancreatic cancer. Pancreas 44, 363\u2013369 (2015).", "journal-title": "Pancreas"}, {"key": "204_CR30", "doi-asserted-by": "crossref", "first-page": "5147", "DOI": "10.1038/s41388-018-0327-8", "volume": "37", "author": "JJ Park", "year": "2018", "unstructured": "Park, J. J. et al. The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer. Oncogene 37, 5147\u20135159 (2018).", "journal-title": "Oncogene"}, {"key": "204_CR31", "doi-asserted-by": "crossref", "first-page": "3523", "DOI": "10.1128/MCB.21.10.3523-3533.2001", "volume": "21", "author": "J Qu", "year": "2001", "unstructured": "Qu, J. et al. Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol. Cell. Biol. 21, 3523\u20133533 (2001).", "journal-title": "Mol. Cell. Biol."}, {"key": "204_CR32", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1016/0092-8674(88)90571-5", "volume": "53", "author": "C Almoguera", "year": "1988", "unstructured": "Almoguera, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549\u2013554 (1988).", "journal-title": "Cell"}, {"key": "204_CR33", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1016/0960-7404(92)90088-3", "volume": "1", "author": "IS Boughdady", "year": "1992", "unstructured": "Boughdady, I. S., Kinsella, A. R., Haboubi, N. Y. & Schofield, P. F. K-ras gene mutations in adenomas and carcinomas of the colon. Surg. Oncol. 1, 275\u2013282 (1992).", "journal-title": "Surg. Oncol."}, {"key": "204_CR34", "first-page": "1444", "volume": "55", "author": "NE Mills", "year": "1995", "unstructured": "Mills, N. E., Fishman, C. L., Rom, W. N., Dubin, N. & Jacobson, D. R. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 55, 1444\u20131447 (1995).", "journal-title": "Cancer Res."}, {"key": "204_CR35", "author": "H King", "volume": "7", "year": "2017", "unstructured": "King, H. et al. PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration. Sci. Rep. 7, 42575 (2017).", "journal-title": "Sci. Rep."}, {"key": "204_CR36", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1186/s13000-015-0404-z", "volume": "10", "author": "XR Shu", "year": "2015", "unstructured": "Shu, X. R., Wu, J., Sun, H., Chi, L. Q. & Wang, J. H. PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway. Diagn. Pathol. 10, 177 (2015).", "journal-title": "Diagn. Pathol."}, {"key": "204_CR37", "doi-asserted-by": "crossref", "first-page": "14173", "DOI": "10.18632/oncotarget.13309", "volume": "8", "author": "K Thillai", "year": "2017", "unstructured": "Thillai, K., Lam, H., Sarker, D. & Wells, C. M. Deciphering the link between PI3K and PAK: an opportunity to target key pathways in pancreatic cancer? Oncotarget 8, 14173\u201314191 (2017).", "journal-title": "Oncotarget"}, {"key": "204_CR38", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1016/j.bbamcr.2011.11.013", "volume": "1823", "author": "Y Li", "year": "2012", "unstructured": "Li, Y. et al. Nucleo-cytoplasmic shuttling of PAK4 modulates beta-catenin intracellular translocation and signaling. Biochim. Biophys. Acta 1823, 465\u2013475 (2012).", "journal-title": "Biochim. Biophys. Acta"}, {"key": "204_CR39", "doi-asserted-by": "crossref", "first-page": "32115", "DOI": "10.1074/jbc.M100871200", "volume": "276", "author": "C Dan", "year": "2001", "unstructured": "Dan, C., Kelly, A., Bernard, O. & Minden, A. Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin. J. Biol. Chem. 276, 32115\u201332121 (2001).", "journal-title": "J. Biol. Chem."}, {"key": "204_CR40", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1242/jcs.01631", "volume": "118", "author": "V DesMarais", "year": "2005", "unstructured": "DesMarais, V., Ghosh, M., Eddy, R. & Condeelis, J. Cofilin takes the lead. J. Cell Sci. 118, 19\u201326 (2005).", "journal-title": "J. Cell Sci."}, {"key": "204_CR41", "doi-asserted-by": "crossref", "first-page": "7838", "DOI": "10.1128/MCB.23.21.7838-7848.2003", "volume": "23", "author": "N Gnesutta", "year": "2003", "unstructured": "Gnesutta, N. & Minden, A. Death receptor-induced activation of initiator caspase 8 is antagonized by serine/threonine kinase PAK4. Mol. Cell. Biol. 23, 7838\u20137848 (2003).", "journal-title": "Mol. Cell. Biol."}, {"key": "204_CR42", "doi-asserted-by": "crossref", "first-page": "863", "DOI": "10.1083/jcb.201501072", "volume": "211", "author": "AE Dart", "year": "2015", "unstructured": "Dart, A. E. et al. PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. J. Cell Biol. 211, 863\u2013879 (2015).", "journal-title": "J. Cell Biol."}, {"key": "204_CR43", "doi-asserted-by": "crossref", "first-page": "20997", "DOI": "10.1074/jbc.271.35.20997", "volume": "271", "author": "ML Galisteo", "year": "1996", "unstructured": "Galisteo, M. L., Chernoff, J., Su, Y. C., Skolnik, E. Y. & Schlessinger, J. The adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1. J. Biol. Chem. 271, 20997\u201321000 (1996).", "journal-title": "J. Biol. Chem."}, {"key": "204_CR44", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/S0960-9822(06)00052-2", "volume": "7", "author": "W Lu", "year": "1997", "unstructured": "Lu, W., Katz, S., Gupta, R. & Mayer, B. J. Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr. Biol. 7, 85\u201394 (1997).", "journal-title": "Curr. Biol."}, {"key": "204_CR45", "first-page": "35454", "volume": "7", "author": "A Steven", "year": "2016", "unstructured": "Steven, A. & Seliger, B. Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target. Oncotarget 7, 35454\u201335465 (2016).", "journal-title": "Oncotarget"}, {"key": "204_CR46", "doi-asserted-by": "crossref", "first-page": "2583", "DOI": "10.1158/1078-0432.CCR-08-1137", "volume": "15", "author": "KM Sakamoto", "year": "2009", "unstructured": "Sakamoto, K. M. & Frank, D. A. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin. Cancer Res. 15, 2583\u20132587 (2009).", "journal-title": "Clin. Cancer Res."}, {"key": "204_CR47", "doi-asserted-by": "crossref", "first-page": "9108", "DOI": "10.1158/0008-5472.CAN-06-1996", "volume": "66", "author": "WC Huang", "year": "2006", "unstructured": "Huang, W. C. et al. beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res. 66, 9108\u20139116 (2006).", "journal-title": "Cancer Res."}, {"key": "204_CR48", "first-page": "45171", "volume": "7", "author": "M Sang", "year": "2016", "unstructured": "Sang, M. et al. GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells. Oncotarget 7, 45171\u201345185 (2016).", "journal-title": "Oncotarget"}, {"key": "204_CR49", "doi-asserted-by": "crossref", "first-page": "367ra170", "DOI": "10.1126/scitranslmed.aaf1629", "volume": "8", "author": "SY Won", "year": "2016", "unstructured": "Won, S. Y. et al. Nigral dopaminergic PAK4 prevents neurodegeneration in rat models of Parkinson\u2019s disease. Sci. Transl. Med. 8, 367ra170 (2016).", "journal-title": "Sci. Transl. Med."}, {"key": "204_CR50", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.2174/156800910791208535", "volume": "10", "author": "X Xiao", "year": "2010", "unstructured": "Xiao, X., Li, B. X., Mitton, B., Ikeda, A. & Sakamoto, K. M. Targeting CREB for cancer therapy: friend or foe. Curr. Cancer Drug Targets 10, 384\u2013391 (2010).", "journal-title": "Curr. Cancer Drug Targets"}, {"key": "204_CR51", "doi-asserted-by": "crossref", "first-page": "S1", "DOI": "10.1038/466S2a", "volume": "466", "author": "M Grayson", "year": "2010", "unstructured": "Grayson, M. Parkinson\u2019s disease. Nature 466, S1 (2010).", "journal-title": "Nature"}, {"key": "204_CR52", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1038/nature22815", "volume": "546", "author": "D Sulzer", "year": "2017", "unstructured": "Sulzer, D. et al. T cells from patients with Parkinson\u2019s disease recognize alpha-synuclein peptides. Nature 546, 656\u2013661 (2017).", "journal-title": "Nature"}, {"key": "204_CR53", "doi-asserted-by": "crossref", "first-page": "622", "DOI": "10.1038/nature09159", "volume": "466", "author": "AV Kravitz", "year": "2010", "unstructured": "Kravitz, A. V. et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466, 622\u2013626 (2010).", "journal-title": "Nature"}, {"key": "204_CR54", "first-page": "133", "volume": "91", "author": "CM Tanner", "year": "2003", "unstructured": "Tanner, C. M. Is the cause of Parkinson\u2019s disease environmental or hereditary? Evidence from twin studies. Adv. Neurol. 91, 133\u2013142 (2003).", "journal-title": "Adv. Neurol."}, {"issue": "Suppl 3", "key": "204_CR55", "first-page": "S23", "volume": "53", "author": "TT Warner", "year": "2003", "unstructured": "Warner, T. T. & Schapira, A. H. Genetic and environmental factors in the cause of Parkinson\u2019s disease. Ann. Neurol. 53(Suppl 3), S23\u201315 (2003). S16-23; discussion.", "journal-title": "Ann. Neurol."}, {"key": "204_CR56", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.3389/fnana.2014.00159", "volume": "8", "author": "A Recasens", "year": "2014", "unstructured": "Recasens, A. & Dehay, B. Alpha-synuclein spreading in Parkinson\u2019s disease. Front. Neuroanat. 8, 159 (2014).", "journal-title": "Front. Neuroanat."}, {"key": "204_CR57", "doi-asserted-by": "crossref", "first-page": "e1004741", "DOI": "10.1371/journal.pgen.1004741", "volume": "10", "author": "DF Lazaro", "year": "2014", "unstructured": "Lazaro, D. F. et al. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. PLoS Genet. 10, e1004741 (2014).", "journal-title": "PLoS Genet."}, {"key": "204_CR58", "doi-asserted-by": "crossref", "first-page": "2401", "DOI": "10.1111/j.1471-4159.2007.04933.x", "volume": "103", "author": "KM Danzer", "year": "2007", "unstructured": "Danzer, K. M., Schnack, C., Sutcliffe, A., Hengerer, B. & Gillardon, F. Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers. J. Neurochem. 103, 2401\u20132407 (2007).", "journal-title": "J. Neurochem."}, {"key": "204_CR59", "doi-asserted-by": "crossref", "first-page": "554", "DOI": "10.1111/jnc.12949", "volume": "131", "author": "I Martin", "year": "2014", "unstructured": "Martin, I., Kim, J. W., Dawson, V. L. & Dawson, T. M. LRRK2 pathobiology in Parkinson\u2019s disease. J. Neurochem. 131, 554\u2013565 (2014).", "journal-title": "J. Neurochem."}, {"issue": "Suppl 1", "key": "204_CR60", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1111/jnc.13731", "volume": "139", "author": "A Bose", "year": "2016", "unstructured": "Bose, A. & Beal, M. F. Mitochondrial dysfunction in Parkinson\u2019s disease. J. Neurochem. 139(Suppl 1), 216\u2013231 (2016).", "journal-title": "J. Neurochem."}, {"key": "204_CR61", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1152/physrev.00026.2013", "volume": "94", "author": "DB Zorov", "year": "2014", "unstructured": "Zorov, D. B., Juhaszova, M. & Sollott, S. J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94, 909\u2013950 (2014).", "journal-title": "Physiol. Rev."}, {"key": "204_CR62", "first-page": "461", "volume": "3", "author": "V Dias", "year": "2013", "unstructured": "Dias, V., Junn, E. & Mouradian, M. M. The role of oxidative stress in Parkinson\u2019s disease. J. Parkinsons Dis. 3, 461\u2013491 (2013).", "journal-title": "J. Parkinsons Dis."}, {"key": "204_CR63", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1186/s13041-016-0230-6", "volume": "9", "author": "H Kim", "year": "2016", "unstructured": "Kim, H. et al. Down-regulation of p21-activated serine/threonine kinase 1 is involved in loss of mesencephalic dopamine neurons. Mol. Brain 9, 45\u201346 (2016).", "journal-title": "Mol. Brain"}, {"key": "204_CR64", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1038/ng882", "volume": "31", "author": "T Mantamadiotis", "year": "2002", "unstructured": "Mantamadiotis, T. et al. Disruption of CREB function in brain leads to neurodegeneration. Nat. Genet. 31, 47\u201354 (2002).", "journal-title": "Nat. Genet."}, {"key": "204_CR65", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1038/nrm3072", "volume": "12", "author": "JY Altarejos", "year": "2011", "unstructured": "Altarejos, J. Y. & Montminy, M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 12, 141\u2013151 (2011).", "journal-title": "Nat. Rev. Mol. Cell Biol."}, {"key": "204_CR66", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1016/j.neuron.2010.12.004", "volume": "69", "author": "T Sasaki", "year": "2011", "unstructured": "Sasaki, T. et al. SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron 69, 106\u2013119 (2011).", "journal-title": "Neuron"}, {"key": "204_CR67", "first-page": "155", "volume": "67", "author": "ZC Xue", "year": "2015", "unstructured": "Xue, Z. C., Wang, C., Wang, Q. W. & Zhang, J. F. CREB-regulated transcription coactivator 1: important roles in neurodegenerative disorders. Sheng Li Xue Bao 67, 155\u2013162 (2015).", "journal-title": "Sheng Li Xue Bao"}, {"key": "204_CR68", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1016/j.neuropharm.2016.03.012", "volume": "107", "author": "EM Meylan", "year": "2016", "unstructured": "Meylan, E. M., Halfon, O., Magistretti, P. J. & Cardinaux, J. R. The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: possible relevance for treatment-resistant depression. Neuropharmacology 107, 111\u2013121 (2016).", "journal-title": "Neuropharmacology"}, {"key": "204_CR69", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1111/pcmr.12080", "volume": "26", "author": "J Bonaventure", "year": "2013", "unstructured": "Bonaventure, J., Domingues, M. J. & Larue, L. Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells. Pigment Cell Melanoma Res. 26, 316\u2013325 (2013).", "journal-title": "Pigment Cell Melanoma Res."}, {"key": "204_CR70", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1111/j.1751-1097.2007.00226.x", "volume": "84", "author": "M Brenner", "year": "2008", "unstructured": "Brenner, M. & Hearing, V. J. The protective role of melanin against UV damage in human skin. Photochem. Photobiol. 84, 539\u2013549 (2008).", "journal-title": "Photochem. Photobiol."}, {"key": "204_CR71", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1016/j.cell.2006.12.045", "volume": "128", "author": "R Cui", "year": "2007", "unstructured": "Cui, R. et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128, 853\u2013864 (2007).", "journal-title": "Cell"}, {"key": "204_CR72", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1111/pcmr.12257", "volume": "27", "author": "JC Garcia-Borron", "year": "2014", "unstructured": "Garcia-Borron, J. C., Abdel-Malek, Z. & Jimenez-Cervantes, C. MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation. Pigment Cell Melanoma Res. 27, 699\u2013720 (2014).", "journal-title": "Pigment Cell Melanoma Res."}, {"key": "204_CR73", "doi-asserted-by": "crossref", "first-page": "406", "DOI": "10.1016/j.molmed.2006.07.008", "volume": "12", "author": "C Levy", "year": "2006", "unstructured": "Levy, C., Khaled, M. & Fisher, D. E. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12, 406\u2013414 (2006).", "journal-title": "Trends Mol. Med."}, {"key": "204_CR74", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1038/ng0894-509", "volume": "7", "author": "AE Hughes", "year": "1994", "unstructured": "Hughes, A. E., Newton, V. E., Liu, X. Z. & Read, A. P. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat. Genet. 7, 509\u2013512 (1994).", "journal-title": "Nat. Genet."}, {"key": "204_CR75", "doi-asserted-by": "crossref", "first-page": "1069", "DOI": "10.1093/hmg/3.7.1069", "volume": "3", "author": "M Tassabehji", "year": "1994", "unstructured": "Tassabehji, M. et al. PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse. Hum. Mol. Genet. 3, 1069\u20131074 (1994).", "journal-title": "Hum. Mol. Genet."}, {"key": "204_CR76", "unstructured": "Lim, X. & Nusse, R. Wnt signaling in skin development, homeostasis, and disease. Cold Spring Harb. Perspect. Biol. 5, a008029 (2013).", "DOI": "10.1101/cshperspect.a008029", "doi-asserted-by": "crossref"}, {"key": "204_CR77", "first-page": "4969", "volume": "125", "author": "M Ikeya", "year": "1998", "unstructured": "Ikeya, M. & Takada, S. Wnt signaling from the dorsal neural tube is required for the formation of the medial dermomyotome. Development 125, 4969\u20134976 (1998).", "journal-title": "Development"}, {"key": "204_CR78", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1186/s13287-015-0103-4", "volume": "6", "author": "Y Shi", "year": "2015", "unstructured": "Shi, Y. et al. Wnt and Notch signaling pathway involved in wound healing by targeting c-Myc and Hes1 separately. Stem Cell Res. Ther. 6, 120 (2015).", "journal-title": "Stem Cell Res. Ther."}, {"key": "204_CR79", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1007/s10103-018-2455-3", "volume": "33", "author": "L Han", "year": "2018", "unstructured": "Han, L. et al. Activation of Wnt/beta-catenin signaling is involved in hair growth-promoting effect of 655-nm red light and LED in in vitro culture model. Lasers Med. Sci. 33, 637\u2013645 (2018).", "journal-title": "Lasers Med. Sci."}, {"key": "204_CR80", "doi-asserted-by": "crossref", "first-page": "720", "DOI": "10.1016/j.stem.2013.10.003", "volume": "13", "author": "YS Choi", "year": "2013", "unstructured": "Choi, Y. S. et al. Distinct functions for Wnt/beta-catenin in hair follicle stem cell proliferation and survival and interfollicular epidermal homeostasis. Cell Stem Cell 13, 720\u2013733 (2013).", "journal-title": "Cell Stem Cell"}, {"key": "204_CR81", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1111/j.1755-148X.2010.00800.x", "volume": "24", "author": "B Bellei", "year": "2011", "unstructured": "Bellei, B., Pitisci, A., Catricala, C., Larue, L. & Picardo, M. Wnt/beta-catenin signaling is stimulated by alpha-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation. Pigment Cell Melanoma Res. 24, 309\u2013325 (2011).", "journal-title": "Pigment Cell Melanoma Res."}, {"key": "204_CR82", "first-page": "158", "volume": "14", "author": "RI Dorsky", "year": "2000", "unstructured": "Dorsky, R. I., Raible, D. W. & Moon, R. T. Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev. 14, 158\u2013162 (2000).", "journal-title": "Genes Dev."}, {"key": "204_CR83", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1038/jid.2012.270", "volume": "133", "author": "JY Kim", "year": "2013", "unstructured": "Kim, J. Y., Lee, T. R. & Lee, A. Y. Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma. J. Invest. Dermatol. 133, 191\u2013200 (2013).", "journal-title": "J. Invest. Dermatol."}, {"key": "204_CR84", "doi-asserted-by": "crossref", "first-page": "2753", "DOI": "10.1038/jid.2013.235", "volume": "133", "author": "T Yamada", "year": "2013", "unstructured": "Yamada, T. et al. Wnt/beta-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation. J. Invest. Dermatol. 133, 2753\u20132762 (2013).", "journal-title": "J. Invest. Dermatol."}, {"key": "204_CR85", "doi-asserted-by": "crossref", "first-page": "1385", "DOI": "10.1038/jid.2014.548", "volume": "135", "author": "CY Yun", "year": "2015", "unstructured": "Yun, C. Y. et al. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and beta-catenin/MITF pathways. J. Invest. Dermatol. 135, 1385\u20131394 (2015).", "journal-title": "J. Invest. Dermatol."}, {"key": "204_CR86", "doi-asserted-by": "crossref", "first-page": "504", "DOI": "10.1111/1523-1747.ep12395649", "volume": "103", "author": "J Grabbe", "year": "1994", "unstructured": "Grabbe, J. et al. Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J. Invest. Dermatol. 103, 504\u2013508 (1994).", "journal-title": "J. Invest. Dermatol."}, {"key": "204_CR87", "doi-asserted-by": "crossref", "first-page": "2099", "DOI": "10.1016/S0002-9440(10)63260-9", "volume": "165", "author": "A Hachiya", "year": "2004", "unstructured": "Hachiya, A. et al. Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-1, in ultraviolet B-induced human melanogenesis. Am. J. Pathol. 165, 2099\u20132109 (2004).", "journal-title": "Am. J. Pathol."}, {"key": "204_CR88", "first-page": "2325", "volume": "126", "author": "GD Wen", "year": "2013", "unstructured": "Wen, G. D. et al. A novel mutation of the KIT gene in a Chinese family with piebaldism. Chin. Med. J. 126, 2325\u20132328 (2013).", "journal-title": "Chin. Med. J."}, {"key": "204_CR89", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1038/34681", "volume": "391", "author": "TJ Hemesath", "year": "1998", "unstructured": "Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T. & Fisher, D. E. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391, 298\u2013301 (1998).", "journal-title": "Nature"}, {"key": "204_CR90", "doi-asserted-by": "crossref", "first-page": "17983", "DOI": "10.1074/jbc.273.29.17983", "volume": "273", "author": "ER Price", "year": "1998", "unstructured": "Price, E. R. et al. Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J. Biol. Chem. 273, 17983\u201317986 (1998).", "journal-title": "J. Biol. Chem."}, {"issue": "Pt 1", "key": "204_CR91", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1042/bj3410211", "volume": "341", "author": "K Thommes", "year": "1999", "unstructured": "Thommes, K., Lennartsson, J., Carlberg, M. & Ronnstrand, L. Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor. Biochem. J. 341(Pt 1), 211\u2013216 (1999).", "journal-title": "Biochem. J."}, {"key": "204_CR92", "first-page": "301", "volume": "14", "author": "M Wu", "year": "2000", "unstructured": "Wu, M. et al. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14, 301\u2013312 (2000).", "journal-title": "Genes Dev."}, {"key": "204_CR93", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1006/excr.2000.4803", "volume": "255", "author": "W Xu", "year": "2000", "unstructured": "Xu, W. et al. Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp. Cell Res. 255, 135\u2013143 (2000).", "journal-title": "Exp. Cell Res."}, {"key": "204_CR94", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/j.cellsig.2017.09.004", "volume": "40", "author": "T Pillaiyar", "year": "2017", "unstructured": "Pillaiyar, T., Manickam, M. & Jung, S. H. Recent development of signaling pathways inhibitors of melanogenesis. Cell. Signal. 40, 99\u2013115 (2017).", "journal-title": "Cell. Signal."}, {"key": "204_CR95", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1038/onc.2011.247", "volume": "31", "author": "Y Gu", "year": "2012", "unstructured": "Gu, Y. et al. Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene 31, 469\u2013479 (2012).", "journal-title": "Oncogene"}, {"key": "204_CR96", "doi-asserted-by": "crossref", "first-page": "809", "DOI": "10.1111/j.1755-148X.2010.00760.x", "volume": "23", "author": "N Horike", "year": "2010", "unstructured": "Horike, N. et al. Downregulation of SIK2 expression promotes the melanogenic program in mice. Pigment Cell Melanoma Res. 23, 809\u2013819 (2010).", "journal-title": "Pigment Cell Melanoma Res."}, {"key": "204_CR97", "doi-asserted-by": "crossref", "first-page": "2177", "DOI": "10.1016/j.celrep.2017.05.042", "volume": "19", "author": "N Mujahid", "year": "2017", "unstructured": "Mujahid, N. et al. A UV-independent topical small-molecule approach for melanin production in human skin. Cell Rep. 19, 2177\u20132184 (2017).", "journal-title": "Cell Rep."}, {"key": "204_CR98", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1111/pcmr.12596", "volume": "30", "author": "S Bang", "year": "2017", "unstructured": "Bang, S. et al. Novel regulation of melanogenesis by adiponectin via the AMPK/CRTC pathway. Pigment Cell Melanoma Res. 30, 553\u2013557 (2017).", "journal-title": "Pigment Cell Melanoma Res."}, {"key": "204_CR99", "doi-asserted-by": "crossref", "first-page": "314", "DOI": "10.5582/ddt.2016.01062", "volume": "10", "author": "TuPT Be", "year": "2017", "unstructured": "Be, Tu,P. T. et al. The serum/PDGF-dependent \u201cmelanogenic\u201d role of the minute level of the oncogenic kinase PAK1 in melanoma cells proven by the highly sensitive kinase assay. Drug Discov. Ther. 10, 314\u2013322 (2017).", "journal-title": "Drug Discov. Ther."}, {"key": "204_CR100", "doi-asserted-by": "crossref", "first-page": "5484", "DOI": "10.1021/acs.jafc.6b01785", "volume": "64", "author": "N Taira", "year": "2016", "unstructured": "Taira, N., Nguyen, B. C., Be Tu, P. T. & Tawata, S. Effect of okinawa propolis on PAK1 activity, Caenorhabditis elegans longevity, melanogenesis, and growth of cancer cells. J. Agric. Food Chem. 64, 5484\u20135489 (2016).", "journal-title": "J. Agric. Food Chem."}, {"key": "204_CR101", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1038/nrc3645", "volume": "14", "author": "M Radu", "year": "2014", "unstructured": "Radu, M., Semenova, G., Kosoff, R. & Chernoff, J. PAK signalling during the development and progression of cancer. Nat. Rev. Cancer 14, 13\u201325 (2014).", "journal-title": "Nat. Rev. Cancer"}, {"key": "204_CR102", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/j.mrrev.2010.06.002", "volume": "705", "author": "D Scherer", "year": "2010", "unstructured": "Scherer, D. & Kumar, R. Genetics of pigmentation in skin cancer--a review. Mutat. Res. 705, 141\u2013153 (2010).", "journal-title": "Mutat. Res."}, {"key": "204_CR103", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1111/j.1600-0625.2009.00846.x", "volume": "18", "author": "LP Fernandez", "year": "2009", "unstructured": "Fernandez, L. P. et al. Pigmentation-related genes and their implication in malignant melanoma susceptibility. Exp. Dermatol. 18, 634\u2013642 (2009).", "journal-title": "Exp. Dermatol."}, {"key": "204_CR104", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1038/nature06128", "volume": "449", "author": "R Dentin", "year": "2007", "unstructured": "Dentin, R. et al. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449, 366\u2013369 (2007).", "journal-title": "Nature"}, {"key": "204_CR105", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1016/j.cmet.2009.06.006", "volume": "10", "author": "J Lay Le", "year": "2009", "unstructured": "Le Lay, J. et al. CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis. Cell Metab. 10, 55\u201362 (2009).", "journal-title": "Cell Metab."}, {"key": "204_CR106", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1016/j.ejmech.2016.09.049", "volume": "125", "author": "V Asati", "year": "2017", "unstructured": "Asati, V., Mahapatra, D. K. & Bharti, S. K. K-Ras and its inhibitors towards personalized cancer treatment: pharmacological and structural perspectives. Eur. J. Med. Chem. 125, 299\u2013314 (2017).", "journal-title": "Eur. J. Med. Chem."}, {"key": "204_CR107", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1158/1535-7163.MCT-16-0205", "volume": "16", "author": "A Aboukameel", "year": "2017", "unstructured": "Aboukameel, A. et al. Novel p21-activated kinase 4 (PAK4) allosteric modulators overcome drug resistance and stemness in pancreatic ductal adenocarcinoma. Mol. Cancer Ther. 16, 76\u201387 (2017).", "journal-title": "Mol. Cancer Ther."}], "container-title": ["Experimental & Molecular Medicine"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/s12276-018-0204-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s12276-018-0204-0", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s12276-018-0204-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 19]], "date-time": "2019-03-19T21:49:41Z", "timestamp": 1553032181000}, "score": 19.71289, "issued": {"date-parts": [[2019, 2]]}, "references-count": 107, "journal-issue": {"published-print": {"date-parts": [[2019, 2]]}, "issue": "2"}, "alternative-id": ["204"], "URL": "http://dx.doi.org/10.1038/s12276-018-0204-0", "relation": {"cites": []}, "ISSN": ["2092-6413"], "issn-type": [{"value": "2092-6413", "type": "electronic"}], "subject": ["Clinical Biochemistry", "Molecular Medicine", "Biochemistry", "Molecular Biology"], "assertion": [{"value": "14 August 2018", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "27 October 2018", "order": 2, "name": "revised", "label": "Revised", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "5 November 2018", "order": 3, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "12 February 2019", "order": 4, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare that they have no conflict of interest.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of interest"}}], "article-number": "11"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T04:24:38Z", "timestamp": 1574223878997}, "reference-count": 48, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2006, 7, 31]], "date-time": "2006-07-31T00:00:00Z", "timestamp": 1154304000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2007, 1]]}, "DOI": "10.1038/sj.onc.1209837", "type": "journal-article", "created": {"date-parts": [[2006, 8, 1]], "date-time": "2006-08-01T12:54:27Z", "timestamp": 1154436867000}, "page": "487-499", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation"], "prefix": "10.1038", "volume": "26", "author": [{"given": "K W", "family": "Jeong", "sequence": "first", "affiliation": []}, {"given": "H-Z", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Y S", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Choe", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2006, 7, 31]]}, "reference": [{"key": "BF1209837_CR1", "unstructured": "Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F . (2003). Oncogene 22: 5938\u20135945.", "DOI": "10.1038/sj.onc.1206894", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR2", "unstructured": "Charest A, Lane K, McMahon K, Housman DE . (2001). J Biol Chem 276: 29456\u201329465.", "DOI": "10.1074/jbc.M104137200", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR3", "unstructured": "Cheng J, Moyer BD, Milewski M, Loffing J, Ikeda M, Mickle JE et al. (2002). J Biol Chem 277: 3520\u20133529.", "DOI": "10.1074/jbc.M110177200", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR4", "unstructured": "Cheng J, Wang H, Guggino WB . (2004). J Biol Chem 279: 1892\u20131898.", "DOI": "10.1074/jbc.M308640200", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR5", "unstructured": "Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Neudauer CL et al. (2001). Nature 410: 944\u2013948.", "DOI": "10.1038/35073608", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR6", "unstructured": "Cuadra AE, Kuo SH, Kawasaki Y, Bredt DS, Chetkovich DM . (2004). J Neurosci 24: 7491\u20137502.", "DOI": "10.1523/JNEUROSCI.1255-04.2004", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR7", "unstructured": "Gao Q, Kumar A, Singh L, Huibregtse JM, Beaudenon S, Srinivasan S et al. (2002). Cancer Res 62: 3315\u20133321."}, {"key": "BF1209837_CR8", "unstructured": "Gentzsch M, Cui L, Mengos A, Chang XB, Chen JH, Riordan JR . (2003). J Biol Chem 278: 6440\u20136449.", "DOI": "10.1074/jbc.M211050200", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR9", "unstructured": "Glaunsinger BA, Lee SS, Thomas M, Banks L, Javier R . (2000). Oncogene 19: 5270\u20135280.", "DOI": "10.1038/sj.onc.1203906", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR10", "unstructured": "Graham FL, van der Eb AJ . (1973). Virology 52: 456\u2013467.", "DOI": "10.1016/0042-6822(73)90341-3", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR11", "unstructured": "Grassmann K, Rapp B, Maschek H, Petry KU, Iftner T . (1996). J Virol 70: 2339\u20132349."}, {"key": "BF1209837_CR12", "unstructured": "Hassel B, Schreff M, Stube EM, Blaich U, Schumacher S . (2003). J Biol Chem 278: 40136\u201340143.", "DOI": "10.1074/jbc.M305577200", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR13", "unstructured": "Hengstermann A, Linares LK, Ciechanover A, Whitaker NJ, Scheffner M . (2001). Proc Natl Acad Sci USA 98: 1218\u20131223.", "DOI": "10.1073/pnas.98.3.1218", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR14", "unstructured": "Huibregtse JM, Scheffner M, Howley PM . (1993). Mol Cell Biol 13: 775\u2013784.", "DOI": "10.1128/MCB.13.2.775", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR15", "unstructured": "Humbert P, Russell S, Richardson H . (2003). Bioessays 25: 542\u2013553.", "DOI": "10.1002/bies.10286", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR16", "unstructured": "Jiang M, Milner J . (2002). Oncogene 21: 6041\u20136048.", "DOI": "10.1038/sj.onc.1205878", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR17", "unstructured": "Kanda T, Watanabe S, Zanma S, Sato H, Furuno A, Yoshiike K . (1991). Virology 185: 536\u2013543.", "DOI": "10.1016/0042-6822(91)90523-E", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR18", "unstructured": "Kao WH, Beaudenon SL, Talis AL, Huibregtse JM, Howley PM . (2000). J Virol 74: 6408\u20136417.", "DOI": "10.1128/JVI.74.14.6408-6417.2000", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR19", "unstructured": "Kelley ML, Keiger KE, Lee CJ, Huibregtse JM . (2005). J Virol 79: 3737\u20133747.", "DOI": "10.1128/JVI.79.6.3737-3747.2005", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR20", "unstructured": "Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M . (1997). Proc Natl Acad Sci USA 94: 11612\u201311616.", "DOI": "10.1073/pnas.94.21.11612", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR21", "unstructured": "Kubbutat MH, Jones SN, Vousden KH . (1997). Nature 387: 299\u2013303.", "DOI": "10.1038/387299a0", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR22", "unstructured": "Kuhne C, Banks L . (1998). J Biol Chem 273: 34302\u201334309.", "DOI": "10.1074/jbc.273.51.34302", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR23", "unstructured": "Kumar S, Talis AL, Howley PM . (1999). J Biol Chem 274: 18785\u201318792.", "DOI": "10.1074/jbc.274.26.18785", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR24", "unstructured": "Lee SS, Glaunsinger B, Mantovani F, Banks L, Javier RT . (2000). J Virol 74: 9680\u20139693.", "DOI": "10.1128/JVI.74.20.9680-9693.2000", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR25", "unstructured": "Lee SS, Weiss RS, Javier RT . (1997). Proc Natl Acad Sci USA 94: 6670\u20136675.", "DOI": "10.1073/pnas.94.13.6670", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR26", "unstructured": "Mantovani F, Banks L . (2001). Oncogene 20: 7874\u20137887.", "DOI": "10.1038/sj.onc.1204869", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR27", "unstructured": "Nakagawa S, Huibregtse JM . (2000). Mol Cell Biol 20: 8244\u20138253.", "DOI": "10.1128/MCB.20.21.8244-8253.2000", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR28", "unstructured": "Nakagawa S, Watanabe S, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T . (1995). Virology 212: 535\u2013542.", "DOI": "10.1006/viro.1995.1511", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR29", "unstructured": "Neudauer CL, Joberty G, Macara IG . (2001). Biochem Biophys Res Commun 280: 541\u2013547.", "DOI": "10.1006/bbrc.2000.4160", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR30", "unstructured": "Pim D, Thomas M, Javier R, Gardiol D, Banks L . (2000). Oncogene 19: 719\u2013725.", "DOI": "10.1038/sj.onc.1203374", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR31", "unstructured": "Piserchio A, Fellows A, Madden DR, Mierke DF . (2005). Biochemistry 44: 16158\u201316166.", "DOI": "10.1021/bi0516475", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR32", "unstructured": "Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . (1990). Cell 63: 1129\u20131136.", "DOI": "10.1016/0092-8674(90)90409-8", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR33", "unstructured": "Schneider-Gadicke A, Kaul S, Schwarz E, Gausepohl H, Frank R, Bastert G . (1988). Cancer Res 48: 2969\u20132974."}, {"key": "BF1209837_CR34", "unstructured": "Schneider-Gadicke A, Schwarz E . (1986). EMBO J 5: 2285\u20132292.", "DOI": "10.1002/j.1460-2075.1986.tb04496.x", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR35", "unstructured": "Sedman SA, Barbosa MS, Vass WC, Hubbert NL, Haas JA, Lowy DR et al. (1991). J Virol 65: 4860\u20134866."}, {"key": "BF1209837_CR36", "unstructured": "Sheng M, Sala C . (2001). Annu Rev Neurosci 24: 1\u201329.", "DOI": "10.1146/annurev.neuro.24.1.1", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR37", "unstructured": "Smotkin D, Wettstein FO . (1986). Proc Natl Acad Sci USA 83: 4680\u20134684.", "DOI": "10.1073/pnas.83.13.4680", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR38", "unstructured": "Thomas M, Banks L . (1998). Oncogene 17: 2943\u20132954.", "DOI": "10.1038/sj.onc.1202223", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR39", "unstructured": "Thomas M, Glaunsinger B, Pim D, Javier R, Banks L . (2001). Oncogene 20: 5431\u20135439.", "DOI": "10.1038/sj.onc.1204719", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR40", "unstructured": "Thomas M, Laura R, Hepner K, Guccione E, Sawyers C, Lasky L et al. (2002). Oncogene 21: 5088\u20135096.", "DOI": "10.1038/sj.onc.1205668", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR41", "unstructured": "Thomas M, Massimi P, Navarro C, Borg JP, Banks L . (2005). Oncogene 24: 6222\u20136230.", "DOI": "10.1038/sj.onc.1208757", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR42", "unstructured": "Yao R, Ito C, Natsume Y, Sugitani Y, Yamanaka H, Kuretake S et al. (2002). Proc Natl Acad Sci USA 99: 11211\u201311216.", "DOI": "10.1073/pnas.162027899", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR43", "unstructured": "Yao R, Maeda T, Takada S, Noda T . (2001). Biochem Biophys Res Commun 286: 771\u2013778.", "DOI": "10.1006/bbrc.2001.5430", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR44", "unstructured": "Yoshinouchi M, Yamada T, Kizaki M, Fen J, Koseki T, Ikeda Y et al. (2003). Mol Ther 8: 762\u2013768.", "DOI": "10.1016/j.ymthe.2003.08.004", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR45", "unstructured": "Yue Z, Horton A, Bravin M, DeJager PL, Selimi F, Heintz N . (2002). Neuron 35: 921\u2013933.", "DOI": "10.1016/S0896-6273(02)00861-9", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR46", "unstructured": "Zimmermann H, Degenkolbe R, Bernard HU, O'Connor MJ . (1999). J Virol 73: 6209\u20136219."}, {"key": "BF1209837_CR47", "unstructured": "zur Hausen H . (1996). Biochim Biophys Acta 1288: F55\u2013F78.", "DOI": "10.1016/0304-419X(96)00020-0", "doi-asserted-by": "crossref"}, {"key": "BF1209837_CR48", "unstructured": "zur Hausen H . (2000). J Natl Cancer Inst 92: 690\u2013698.", "DOI": "10.1093/jnci/92.9.690", "doi-asserted-by": "crossref"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1209837.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1209837", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1209837.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 20]], "date-time": "2019-04-20T12:29:53Z", "timestamp": 1555763393000}, "score": 19.664968, "issued": {"date-parts": [[2006, 7, 31]]}, "references-count": 48, "journal-issue": {"published-print": {"date-parts": [[2007, 1]]}, "issue": "4"}, "alternative-id": ["BF1209837"], "URL": "http://dx.doi.org/10.1038/sj.onc.1209837", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:18:55Z", "timestamp": 1574284735136}, "publisher-location": "100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959", "reference-count": 0, "publisher": "ASTM International", "isbn-type": [{"value": "9780803114920", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1520/stp19614s", "type": "book-chapter", "created": {"date-parts": [[2009, 3, 9]], "date-time": "2009-03-09T20:33:24Z", "timestamp": 1236630804000}, "page": "186-186-11", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Influence of Aggregate Microstructure on the Volume Stability of Lightweight Concrete Masonry"], "prefix": "10.1520", "author": [{"given": "TW", "family": "Bremner", "sequence": "first", "affiliation": []}, {"given": "D", "family": "Rae", "sequence": "additional", "affiliation": []}], "member": "381", "container-title": ["Masonry: Design and Construction, Problems and Repair"], "deposited": {"date-parts": [[2015, 4, 7]], "date-time": "2015-04-07T18:57:46Z", "timestamp": 1428433066000}, "score": 19.577429, "issued": {"date-parts": [[null]]}, "ISBN": ["9780803114920"], "references-count": 0, "URL": "http://dx.doi.org/10.1520/stp19614s"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:34:56Z", "timestamp": 1574296496044}, "publisher-location": "New York, NY", "reference-count": 121, "publisher": "Springer US", "isbn-type": [{"value": "9780387691435", "type": "print"}, {"value": "9780387691473", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-0-387-69147-3_4", "type": "book-chapter", "created": {"date-parts": [[2009, 4, 18]], "date-time": "2009-04-18T17:09:06Z", "timestamp": 1240074546000}, "page": "45-63", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Modulation of Protein Stability: Targeting the VHL Pathway"], "prefix": "10.1007", "author": [{"given": "William Y.", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "William G.", "family": "Kaelin", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 3, 16]]}, "reference": [{"issue": "5", "key": "4_CR1_4", "doi-asserted-by": "crossref", "first-page": "1289", "DOI": "10.1167/iovs.03-0282", "volume": "45", "author": "H. Akiyama", "year": "2004", "unstructured": "Akiyama, H., T. Tanaka, et al (2004). \u201cInhibition of ocular angiogenesis by an adenovirus carrying the human von Hippel-Lindau tumor-suppressor gene in vivo\u201d. Invest Ophthalmol Vis Sci 45(5): 1289\u201396.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "5", "key": "4_CR2_4", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1200/JCO.2004.08.185", "volume": "22", "author": "M.B. Atkins", "year": "2004", "unstructured": "Atkins, M.B., M. Hidalgo, et al (2004). \u201cRandomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma\u201d. J Clin Oncol 22(5): 909\u201318.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "4_CR3_4", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/S0092-8674(00)80098-7", "volume": "86", "author": "C. Bai", "year": "1996", "unstructured": "Bai, C., P. Sen, et al (1996). \u201cSKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.\u201d Cell 86(2): 263\u201374.", "journal-title": "Cell"}, {"issue": "2", "key": "4_CR4_4", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1172/JCI5028", "volume": "103", "author": "L.E. Benjamin", "year": "1999", "unstructured": "Benjamin, L.E., D. Golijanin, et al (1999). \u201cSelective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal\u201d. J Clin Invest 103(2): 159\u201365.", "journal-title": "J Clin Invest"}, {"issue": "6", "key": "4_CR5_4", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1038/nrc1093", "volume": "3", "author": "G. Bergers", "year": "2003", "unstructured": "Bergers, G. and L.E. Benjamin (2003). \u201cTumorigenesis and the angiogenic switch\u201d. Nat Rev Cancer 3(6): 401\u201310.", "journal-title": "Nat Rev Cancer"}, {"issue": "9", "key": "4_CR6_4", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1172/JCI200317929", "volume": "111", "author": "G. Bergers", "year": "2003", "unstructured": "Bergers, G., S. Song, et al (2003). \u201cBenefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.\u201d J Clin Invest 111(9): 1287\u201395.", "journal-title": "J Clin Invest"}, {"issue": "8", "key": "4_CR7_4", "doi-asserted-by": "crossref", "first-page": "1529", "DOI": "10.1038/sj.onc.1202473", "volume": "18", "author": "C. Blankenship", "year": "1999", "unstructured": "Blankenship, C., J.G. Naglich, et al (1999). \u201cAlternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity.\u201d Oncogene 18(8): 1529\u201335.", "journal-title": "Oncogene"}, {"issue": "9", "key": "4_CR8_4", "doi-asserted-by": "crossref", "first-page": "769", "DOI": "10.1038/nrd2133", "volume": "5", "author": "J.E. Bolden", "year": "2006", "unstructured": "Bolden, J.E., M.J. Peart, et al (2006). \u201cAnticancer activities of histone deacetylase inhibitors.\u201d Nat Rev Drug Discov 5(9): 769\u201384.", "journal-title": "Nat Rev Drug Discov"}, {"issue": "2", "key": "4_CR9_4", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1016/S1535-6108(03)00187-9", "volume": "4", "author": "J.B. Brugarolas", "year": "2003", "unstructured": "Brugarolas, J.B., F. Vazquez, et al (2003). \u201cTSC2 regulates VEGF through mTOR-dependent and -independent pathways.\u201d Cancer Cell 4(2): 147\u201358.", "journal-title": "Cancer Cell"}, {"issue": "5545", "key": "4_CR10_4", "doi-asserted-by": "crossref", "first-page": "1337", "DOI": "10.1126/science.1066373", "volume": "294", "author": "R.K. Bruick", "year": "2001", "unstructured": "Bruick, R.K.and S.L. McKnight (2001). \u201cA conserved family of prolyl-4-hydroxylases that modify HIF.\u201d Science 294(5545): 1337\u201340.", "journal-title": "Science"}, {"issue": "29", "key": "4_CR11_4", "doi-asserted-by": "crossref", "first-page": "4536", "DOI": "10.1200/JCO.2007.11.5154", "volume": "25", "author": "R.M. Bukowski", "year": "2007", "unstructured": "Bukowski, R.M., F.F. Kabbinavar, et al (2007). \u201cRandomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer.\u201d J Clin Oncol 25(29): 4536\u201341.", "journal-title": "J Clin Oncol"}, {"issue": "6", "key": "4_CR12_4", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1038/sj.onc.1205140", "volume": "21", "author": "M.C. Caldwell", "year": "2002", "unstructured": "Caldwell, M.C., C. Hough, et al (2002). \u201cSerial analysis of gene expression in renal carcinoma cells reveals VHL-dependent sensitivity to TNFalpha cytotoxicity.\u201d Oncogene 21(6): 929\u201336.", "journal-title": "Oncogene"}, {"issue": "6 Pt 1", "key": "4_CR13_4", "doi-asserted-by": "crossref", "first-page": "2176", "DOI": "10.1097/01.ju.0000127727.33232.cf", "volume": "171", "author": "M. Castillo", "year": "2004", "unstructured": "Castillo, M., A. Petit, et al (2004). \u201cC-kit expression in sarcomatoid renal cell carcinoma: potential therapy with imatinib.\u201d J Urol 171(6 Pt 1): 2176\u201380.", "journal-title": "J Urol"}, {"issue": "33", "key": "4_CR14_4", "doi-asserted-by": "crossref", "first-page": "25733", "DOI": "10.1074/jbc.M002740200", "volume": "275", "author": "M.E. Cockman", "year": "2000", "unstructured": "Cockman, M.E., N. Masson, et al (2000). \u201cHypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel\u2013Lindau tumor suppressor protein.\u201d J Biol Chem 275(33): 25733\u201341.", "journal-title": "J Biol Chem"}, {"issue": "12", "key": "4_CR15_4", "doi-asserted-by": "crossref", "first-page": "1404", "DOI": "10.1634/theoncologist.12-12-1404", "volume": "12", "author": "L.J. Costa", "year": "2007", "unstructured": "Costa, L.J.and H.A. Drabkin (2007). \u201cRenal cell carcinoma: new developments in molecular biology and potential for targeted therapies.\u201d Oncologist 12(12): 1404\u201315.", "journal-title": "Oncologist"}, {"issue": "4", "key": "4_CR16_4", "first-page": "1387", "volume": "98", "author": "N. de Paulsen", "year": "2001", "unstructured": "de Paulsen, N., A. Brychzy, et al (2001). \u201cRole of transforming growth factor-alpha in von Hippel-Lindau (VHL) (\u2212/\u2212) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.\u201d Proc Natl Acad Sci U S A 98(4): 1387\u201392.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "No. 18S (June 2", "key": "4_CR17_4", "first-page": "5106", "volume": "25", "author": "A. Dham", "year": "2007", "unstructured": "Dham, A.and A.Z. Dudek (2007). \u201cSequential therapy with sorafenib and sunitinib in renal cell carcinoma.\u201d J Clin Oncol, ASCO Annual Meeting Proceedings Part I 25(No. 18S (June 20 Supplement)): 5106.", "journal-title": "J Clin Oncol"}, {"issue": "5229", "key": "4_CR18_4", "doi-asserted-by": "crossref", "first-page": "1402", "DOI": "10.1126/science.7660122", "volume": "269", "author": "D.R. Duan", "year": "1995", "unstructured": "Duan, D.R., A. Pause, et al (1995). \u201cInhibition of transcription elongation by the VHL tumor suppressor protein.\u201d Science 269(5229): 1402\u20136.", "journal-title": "Science"}, {"issue": "1", "key": "4_CR19_4", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/S0092-8674(01)00507-4", "volume": "107", "author": "A.C. Epstein", "year": "2001", "unstructured": "Epstein, A.C., J.M. Gleadle, et al (2001). \u201cC. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.\u201d Cell 107(1): 43\u201354.", "journal-title": "Cell"}, {"issue": "2", "key": "4_CR20_4", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1056/NEJMoa060655", "volume": "356", "author": "B. Escudier", "year": "2007", "unstructured": "Escudier, B., T. Eisen, et al (2007). \u201cSorafenib in advanced clear-cell renal-cell carcinoma.\u201d N Engl J Med 356(2): 125\u201334.", "journal-title": "N Engl J Med"}, {"issue": "9605", "key": "4_CR21_4", "doi-asserted-by": "crossref", "first-page": "2103", "DOI": "10.1016/S0140-6736(07)61904-7", "volume": "370", "author": "B. Escudier", "year": "2007", "unstructured": "Escudier, B., A. Pluzanska, et al (2007). \u201cBevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.\u201d Lancet 370(9605): 2103\u201311.", "journal-title": "Lancet"}, {"issue": "3", "key": "4_CR22_4", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1002/path.1520", "volume": "202", "author": "S.B. Fox", "year": "2004", "unstructured": "Fox, S.B., H. Turley, et al (2004). \u201cPhosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus.\u201d J Pathol 202(3): 313\u201320.", "journal-title": "J Pathol"}, {"issue": "7", "key": "4_CR23_4", "doi-asserted-by": "crossref", "first-page": "2316", "DOI": "10.1128/MCB.23.7.2316-2328.2003", "volume": "23", "author": "S. Galban", "year": "2003", "unstructured": "Galban, S., J. Fan, et al (2003). \u201cvon Hippel\u2013Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays.\u201d Mol Cell Biol 23(7): 2316\u201328.", "journal-title": "Mol Cell Biol"}, {"issue": "10", "key": "4_CR24_4", "doi-asserted-by": "crossref", "first-page": "3645", "DOI": "10.1158/0008-5472.CAN-04-0006", "volume": "64", "author": "P. George", "year": "2004", "unstructured": "George, P., P. Bali, et al (2004). \u201cCotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3.\u201d Cancer Res 64(10): 3645\u201352.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "4_CR25_4", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.4161/cbt.5.6.2709", "volume": "5", "author": "K. Gong", "year": "2006", "unstructured": "Gong, K., N. Zhang, et al (2006). \u201cCoexpression of erythopoietin and erythopoietin receptor in sporadic clear cell renal cell carcinoma.\u201d Cancer Biol Ther 5(6): 582\u20135.", "journal-title": "Cancer Biol Ther"}, {"issue": "10", "key": "4_CR26_4", "doi-asserted-by": "crossref", "first-page": "5221", "DOI": "10.1128/MCB.16.10.5221", "volume": "16", "author": "K. Gradin", "year": "1996", "unstructured": "Gradin, K., J. McGuire, et al (1996). \u201cFunctional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor.\u201d Mol Cell Biol 16(10): 5221\u201331.", "journal-title": "Mol Cell Biol"}, {"issue": "45", "key": "4_CR27_4", "doi-asserted-by": "crossref", "first-page": "44966", "DOI": "10.1074/jbc.M305502200", "volume": "278", "author": "L. Gunaratnam", "year": "2003", "unstructured": "Gunaratnam, L., M. Morley, et al (2003). \u201cHypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL (\u2212/\u2212) renal cell carcinoma cells.\u201d J Biol Chem 278(45): 44966\u201374.", "journal-title": "J Biol Chem"}, {"issue": "5644", "key": "4_CR28_4", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1126/science.1088547", "volume": "302", "author": "S. Hacein-Bey-Abina", "year": "2003", "unstructured": "Hacein-Bey-Abina, S., C. Von Kalle, et al (2003). \u201cLMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.\u201d Science 302(5644): 415\u20139.", "journal-title": "Science"}, {"issue": "11", "key": "4_CR29_4", "doi-asserted-by": "crossref", "first-page": "4682", "DOI": "10.1210/en.2005-0416", "volume": "146", "author": "M. Hayashi", "year": "2005", "unstructured": "Hayashi, M., M. Sakata, et al (2005). \u201cUp-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1alpha is involved in trophoblast invasion under low-oxygen tension.\u201d Endocrinology 146(11): 4682\u20139.", "journal-title": "Endocrinology"}, {"issue": "1", "key": "4_CR30_4", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1038/ncb899", "volume": "5", "author": "A. Hergovich", "year": "2003", "unstructured": "Hergovich, A., J. Lisztwan, et al (2003). \u201cRegulation of microtubule stability by the von Hippel\u2013Lindau tumour suppressor protein pVHL.\u201d Nat Cell Biol 5(1): 64\u201370.", "journal-title": "Nat Cell Biol"}, {"issue": "15", "key": "4_CR31_4", "doi-asserted-by": "crossref", "first-page": "5784", "DOI": "10.1128/MCB.00232-06", "volume": "26", "author": "A. Hergovich", "year": "2006", "unstructured": "Hergovich, A., J. Lisztwan, et al (2006). \u201cPriming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.\u201d Mol Cell Biol 26(15): 5784\u201396.", "journal-title": "Mol Cell Biol"}, {"issue": "5577", "key": "4_CR32_4", "doi-asserted-by": "crossref", "first-page": "2404", "DOI": "10.1126/science.1070200", "volume": "296", "author": "J.D. Hood", "year": "2002", "unstructured": "Hood, J.D., M. Bednarski, et al (2002). \u201cTumor regression by targeted gene delivery to the neovasculature.\u201d Science 296(5577): 2404\u20137.", "journal-title": "Science"}, {"issue": "14", "key": "4_CR33_4", "doi-asserted-by": "crossref", "first-page": "7987", "DOI": "10.1073/pnas.95.14.7987", "volume": "95", "author": "L.E. Huang", "year": "1998", "unstructured": "Huang, L.E., J. Gu, et al (1998). \u201cRegulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.\u201d Proc Natl Acad Sci U S A 95(14): 7987\u201392.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "22", "key": "4_CR34_4", "doi-asserted-by": "crossref", "first-page": "2271", "DOI": "10.1056/NEJMoa066838", "volume": "356", "author": "G. Hudes", "year": "2007", "unstructured": "Hudes, G., M. Carducci, et al (2007). \u201cTemsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.\u201d N Engl J Med 356(22): 2271\u201381.", "journal-title": "N Engl J Med"}, {"issue": "20", "key": "4_CR35_4", "doi-asserted-by": "crossref", "first-page": "7004", "DOI": "10.1128/MCB.22.20.7004-7014.2002", "volume": "22", "author": "C.C. Hudson", "year": "2002", "unstructured": "Hudson, C.C., M. Liu, et al (2002). \u201cRegulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.\u201d Mol Cell Biol 22(20): 7004\u201314.", "journal-title": "Mol Cell Biol"}, {"issue": "June 20 Supplem", "key": "4_CR36_4", "first-page": "5031", "volume": "25", "author": "T.E. Hutson", "year": "2007", "unstructured": "Hutson, T.E., I.D. Davis, et al (2007). \u201cPazopanib (GW786034) is active in metastatic renal cell carcinoma (RCC): Interim results of a phase II randomized discontinuation trial (RDT).\u201d J Clin Oncol, ASCO Annual Meeting Proceedings 25 (June 20 Supplement): 5031.", "journal-title": "J Clin Oncol"}, {"issue": "8", "key": "4_CR37_4", "doi-asserted-by": "crossref", "first-page": "822", "DOI": "10.1038/nm0895-822", "volume": "1", "author": "O. Iliopoulos", "year": "1995", "unstructured": "Iliopoulos, O., A. Kibel, et al (1995). \u201cTumour suppression by the human von Hippel\u2013Lindau gene product.\u201d Nat Med 1(8): 822\u20136.", "journal-title": "Nat Med"}, {"issue": "20", "key": "4_CR38_4", "doi-asserted-by": "crossref", "first-page": "10595", "DOI": "10.1073/pnas.93.20.10595", "volume": "93", "author": "O. Iliopoulos", "year": "1996", "unstructured": "Iliopoulos, O., A.P. Levy, et al (1996). \u201cNegative regulation of hypoxia-inducible genes by the von Hippel\u2013Lindau protein.\u201d Proc Natl Acad Sci U S A 93(20): 10595\u20139.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "20", "key": "4_CR39_4", "doi-asserted-by": "crossref", "first-page": "11661", "DOI": "10.1073/pnas.95.20.11661", "volume": "95", "author": "O. Iliopoulos", "year": "1998", "unstructured": "Iliopoulos, O., M. Ohh, et al (1998). \u201cpVHL19 is a biologically active product of the von Hippel\u2013Lindau gene arising from internal translation initiation.\u201d Proc Natl Acad Sci U S A 95(20): 11661\u20136.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "33", "key": "4_CR40_4", "doi-asserted-by": "crossref", "first-page": "29936", "DOI": "10.1074/jbc.M204733200", "volume": "277", "author": "J.S. Isaacs", "year": "2002", "unstructured": "Isaacs, J.S., Y.J. Jung, et al (2002). \u201cHsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.\u201d J Biol Chem 277(33): 29936\u201344.", "journal-title": "J Biol Chem"}, {"issue": "3", "key": "4_CR41_4", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1016/S1535-6108(03)00029-1", "volume": "3", "author": "J.S. Isaacs", "year": "2003", "unstructured": "Isaacs, J.S., W. Xu, et al (2003). \u201cHeat shock protein 90 as a molecular target for cancer therapeutics.\u201d Cancer Cell 3(3): 213\u20137.", "journal-title": "Cancer Cell"}, {"issue": "21", "key": "4_CR42_4", "doi-asserted-by": "crossref", "first-page": "13459", "DOI": "10.1073/pnas.192342099", "volume": "99", "author": "M. Ivan", "year": "2002", "unstructured": "Ivan, M., T. Haberberger, et al (2002). \u201cBiochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.\u201d Proc Natl Acad Sci U S A 99(21): 13459\u201364.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "5516", "key": "4_CR43_4", "doi-asserted-by": "crossref", "first-page": "464", "DOI": "10.1126/science.1059817", "volume": "292", "author": "M. Ivan", "year": "2001", "unstructured": "Ivan, M., K. Kondo, et al (2001). \u201cHIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.\u201d Science 292(5516): 464\u20138.", "journal-title": "Science"}, {"issue": "5516", "key": "4_CR44_4", "doi-asserted-by": "crossref", "first-page": "468", "DOI": "10.1126/science.1059796", "volume": "292", "author": "P. Jaakkola", "year": "2001", "unstructured": "Jaakkola, P., D.R. Mole, et al (2001). \u201cTargeting of HIF-alpha to the von Hippel\u2013Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.\u201d Science 292(5516): 468\u201372.", "journal-title": "Science"}, {"issue": "5", "key": "4_CR45_4", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1016/S0092-8674(02)01085-1", "volume": "111", "author": "J.W. Jeong", "year": "2002", "unstructured": "Jeong, J.W., M.K. Bae, et al (2002). \u201cRegulation and destabilization of HIF-1alpha by ARD1-mediated acetylation.\u201d Cell 111(5): 709\u201320.", "journal-title": "Cell"}, {"issue": "6", "key": "4_CR46_4", "first-page": "453", "volume": "1", "author": "Y. Jiang", "year": "2003", "unstructured": "Jiang, Y., W. Zhang, et al (2003). \u201cGene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways.\u201d Mol Cancer Res 1(6): 453\u201362.", "journal-title": "Mol Cancer Res"}, {"issue": "2", "key": "4_CR47_4", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1016/j.ddmec.2005.04.003", "volume": "2", "author": "W.G. Kaelin", "year": "2005", "unstructured": "Kaelin, W.G. (2005). \u201cvon Hippel\u2013Lindau-associated malignancies: Mechanisms and therapeutic opportunities.\u201d Drug Discov Today 2(2): 225\u201331.", "journal-title": "Drug Discov Today"}, {"issue": "9", "key": "4_CR48_4", "doi-asserted-by": "crossref", "first-page": "673", "DOI": "10.1038/nrc885", "volume": "2", "author": "W.G. Kaelin Jr.", "year": "2002", "unstructured": "Kaelin, W.G., Jr. (2002). \u201cMolecular basis of the VHL hereditary cancer syndrome.\u201d Nat Rev Cancer 2(9): 673\u201382.", "journal-title": "Nat Rev Cancer"}, {"issue": "22", "key": "4_CR49_4", "doi-asserted-by": "crossref", "first-page": "2928", "DOI": "10.1101/gad.13.22.2928", "volume": "13", "author": "T. Kamura", "year": "1999", "unstructured": "Kamura, T., M.N. Conrad, et al (1999). \u201cThe Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2.\u201d Genes Dev 13(22): 2928\u201333.", "journal-title": "Genes Dev"}, {"issue": "19", "key": "4_CR50_4", "doi-asserted-by": "crossref", "first-page": "10430", "DOI": "10.1073/pnas.190332597", "volume": "97", "author": "T. Kamura", "year": "2000", "unstructured": "Kamura, T., S. Sato, et al (2000). \u201cActivation of HIF1alpha ubiquitination by a reconstituted von Hippel\u2013Lindau (VHL) tumor suppressor complex.\u201d Proc Natl Acad Sci U S A 97(19): 10430\u20135.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "5229", "key": "4_CR51_4", "doi-asserted-by": "crossref", "first-page": "1444", "DOI": "10.1126/science.7660130", "volume": "269", "author": "A. Kibel", "year": "1995", "unstructured": "Kibel, A., O. Iliopoulos, et al (1995). \u201cBinding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.\u201d Science 269(5229): 1444\u20136.", "journal-title": "Science"}, {"issue": "4", "key": "4_CR52_4", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1038/86507", "volume": "7", "author": "M.S. Kim", "year": "2001", "unstructured": "Kim, M.S., H.J. Kwon, et al (2001). \u201cHistone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes.\u201d Nat Med 7(4): 437\u201343.", "journal-title": "Nat Med"}, {"issue": "24", "key": "4_CR53_4", "doi-asserted-by": "crossref", "first-page": "4991", "DOI": "10.1200/JCO.2004.05.061", "volume": "22", "author": "W.Y. Kim", "year": "2004", "unstructured": "Kim, W.Y. and W.G. Kaelin (2004). \u201cRole of VHL gene mutation in human cancer.\u201d J Clin Oncol 22(24): 4991\u20135004.", "journal-title": "J Clin Oncol"}, {"issue": "19", "key": "4_CR54_4", "doi-asserted-by": "crossref", "first-page": "4650", "DOI": "10.1038/sj.emboj.7601300", "volume": "25", "author": "W.Y. Kim", "year": "2006", "unstructured": "Kim, W.Y., M. Safran, et al (2006). \u201cFailure to prolyl hydroxylate HIFalpha phenocopies VHL inactivation in vivo.\u201d Embo J 25(19): 4650\u201362.", "journal-title": "Embo J"}, {"issue": "20", "key": "4_CR55_4", "first-page": "4544", "volume": "55", "author": "T. Kishida", "year": "1995", "unstructured": "Kishida, T., T.M. Stackhouse, et al (1995). \u201cCellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations.\u201d Cancer Res 55(20): 4544\u20138.", "journal-title": "Cancer Res"}, {"issue": "2", "key": "4_CR56_4", "first-page": "226", "volume": "58", "author": "B. Knebelmann", "year": "1998", "unstructured": "Knebelmann, B., S. Ananth, et al (1998). \u201cTransforming growth factor alpha is a target for the von Hippel\u2013Lindau tumor suppressor.\u201d Cancer Res 58(2): 226\u201331.", "journal-title": "Cancer Res"}, {"issue": "4", "key": "4_CR57_4", "doi-asserted-by": "crossref", "first-page": "820", "DOI": "10.1073/pnas.68.4.820", "volume": "68", "author": "A.G. Knudson Jr.", "year": "1971", "unstructured": "Knudson, A.G., Jr. (1971). \u201cMutation and cancer: statistical study of retinoblastoma.\u201d Proc Natl Acad Sci U S A 68(4): 820\u20133.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "3", "key": "4_CR58_4", "doi-asserted-by": "crossref", "first-page": "E83", "DOI": "10.1371/journal.pbio.0000083", "volume": "1", "author": "K. Kondo", "year": "2003", "unstructured": "Kondo, K., W.Y. Kim, et al (2003). \u201cInhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.\u201d PLoS Biol 1(3): E83.", "journal-title": "PLoS Biol"}, {"issue": "3", "key": "4_CR59_4", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/S1535-6108(02)00043-0", "volume": "1", "author": "K. Kondo", "year": "2002", "unstructured": "Kondo, K., J. Klco, et al (2002). \u201cInhibition of HIF is necessary for tumor suppression by the von Hippel\u2013Lindau protein.\u201d Cancer Cell 1(3): 237\u201346.", "journal-title": "Cancer Cell"}, {"issue": "6", "key": "4_CR60_4", "doi-asserted-by": "crossref", "first-page": "2019", "DOI": "10.1128/MCB.26.6.2019-2028.2006", "volume": "26", "author": "X. Kong", "year": "2006", "unstructured": "Kong, X., Z. Lin, et al (2006). \u201cHistone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1{alpha}.\u201d Mol Cell Biol 26(6): 2019\u201328.", "journal-title": "Mol Cell Biol"}, {"issue": "2", "key": "4_CR61_4", "doi-asserted-by": "crossref", "first-page": "670", "DOI": "10.1172/JCI114759", "volume": "86", "author": "S. Kourembanas", "year": "1990", "unstructured": "Kourembanas, S., R.L. Hannan, et al (1990). \u201cOxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells.\u201d J Clin Invest 86(2): 670\u20134.", "journal-title": "J Clin Invest"}, {"issue": "2\u20133", "key": "4_CR62_4", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1159/000086783", "volume": "68", "author": "S. Kruger", "year": "2005", "unstructured": "Kruger, S., K. Sotlar, et al (2005). \u201cExpression of KIT (CD117) in renal cell carcinoma and renal oncocytoma.\u201d Oncology 68(2\u20133): 269\u201375.", "journal-title": "Oncology"}, {"issue": "5112", "key": "4_CR63_4", "doi-asserted-by": "crossref", "first-page": "1317", "DOI": "10.1126/science.8493574", "volume": "260", "author": "F. Latif", "year": "1993", "unstructured": "Latif, F., K. Tory, et al (1993). \u201cIdentification of the von Hippel-Lindau disease tumor suppressor gene.\u201d Science 260(5112): 1317\u201320.", "journal-title": "Science"}, {"issue": "5", "key": "4_CR64_4", "doi-asserted-by": "crossref", "first-page": "1770", "DOI": "10.1073/pnas.93.5.1770", "volume": "93", "author": "S. Lee", "year": "1996", "unstructured": "Lee, S., D.Y. Chen, et al (1996). \u201cNuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density.\u201d Proc Natl Acad Sci U S A 93(5): 1770\u20135.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "2", "key": "4_CR65_4", "doi-asserted-by": "crossref", "first-page": "1486", "DOI": "10.1128/MCB.19.2.1486", "volume": "19", "author": "S. Lee", "year": "1999", "unstructured": "Lee, S., M. Neumann, et al (1999). \u201cTranscription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel\u2013Lindau tumor suppressor protein.\u201d Mol Cell Biol 19(2): 1486\u201397.", "journal-title": "Mol Cell Biol"}, {"issue": "3", "key": "4_CR66_4", "first-page": "1059", "volume": "11", "author": "Y.S. Lee", "year": "2005", "unstructured": "Lee, Y.S., A.O. Vortmeyer, et al (2005). \u201cCoexpression of erythropoietin and erythropoietin receptor in von Hippel\u2013Lindau disease-associated renal cysts and renal cell carcinoma.\u201d Clin Cancer Res 11(3): 1059\u201364.", "journal-title": "Clin Cancer Res"}, {"issue": "2 Pt 2", "key": "4_CR67_4", "doi-asserted-by": "crossref", "first-page": "671s", "DOI": "10.1158/1078-0432.CCR-06-1870", "volume": "13", "author": "W.M. Linehan", "year": "2007", "unstructured": "Linehan, W.M., P.A. Pinto, et al (2007). \u201cIdentification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics.\u201d Clin Cancer Res 13(2 Pt 2): 671s\u2013679s.", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "4_CR68_4", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/j.molcel.2007.01.001", "volume": "25", "author": "Y.V. Liu", "year": "2007", "unstructured": "Liu, Y.V., J.H. Baek, et al (2007). \u201cRACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.\u201d Mol Cell 25(2): 207\u201317.", "journal-title": "Mol Cell"}, {"issue": "23", "key": "4_CR69_4", "doi-asserted-by": "crossref", "first-page": "22205", "DOI": "10.1074/jbc.M503220200", "volume": "280", "author": "M.P. Lolkema", "year": "2005", "unstructured": "Lolkema, M.P., M.L. Gervais, et al (2005). \u201cTumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain.\u201d J Biol Chem 280(23): 22205\u201311.", "journal-title": "J Biol Chem"}, {"issue": "2", "key": "4_CR70_4", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1128/MCB.18.2.732", "volume": "18", "author": "K.M. Lonergan", "year": "1998", "unstructured": "Lonergan, K.M., O. Iliopoulos, et al (1998). \u201cRegulation of hypoxia-inducible mRNAs by the von Hippel\u2013Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.\u201d Mol Cell Biol 18(2): 732\u201341.", "journal-title": "Mol Cell Biol"}, {"issue": "21", "key": "4_CR71_4", "doi-asserted-by": "crossref", "first-page": "2129", "DOI": "10.1056/NEJMoa040938", "volume": "350", "author": "T.J. Lynch", "year": "2004", "unstructured": "Lynch, T.J., D.W. Bell, et al (2004). \u201cActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.\u201d N Engl J Med 350(21): 2129\u201339.", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "4_CR72_4", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1016/S1535-6108(03)00077-1", "volume": "3", "author": "N.J. Mabjeesh", "year": "2003", "unstructured": "Mabjeesh, N.J., D. Escuin, et al (2003). \u201c2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.\u201d Cancer Cell 3(4): 363\u201375.", "journal-title": "Cancer Cell"}, {"issue": "9", "key": "4_CR73_4", "first-page": "2478", "volume": "62", "author": "N.J. Mabjeesh", "year": "2002", "unstructured": "Mabjeesh, N.J., D.E. Post, et al (2002). \u201cGeldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.\u201d Cancer Res 62(9): 2478\u201382.", "journal-title": "Cancer Res"}, {"issue": "5", "key": "4_CR74_4", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1016/S1535-6108(02)00071-5", "volume": "1", "author": "S.J. Mandriota", "year": "2002", "unstructured": "Mandriota, S.J., K.J. Turner, et al (2002). \u201cHIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.\u201d Cancer Cell 1(5): 459\u201368.", "journal-title": "Cancer Cell"}, {"issue": "3", "key": "4_CR75_4", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1016/S1535-6108(02)00044-2", "volume": "1", "author": "J.K. Maranchie", "year": "2002", "unstructured": "Maranchie, J.K., J.R. Vasselli, et al (2002). \u201cThe contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.\u201d Cancer Cell 1(3): 247\u201355.", "journal-title": "Cancer Cell"}, {"issue": "18", "key": "4_CR76_4", "doi-asserted-by": "crossref", "first-page": "5197", "DOI": "10.1093/emboj/20.18.5197", "volume": "20", "author": "N. Masson", "year": "2001", "unstructured": "Masson, N., C. Willam, et al (2001). \u201cIndependent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.\u201d Embo J 20(18): 5197\u2013206.", "journal-title": "Embo J"}, {"issue": "6733", "key": "4_CR77_4", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1038/20459", "volume": "399", "author": "P.H. Maxwell", "year": "1999", "unstructured": "Maxwell, P.H., M.S. Wiesener, et al (1999). \u201cThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.\u201d Nature 399(6733): 271\u20135.", "journal-title": "Nature"}, {"key": "4_CR78_4", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1016/S0076-6879(07)35020-9", "volume": "435", "author": "G. Melillo", "year": "2007", "unstructured": "Melillo, G. (2007). \u201cHypoxia-inducible factor 1 inhibitors.\u201d Methods Enzymol 435: 385\u2013402.", "journal-title": "Methods Enzymol"}, {"issue": "6", "key": "4_CR79_4", "doi-asserted-by": "crossref", "first-page": "2857", "DOI": "10.1128/MCB.16.6.2857", "volume": "16", "author": "R. Mendez", "year": "1996", "unstructured": "Mendez, R., M.G. Myers, Jr., et al (1996). \u201cStimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase.\u201d Mol Cell Biol 16(6): 2857\u201364.", "journal-title": "Mol Cell Biol"}, {"issue": "21", "key": "4_CR80_4", "doi-asserted-by": "crossref", "first-page": "6321", "DOI": "10.1046/j.1432-1327.2000.01719.x", "volume": "267", "author": "O. Meyuhas", "year": "2000", "unstructured": "Meyuhas, O. (2000). \u201cSynthesis of the translational apparatus is regulated at the translational level.\u201d Eur J Biochem 267(21): 6321\u201330.", "journal-title": "Eur J Biochem"}, {"issue": "1", "key": "4_CR81_4", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1023/A:1022928612511", "volume": "21", "author": "R.J. Motzer", "year": "2003", "unstructured": "Motzer, R.J., R. Amato, et al (2003). \u201cPhase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma.\u201d Invest New Drugs 21(1): 99\u2013101.", "journal-title": "Invest New Drugs"}, {"issue": "2", "key": "4_CR82_4", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1056/NEJMoa065044", "volume": "356", "author": "R.J. Motzer", "year": "2007", "unstructured": "Motzer, R.J., T.E. Hutson, et al (2007). \u201cSunitinib versus interferon alfa in metastatic renal-cell carcinoma.\u201d N Engl J Med 356(2): 115\u201324.", "journal-title": "N Engl J Med"}, {"issue": "7", "key": "4_CR83_4", "doi-asserted-by": "crossref", "first-page": "3699", "DOI": "10.1158/0008-5472.CAN-05-0617", "volume": "66", "author": "N. Nakaigawa", "year": "2006", "unstructured": "Nakaigawa, N., M. Yao, et al (2006). \u201cInactivation of von Hippel\u2013Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma.\u201d Cancer Res 66(7): 3699\u2013705.", "journal-title": "Cancer Res"}, {"issue": "4", "key": "4_CR84_4", "doi-asserted-by": "crossref", "first-page": "1482", "DOI": "10.1016/S0022-5347(01)65028-6", "volume": "157", "author": "D. Nicol", "year": "1997", "unstructured": "Nicol, D., S.I. Hii, et al (1997). \u201cVascular endothelial growth factor expression is increased in renal cell carcinoma.\u201d J Urol 157(4): 1482\u20136.", "journal-title": "J Urol"}, {"issue": "7", "key": "4_CR85_4", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1038/35017054", "volume": "2", "author": "M. Ohh", "year": "2000", "unstructured": "Ohh, M., C.W. Park, et al (2000). \u201cUbiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel\u2013Lindau protein.\u201d Nat Cell Biol 2(7): 423\u20137.", "journal-title": "Nat Cell Biol"}, {"issue": "5676", "key": "4_CR86_4", "doi-asserted-by": "crossref", "first-page": "1497", "DOI": "10.1126/science.1099314", "volume": "304", "author": "J.G. Paez", "year": "2004", "unstructured": "Paez, J.G., P.A. Janne, et al (2004). \u201cEGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.\u201d Science 304(5676): 1497\u2013500.", "journal-title": "Science"}, {"issue": "6", "key": "4_CR87_4", "doi-asserted-by": "crossref", "first-page": "2156", "DOI": "10.1073/pnas.94.6.2156", "volume": "94", "author": "A. Pause", "year": "1997", "unstructured": "Pause, A., S. Lee, et al (1997). \u201cThe von Hippel\u2013Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.\u201d Proc Natl Acad Sci U S A 94(6): 2156\u201361.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "4", "key": "4_CR88_4", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1016/S1535-6108(03)00085-0", "volume": "3", "author": "S. Pennacchietti", "year": "2003", "unstructured": "Pennacchietti, S., P. Michieli, et al (2003). \u201cHypoxia promotes invasive growth by transcriptional activation of the met protooncogene.\u201d Cancer Cell 3(4): 347\u201361.", "journal-title": "Cancer Cell"}, {"issue": "3 Pt 1", "key": "4_CR89_4", "doi-asserted-by": "crossref", "first-page": "724", "DOI": "10.1016/S0022-5347(01)64301-5", "volume": "158", "author": "L.L. Pisters", "year": "1997", "unstructured": "Pisters, L.L., A.K. el-Naggar, et al (1997). \u201cC-met proto-oncogene expression in benign and malignant human renal tissues.\u201d J Urol 158(3 Pt 1): 724\u20138.", "journal-title": "J Urol"}, {"issue": "17", "key": "4_CR90_4", "doi-asserted-by": "crossref", "first-page": "8814", "DOI": "10.1158/0008-5472.CAN-05-4598", "volume": "66", "author": "D.Z. Qian", "year": "2006", "unstructured": "Qian, D.Z., S.K. Kachhap, et al (2006). \u201cClass II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha.\u201d Cancer Res 66(17): 8814\u201321.", "journal-title": "Cancer Res"}, {"issue": "23", "key": "4_CR91_4", "first-page": "8420", "volume": "63", "author": "M. Rahmani", "year": "2003", "unstructured": "Rahmani, M., C. Yu, et al (2003). \u201cCoadministration of the heat shock protein 90 antagonist 17-allylamino-17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells.\u201d Cancer Res 63(23): 8420\u20137.", "journal-title": "Cancer Res"}, {"issue": "8", "key": "4_CR92_4", "doi-asserted-by": "crossref", "first-page": "3163", "DOI": "10.1128/MCB.25.8.3163-3172.2005", "volume": "25", "author": "E.B. Rankin", "year": "2005", "unstructured": "Rankin, E.B., D.F. Higgins, et al (2005). \u201cInactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel\u2013Lindau disease-associated vascular tumors in mice.\u201d Mol Cell Biol 25(8): 3163\u201372.", "journal-title": "Mol Cell Biol"}, {"issue": "5", "key": "4_CR93_4", "doi-asserted-by": "crossref", "first-page": "2576", "DOI": "10.1158/0008-5472.CAN-05-3241", "volume": "66", "author": "E.B. Rankin", "year": "2006", "unstructured": "Rankin, E.B., J.E. Tomaszewski, et al (2006). \u201cRenal cyst development in mice with conditional inactivation of the von Hippel\u2013Lindau tumor suppressor.\u201d Cancer Res 66(5): 2576\u201383.", "journal-title": "Cancer Res"}, {"issue": "4", "key": "4_CR94_4", "doi-asserted-by": "crossref", "first-page": "1475", "DOI": "10.1158/0008-5472.CAN-03-3139", "volume": "64", "author": "A. Rapisarda", "year": "2004", "unstructured": "Rapisarda, A., B. Uranchimeg, et al (2004). \u201cTopoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications.\u201d Cancer Res 64(4): 1475\u201382.", "journal-title": "Cancer Res"}, {"issue": "11", "key": "4_CR95_4", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1016/S1470-2045(07)70285-1", "volume": "8", "author": "O. Rixe", "year": "2007", "unstructured": "Rixe, O., R.M. Bukowski, et al (2007). \u201cAxitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.\u201d Lancet Oncol 8(11): 975\u201384.", "journal-title": "Lancet Oncol"}, {"issue": "6", "key": "4_CR96_4", "doi-asserted-by": "crossref", "first-page": "543", "DOI": "10.1007/s10637-006-9208-z", "volume": "24", "author": "E.A. Ronnen", "year": "2006", "unstructured": "Ronnen, E.A., G.V. Kondagunta, et al (2006). \u201cA phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma.\u201d Invest New Drugs 24(6): 543\u20136.", "journal-title": "Invest New Drugs"}, {"issue": "36", "key": "4_CR97_4", "doi-asserted-by": "crossref", "first-page": "21176", "DOI": "10.1074/jbc.270.36.21176", "volume": "270", "author": "I.B. Rosenwald", "year": "1995", "unstructured": "Rosenwald, I.B., R. Kaspar, et al (1995). \u201cEukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels.\u201d J Biol Chem 270(36): 21176\u201380.", "journal-title": "J Biol Chem"}, {"issue": "15", "key": "4_CR98_4", "doi-asserted-by": "crossref", "first-page": "3003", "DOI": "10.1200/JCO.2004.11.061", "volume": "22", "author": "E.K. Rowinsky", "year": "2004", "unstructured": "Rowinsky, E.K., G.H. Schwartz, et al (2004). \u201cSafety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer.\u201d J Clin Oncol 22(15): 3003\u201315.", "journal-title": "J Clin Oncol"}, {"issue": "10", "key": "4_CR99_4", "doi-asserted-by": "crossref", "first-page": "1757", "DOI": "10.1007/s11095-005-7094-2", "volume": "22", "author": "T. Sakaeda", "year": "2005", "unstructured": "Sakaeda, T., N. Okamura, et al (2005). \u201cEGFR mRNA is upregulated, but somatic mutations of the gene are hardly found in renal cell carcinoma in Japanese patients.\u201d Pharm Res 22(10): 1757\u201361.", "journal-title": "Pharm Res"}, {"issue": "1", "key": "4_CR100_4", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1038/ng0597-68", "volume": "16", "author": "L. Schmidt", "year": "1997", "unstructured": "Schmidt, L., F.M. Duh, et al (1997). \u201cGermline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.\u201d Nat Genet 16(1): 68\u201373.", "journal-title": "Nat Genet"}, {"issue": "15", "key": "4_CR101_4", "doi-asserted-by": "crossref", "first-page": "8817", "DOI": "10.1073/pnas.95.15.8817", "volume": "95", "author": "A. Schoenfeld", "year": "1998", "unstructured": "Schoenfeld, A., E.J. Davidowitz, et al (1998). \u201cA second major native von Hippel\u2013Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.\u201d Proc Natl Acad Sci U S A 95(15): 8817\u201322.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "6161", "key": "4_CR102_4", "doi-asserted-by": "crossref", "first-page": "268", "DOI": "10.1038/332268a0", "volume": "332", "author": "B.R. Seizinger", "year": "1988", "unstructured": "Seizinger, B.R., G.A. Rouleau, et al (1988). \u201cVon Hippel\u2013Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.\u201d Nature 332(6161): 268\u20139.", "journal-title": "Nature"}, {"issue": "10", "key": "4_CR103_4", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1038/nrc1187", "volume": "3", "author": "G.L. Semenza", "year": "2003", "unstructured": "Semenza, G.L. (2003). \u201cTargeting HIF-1 for cancer therapy.\u201d Nat Rev Cancer 3(10): 721\u201332.", "journal-title": "Nat Rev Cancer"}, {"issue": "1", "key": "4_CR104_4", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/S0022-5347(05)00059-5", "volume": "175", "author": "S. Sengupta", "year": "2006", "unstructured": "Sengupta, S., J.C. Cheville, et al (2006). \u201cRare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma.\u201d J Urol 175(1): 53\u20136.", "journal-title": "J Urol"}, {"issue": "7092", "key": "4_CR105_4", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1038/nature04869", "volume": "441", "author": "R.J. Shaw", "year": "2006", "unstructured": "Shaw, R.J. and L.C. Cantley (2006). \u201cRas, PI(3)K and mTOR signalling controls tumour cell growth.\u201d Nature 441(7092): 424\u201330.", "journal-title": "Nature"}, {"issue": "6", "key": "4_CR106_4", "doi-asserted-by": "crossref", "first-page": "1775", "DOI": "10.1158/1078-0432.CCR-06-1863", "volume": "13", "author": "D.B. Solit", "year": "2007", "unstructured": "Solit, D.B., S.P. Ivy, et al (2007). \u201cPhase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.\u201d Clin Cancer Res 13(6): 1775\u201382.", "journal-title": "Clin Cancer Res"}, {"issue": "5413", "key": "4_CR107_4", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1126/science.284.5413.455", "volume": "284", "author": "C.E. Stebbins", "year": "1999", "unstructured": "Stebbins, C.E., W.G. Kaelin, Jr., et al (1999). \u201cStructure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.\u201d Science 284(5413): 455\u201361.", "journal-title": "Science"}, {"issue": "15", "key": "4_CR108_4", "first-page": "4233", "volume": "54", "author": "A. Takahashi", "year": "1994", "unstructured": "Takahashi, A., H. Sasaki, et al (1994). \u201cMarkedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.\u201d Cancer Res 54(15): 4233\u20137.", "journal-title": "Cancer Res"}, {"issue": "16", "key": "4_CR109_4", "doi-asserted-by": "crossref", "first-page": "4298", "DOI": "10.1093/emboj/19.16.4298", "volume": "19", "author": "K. Tanimoto", "year": "2000", "unstructured": "Tanimoto, K., Y. Makino, et al (2000). \u201cMechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel\u2013Lindau tumor suppressor protein.\u201d Embo J 19(16): 4298\u2013309.", "journal-title": "Embo J"}, {"issue": "1", "key": "4_CR110_4", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1016/j.gde.2005.12.003", "volume": "16", "author": "G.V. Thomas", "year": "2006", "unstructured": "Thomas, G.V. (2006). \u201cmTOR and cancer: Reason for dancing at the crossroads?\u201d Curr Opin Genet Dev 16(1): 78\u201384.", "journal-title": "Curr Opin Genet Dev"}, {"issue": "1", "key": "4_CR111_4", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1038/nm1337", "volume": "12", "author": "G.V. Thomas", "year": "2006", "unstructured": "Thomas, G.V., C. Tran, et al (2006). \u201cHypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.\u201d Nat Med 12(1): 122\u20137.", "journal-title": "Nat Med"}, {"issue": "31", "key": "4_CR112_4", "doi-asserted-by": "crossref", "first-page": "27975", "DOI": "10.1074/jbc.M204152200", "volume": "277", "author": "C. Treins", "year": "2002", "unstructured": "Treins, C., S. Giorgetti-Peraldi, et al (2002). \u201cInsulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway.\u201d J Biol Chem 277(31): 27975\u201381.", "journal-title": "J Biol Chem"}, {"issue": "185", "key": "4_CR113_4", "first-page": "3531", "volume": "25", "author": "U. Vaishampayan", "year": "2007", "unstructured": "Vaishampayan, U., E. Sausville, et al (2007). \u201cPhase I trial of intravenous 17-allylaminogeldanamycin (A) and oral sorafenib (B) in pretreated advanced malignancy: Plasma Hsp90\u03b1 induction correlates with clinical benefit.\u201d Am Soc Clin Oncol 25(185): 3531.", "journal-title": "Am Soc Clin Oncol"}, {"issue": "1", "key": "4_CR114_4", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1007/s10637-005-4543-z", "volume": "24", "author": "J. Vuky", "year": "2006", "unstructured": "Vuky, J., C. Isacson, et al (2006). \u201cPhase II trial of imatinib (Gleevec) in patients with metastatic renal cell carcinoma.\u201d Invest New Drugs 24(1): 85\u20138.", "journal-title": "Invest New Drugs"}, {"issue": "2", "key": "4_CR115_4", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1046/j.1523-1755.2000.00211.x", "volume": "58", "author": "C. Westenfelder", "year": "2000", "unstructured": "Westenfelder, C. and R.L. Baranowski (2000). \u201cErythropoietin stimulates proliferation of human renal carcinoma cells.\u201d Kidney Int 58(2): 647\u201357.", "journal-title": "Kidney Int"}, {"issue": "11", "key": "4_CR116_4", "doi-asserted-by": "crossref", "first-page": "2434", "DOI": "10.1002/ijc.22961", "volume": "121", "author": "M.S. Wiesener", "year": "2007", "unstructured": "Wiesener, M.S., P. Munchenhagen, et al (2007). \u201cErythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia.\u201d Int J Cancer 121(11): 2434\u201342.", "journal-title": "Int J Cancer"}, {"issue": "2 Pt 1", "key": "4_CR117_4", "doi-asserted-by": "crossref", "first-page": "890", "DOI": "10.1097/01.ju.0000092861.21122.d2", "volume": "171", "author": "M. Yamauchi", "year": "2004", "unstructured": "Yamauchi, M., H. Kataoka, et al (2004). \u201cHepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma.\u201d J Urol 171(2 Pt 1): 890\u20136.", "journal-title": "J Urol"}, {"issue": "5", "key": "4_CR118_4", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1056/NEJMoa021491", "volume": "349", "author": "J.C. Yang", "year": "2003", "unstructured": "Yang, J.C., L. Haworth, et al (2003). \u201cA randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.\u201d N Engl J Med 349(5): 427\u201334.", "journal-title": "N Engl J Med"}, {"issue": "17", "key": "4_CR119_4", "doi-asserted-by": "crossref", "first-page": "9630", "DOI": "10.1073/pnas.181341498", "volume": "98", "author": "F. Yu", "year": "2001", "unstructured": "Yu, F., S.B. White, et al (2001). \u201cHIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation.\u201d Proc Natl Acad Sci U S A 98(17): 9630\u20135.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "3", "key": "4_CR120_4", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1111/j.1464-410X.2005.05290.x", "volume": "95", "author": "R. Zigeuner", "year": "2005", "unstructured": "Zigeuner, R., M. Ratschek, et al (2005). \u201cKit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.\u201d BJU Int 95(3): 315\u20138.", "journal-title": "BJU Int"}, {"issue": "2", "key": "4_CR121_4", "first-page": "89", "volume": "2", "author": "M. Zimmer", "year": "2004", "unstructured": "Zimmer, M., D. Doucette, et al (2004). \u201cInhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL\u2212/\u2212 tumors.\u201d Mol Cancer Res 2(2): 89\u201395.", "journal-title": "Mol Cancer Res"}], "container-title": ["Modulation of Protein Stability in Cancer Therapy"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-0-387-69147-3_4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 26]], "date-time": "2019-01-26T23:13:53Z", "timestamp": 1548544433000}, "score": 19.429487, "issued": {"date-parts": [[2009]]}, "ISBN": ["9780387691435", "9780387691473"], "references-count": 121, "URL": "http://dx.doi.org/10.1007/978-0-387-69147-3_4", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T12:38:45Z", "timestamp": 1575203925711}, "reference-count": 46, "publisher": "Springer Science and Business Media LLC", "issue": "11", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2013, 4, 1]], "date-time": "2013-04-01T00:00:00Z", "timestamp": 1364774400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2014, 3]]}, "DOI": "10.1038/onc.2013.76", "type": "journal-article", "created": {"date-parts": [[2013, 4, 1]], "date-time": "2013-04-01T10:24:25Z", "timestamp": 1364811865000}, "page": "1458-1467", "source": "Crossref", "is-referenced-by-count": 15, "title": ["RUNX3 inhibits hypoxia-inducible factor-1\u03b1 protein stability by interacting with prolyl hydroxylases in gastric cancer cells"], "prefix": "10.1038", "volume": "33", "author": [{"given": "S H", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "S C", "family": "Bae", "sequence": "additional", "affiliation": []}, {"given": "K W", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Y M", "family": "Lee", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2013, 4, 1]]}, "reference": [{"key": "BFonc201376_CR1", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1038/onc.2008.377", "volume": "28", "author": "SH Lee", "year": "2009", "unstructured": "Lee SH, Kim J, Kim WH, Lee YM . Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 2009; 28: 184\u2013194.", "journal-title": "Oncogene"}, {"key": "BFonc201376_CR2", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1146/annurev.med.54.101601.152418", "volume": "54", "author": "GL Semenza", "year": "2003", "unstructured": "Semenza GL . Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 2003; 54: 17\u201328.", "journal-title": "Annu Rev Med"}, {"key": "BFonc201376_CR3", "doi-asserted-by": "publisher", "first-page": "38", "DOI": "10.1038/nrc704", "volume": "2", "author": "AL Harris", "year": "2002", "unstructured": "Harris AL . Hypoxia\u2014a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38\u201347.", "journal-title": "Nat Rev Cancer"}, {"key": "BFonc201376_CR4", "doi-asserted-by": "publisher", "first-page": "4", "DOI": "10.1093/jnci/82.1.4", "volume": "82", "author": "J Folkman", "year": "1990", "unstructured": "Folkman J . What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4\u20136.", "journal-title": "J Natl Cancer Inst"}, {"key": "BFonc201376_CR5", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1016/S0065-230X(06)97009-2", "volume": "97", "author": "Y Cao", "year": "2007", "unstructured": "Cao Y, Liu Q . Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis. Adv Cancer Res 2007; 97: 203\u2013224.", "journal-title": "Adv Cancer Res"}, {"key": "BFonc201376_CR6", "doi-asserted-by": "publisher", "first-page": "22642", "DOI": "10.1074/jbc.272.36.22642", "volume": "272", "author": "S Salceda", "year": "1997", "unstructured": "Salceda S, Caro J . Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997; 272: 22642\u201322647.", "journal-title": "J Biol Chem"}, {"key": "BFonc201376_CR7", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1038/35017054", "volume": "2", "author": "M Ohh", "year": "2000", "unstructured": "Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2000; 2: 423\u2013427.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc201376_CR8", "doi-asserted-by": "publisher", "first-page": "5197", "DOI": "10.1093/emboj/20.18.5197", "volume": "20", "author": "N Masson", "year": "2001", "unstructured": "Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ . Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J 2001; 20: 5197\u20135206.", "journal-title": "EMBO J"}, {"key": "BFonc201376_CR9", "doi-asserted-by": "publisher", "first-page": "464", "DOI": "10.1126/science.1059817", "volume": "292", "author": "M Ivan", "year": "2001", "unstructured": "Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464\u2013468.", "journal-title": "Science"}, {"key": "BFonc201376_CR10", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1016/S0092-8674(02)00690-6", "volume": "109", "author": "QL Li", "year": "2002", "unstructured": "Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113\u2013124.", "journal-title": "Cell"}, {"key": "BFonc201376_CR11", "doi-asserted-by": "publisher", "first-page": "2605", "DOI": "10.1038/onc.2010.88", "volume": "29", "author": "LS Chuang", "year": "2010", "unstructured": "Chuang LS, Ito Y . RUNX3 is multifunctional in carcinogenesis of multiple solid tumors. Oncogene 2010; 29: 2605\u20132615.", "journal-title": "Oncogene"}, {"key": "BFonc201376_CR12", "doi-asserted-by": "publisher", "first-page": "4809", "DOI": "10.1158/0008-5472.CAN-04-3741", "volume": "65", "author": "D Wei", "year": "2005", "unstructured": "Wei D, Gong W, Oh SC, Li Q, Kim WD, Wang L et al. Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res 2005; 65: 4809\u20134816.", "journal-title": "Cancer Res"}, {"key": "BFonc201376_CR13", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1016/S1535-6108(02)00049-1", "volume": "1", "author": "AH Lund", "year": "2002", "unstructured": "Lund AH, van Lohuizen M . RUNX: a trilogy of cancer genes. Cancer Cell 2002; 1: 213\u2013215.", "journal-title": "Cancer Cell"}, {"key": "BFonc201376_CR14", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1016/S0065-230X(07)99002-8", "volume": "99", "author": "Y Ito", "year": "2008", "unstructured": "Ito Y . RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res 2008; 99: 33\u201376.", "journal-title": "Adv Cancer Res"}, {"key": "BFonc201376_CR15", "doi-asserted-by": "publisher", "first-page": "6386", "DOI": "10.1158/1078-0432.CCR-05-2359", "volume": "12", "author": "Z Peng", "year": "2006", "unstructured": "Peng Z, Wei D, Wang L, Tang H, Zhang J, Le X et al. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer. Clin Cancer Res 2006; 12: 6386\u20136394.", "journal-title": "Clin Cancer Res"}, {"key": "BFonc201376_CR16", "first-page": "211", "volume": "26", "author": "CH Jeong", "year": "2005", "unstructured": "Jeong CH, Lee YM, Choi KS, Seong YR, Kim YJ, Im DS et al. Hypoxia-responsive element-mediated soluble Tie2 vector exhibits an anti-angiogenic activity in vitro under hypoxic condition. Int J Oncol 2005; 26: 211\u2013216.", "journal-title": "Int J Oncol"}, {"key": "BFonc201376_CR17", "doi-asserted-by": "publisher", "first-page": "2132", "DOI": "10.1161/ATVBAHA.109.196071", "volume": "29", "author": "K Takeda", "year": "2009", "unstructured": "Takeda K, Ichiki T, Narabayashi E, Inanaga K, Miyazaki R, Hashimoto T et al. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression. Arterioscler Thromb Vasc Biol 2009; 29: 2132\u20132137.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "BFonc201376_CR18", "doi-asserted-by": "publisher", "first-page": "471", "DOI": "10.1158/1541-7786.MCR-05-0234", "volume": "4", "author": "N Pore", "year": "2006", "unstructured": "Pore N, Jiang Z, Shu HK, Bernhard E, Kao GD, Maity A . Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol Cancer Res 2006; 4: 471\u2013479.", "journal-title": "Mol Cancer Res"}, {"key": "BFonc201376_CR19", "doi-asserted-by": "publisher", "first-page": "1035", "DOI": "10.1093/protein/12.12.1035", "volume": "12", "author": "P Corish", "year": "1999", "unstructured": "Corish P, Tyler-Smith C . Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng 1999; 12: 1035\u20131040.", "journal-title": "Protein Eng"}, {"key": "BFonc201376_CR20", "doi-asserted-by": "publisher", "first-page": "2520", "DOI": "10.1158/0008-5472.CAN-03-2735", "volume": "65", "author": "MK Bae", "year": "2005", "unstructured": "Bae MK, Jeong JW, Kim SH, Kim SY, Kang HJ, Kim DM et al. Tid-1 interacts with the von Hippel-Lindau protein and modulates angiogenesis by destabilization of HIF-1alpha. Cancer Res 2005; 65: 2520\u20132525.", "journal-title": "Cancer Res"}, {"key": "BFonc201376_CR21", "doi-asserted-by": "publisher", "first-page": "1975", "DOI": "10.1126/science.1088805", "volume": "302", "author": "T Hagen", "year": "2003", "unstructured": "Hagen T, Taylor CT, Lam F, Moncada S . Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 2003; 302: 1975\u20131978.", "journal-title": "Science"}, {"key": "BFonc201376_CR22", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1023/A:1026544214667", "volume": "19", "author": "GL Semenza", "year": "2000", "unstructured": "Semenza GL . HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev 2000; 19: 59\u201365.", "journal-title": "Cancer Metastasis Rev"}, {"key": "BFonc201376_CR23", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1016/j.molcel.2008.04.009", "volume": "30", "author": "WG Kaelin", "year": "2008", "unstructured": "Kaelin WG, Ratcliffe PJ . Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30: 393\u2013402.", "journal-title": "Mol Cell"}, {"key": "BFonc201376_CR24", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1038/32925", "volume": "392", "author": "WG An", "year": "1998", "unstructured": "An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM . Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998; 392: 405\u2013408.", "journal-title": "Nature"}, {"key": "BFonc201376_CR25", "first-page": "1541", "volume": "60", "author": "H Zhong", "year": "2000", "unstructured": "Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60: 1541\u20131545.", "journal-title": "Cancer Res"}, {"key": "BFonc201376_CR26", "doi-asserted-by": "publisher", "first-page": "709", "DOI": "10.1016/S0092-8674(02)01085-1", "volume": "111", "author": "JW Jeong", "year": "2002", "unstructured": "Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002; 111: 709\u2013720.", "journal-title": "Cell"}, {"key": "BFonc201376_CR27", "doi-asserted-by": "publisher", "first-page": "426", "DOI": "10.1093/jnci/djq026", "volume": "102", "author": "MN Lee", "year": "2010", "unstructured": "Lee MN, Lee SN, Kim SH, Kim B, Jung BK, Seo JH et al. Roles of arrest-defective protein 1(225) and hypoxia-inducible factor 1alpha in tumor growth and metastasis. J Natl Cancer Inst 2010; 102: 426\u2013442.", "journal-title": "J Natl Cancer Inst"}, {"key": "BFonc201376_CR28", "doi-asserted-by": "publisher", "first-page": "2331", "DOI": "10.1161/ATVBAHA.110.214106", "volume": "30", "author": "C Coulon", "year": "2010", "unstructured": "Coulon C, Georgiadou M, Roncal C, De Bock K, Langenberg T, Carmeliet P . From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery. Arterioscler Thromb Vasc Biol 2010; 30: 2331\u20132336.", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "BFonc201376_CR29", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1038/nrc1187", "volume": "3", "author": "GL Semenza", "year": "2003", "unstructured": "Semenza GL . Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721\u2013732.", "journal-title": "Nat Rev Cancer"}, {"key": "BFonc201376_CR30", "doi-asserted-by": "publisher", "first-page": "16975", "DOI": "10.1074/jbc.M111.334466", "volume": "287", "author": "N Fujita", "year": "2012", "unstructured": "Fujita N, Markova D, Anderson DG, Chiba K, Toyama Y, Shapiro IM et al. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1alpha activity in hypoxia. J Biol Chem 2012; 287: 16975\u201316986.", "journal-title": "J Biol Chem"}, {"key": "BFonc201376_CR31", "doi-asserted-by": "publisher", "first-page": "6415", "DOI": "10.1128/MCB.25.15.6415-6426.2005", "volume": "25", "author": "DA Chan", "year": "2005", "unstructured": "Chan DA, Sutphin PD, Yen SE, Giaccia AJ . Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Mol Cell Biol 2005; 25: 6415\u20136426.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc201376_CR32", "doi-asserted-by": "publisher", "first-page": "23482", "DOI": "10.1074/jbc.M601719200", "volume": "281", "author": "DP Stiehl", "year": "2006", "unstructured": "Stiehl DP, Wirthner R, Koditz J, Spielmann P, Camenisch G, Wenger RH . Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem 2006; 281: 23482\u201323491.", "journal-title": "J Biol Chem"}, {"key": "BFonc201376_CR33", "doi-asserted-by": "publisher", "first-page": "e26", "DOI": "10.1017/S1462399409001173", "volume": "11", "author": "E Poon", "year": "2009", "unstructured": "Poon E, Harris AL, Ashcroft M . Targeting the hypoxia-inducible factor (HIF) pathway in cancer. Expert Rev Mol Med 2009; 11: e26.", "journal-title": "Expert Rev Mol Med"}, {"key": "BFonc201376_CR34", "first-page": "RA175", "volume": "13", "author": "Y Zhang", "year": "2007", "unstructured": "Zhang Y, Li M, Yao Q, Chen C . Recent advances in tumor hypoxia: tumor progression, molecular mechanisms, and therapeutic implications. Med Sci Monit 2007; 13: RA175\u2013RA180.", "journal-title": "Med Sci Monit"}, {"key": "BFonc201376_CR35", "doi-asserted-by": "publisher", "first-page": "8351", "DOI": "10.1038/sj.onc.1206037", "volume": "21", "author": "WH Guo", "year": "2002", "unstructured": "Guo WH, Weng LQ, Ito K, Chen LF, Nakanishi H, Tatematsu M et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene 2002; 21: 8351\u20138355.", "journal-title": "Oncogene"}, {"key": "BFonc201376_CR36", "doi-asserted-by": "publisher", "first-page": "7743", "DOI": "10.1158/0008-5472.CAN-05-0743", "volume": "65", "author": "K Ito", "year": "2005", "unstructured": "Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H et al. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 2005; 65: 7743\u20137750.", "journal-title": "Cancer Res"}, {"key": "BFonc201376_CR37", "doi-asserted-by": "publisher", "first-page": "4474", "DOI": "10.1128/MCB.01926-05", "volume": "26", "author": "T Yano", "year": "2006", "unstructured": "Yano T, Ito K, Fukamachi H, Chi XZ, Wee HJ, Inoue K et al. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol 2006; 26: 4474\u20134488.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc201376_CR38", "doi-asserted-by": "publisher", "first-page": "6512", "DOI": "10.1158/0008-5472.CAN-06-0369", "volume": "66", "author": "QC Lau", "year": "2006", "unstructured": "Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 2006; 66: 6512\u20136520.", "journal-title": "Cancer Res"}, {"key": "BFonc201376_CR39", "doi-asserted-by": "publisher", "first-page": "1048", "DOI": "10.1002/jcb.21906", "volume": "105", "author": "HR Kim", "year": "2008", "unstructured": "Kim HR, Oh BC, Choi JK, Bae SC . Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization. J Cell Biochem 2008; 105: 1048\u20131058.", "journal-title": "J Cell Biochem"}, {"key": "BFonc201376_CR40", "doi-asserted-by": "publisher", "first-page": "10122", "DOI": "10.1074/jbc.M109.071381", "volume": "285", "author": "YM Goh", "year": "2010", "unstructured": "Goh YM, Cinghu S, Hong ET, Lee YS, Kim JH, Jang JW et al. Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm. J Biol Chem 2010; 285: 10122\u201310129.", "journal-title": "J Biol Chem"}, {"key": "BFonc201376_CR41", "doi-asserted-by": "publisher", "first-page": "557", "DOI": "10.1002/jcb.22157", "volume": "107", "author": "JH Kim", "year": "2009", "unstructured": "Kim JH, Choi JK, Cinghu S, Jang JW, Lee YS, Li YH et al. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3. J Cell Biochem 2009; 107: 557\u2013565.", "journal-title": "J Cell Biochem"}, {"key": "BFonc201376_CR42", "doi-asserted-by": "publisher", "first-page": "567", "DOI": "10.1111/j.1600-0714.2011.01009.x", "volume": "40", "author": "CC Chang", "year": "2011", "unstructured": "Chang CC, Lin BR, Chen ST, Hsieh TH, Li YJ, Kuo MY . HDAC2 promotes cell migration/invasion abilities through HIF-1alpha stabilization in human oral squamous cell carcinoma. J Oral Pathol Med 2011; 40: 567\u2013575.", "journal-title": "J Oral Pathol Med"}, {"key": "BFonc201376_CR43", "doi-asserted-by": "publisher", "first-page": "437", "DOI": "10.1038/86507", "volume": "7", "author": "MS Kim", "year": "2001", "unstructured": "Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001; 7: 437\u2013443.", "journal-title": "Nat Med"}, {"key": "BFonc201376_CR44", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1016/j.canlet.2008.11.012", "volume": "280", "author": "L Ellis", "year": "2009", "unstructured": "Ellis L, Hammers H, Pili R . Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett 2009; 280: 145\u2013153.", "journal-title": "Cancer Lett"}, {"key": "BFonc201376_CR45", "doi-asserted-by": "publisher", "first-page": "562", "DOI": "10.1038/sj.bjc.6602372", "volume": "92", "author": "Y Nakase", "year": "2005", "unstructured": "Nakase Y, Sakakura C, Miyagawa K, Kin S, Fukuda K, Yanagisawa A et al. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. Br J Cancer 2005; 92: 562\u2013569.", "journal-title": "Br J Cancer"}, {"key": "BFonc201376_CR46", "unstructured": "Isobe T, Aoyagi K, Koufuji K, Shirouzu K, Kawahara A, Taira T et al. Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1\u03b1) expression in gastric cancer. Int J Clin Oncol 2012, (e-pub ahead of printer 18 February 2012).", "DOI": "10.1007/s10147-012-0467-8", "doi-asserted-by": "crossref"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc201376.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc201376", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc201376.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 11]], "date-time": "2019-07-11T16:09:29Z", "timestamp": 1562861369000}, "score": 19.383854, "issued": {"date-parts": [[2013, 4, 1]]}, "references-count": 46, "journal-issue": {"published-print": {"date-parts": [[2014, 3]]}, "issue": "11"}, "alternative-id": ["BFonc201376"], "URL": "http://dx.doi.org/10.1038/onc.2013.76", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}], "subject": ["Genetics", "Cancer Research", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T23:44:12Z", "timestamp": 1574725452778}, "reference-count": 52, "publisher": "Springer Science and Business Media LLC", "issue": "20", "license": [{"URL": "https://creativecommons.org/licenses/by-nc-sa/4.0", "start": {"date-parts": [[2016, 12, 12]], "date-time": "2016-12-12T00:00:00Z", "timestamp": 1481500800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2017, 5]]}, "DOI": "10.1038/onc.2016.441", "type": "journal-article", "created": {"date-parts": [[2016, 12, 12]], "date-time": "2016-12-12T23:27:21Z", "timestamp": 1481585241000}, "page": "2802-2812", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer"], "prefix": "10.1038", "volume": "36", "author": [{"given": "Y M", "family": "Choi", "sequence": "first", "affiliation": []}, {"given": "K B", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "J H", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Y K", "family": "Chun", "sequence": "additional", "affiliation": []}, {"given": "I S", "family": "An", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "An", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Bae", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 12, 12]]}, "reference": [{"key": "BFonc2016441_CR1", "doi-asserted-by": "publisher", "first-page": "2009", "DOI": "10.1038/sj.onc.1207373", "volume": "23", "author": "HG Zhang", "year": "2004", "unstructured": "Zhang HG, Wang J, Yang X, Hsu HC, Mountz JD . Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 2004; 23: 2009\u20132015.", "journal-title": "Oncogene"}, {"key": "BFonc2016441_CR2", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1038/nrd3321", "volume": "10", "author": "L Bedford", "year": "2011", "unstructured": "Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE . Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov 2011; 10: 29\u201346.", "journal-title": "Nat Rev Drug Discov"}, {"key": "BFonc2016441_CR3", "doi-asserted-by": "publisher", "first-page": "1681", "DOI": "10.1038/sj.emboj.7600186", "volume": "23", "author": "L Pintard", "year": "2004", "unstructured": "Pintard L, Willems A, Peter M . Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. EMBO J 2004; 23: 1681\u20131687.", "journal-title": "EMBO J"}, {"key": "BFonc2016441_CR4", "doi-asserted-by": "publisher", "first-page": "R59", "DOI": "10.1016/j.cub.2003.12.044", "volume": "14", "author": "S van den Heuvel", "year": "2004", "unstructured": "van den Heuvel S . Protein degradation: CUL-3 and BTB\u2014partners in proteolysis. Curr Biol 2004; 14: R59\u2013R61.", "journal-title": "Curr Biol"}, {"key": "BFonc2016441_CR5", "doi-asserted-by": "publisher", "first-page": "10717", "DOI": "10.1073/pnas.91.22.10717", "volume": "91", "author": "S Zollman", "year": "1994", "unstructured": "Zollman S, Godt D, Prive GG, Couderc JL, Laski FA . The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc Natl Acad Sci USA 1994; 91: 10717\u201310721.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2016441_CR6", "doi-asserted-by": "publisher", "first-page": "783", "DOI": "10.1016/S1097-2765(03)00341-1", "volume": "12", "author": "R Geyer", "year": "2003", "unstructured": "Geyer R, Wee S, Anderson S, Yates J, Wolf DA . BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases. Mol Cell 2003; 12: 783\u2013790.", "journal-title": "Mol Cell"}, {"key": "BFonc2016441_CR7", "doi-asserted-by": "publisher", "first-page": "316", "DOI": "10.1038/nature01985", "volume": "425", "author": "L Xu", "year": "2003", "unstructured": "Xu L, Wei Y, Reboul J, Vaglio P, Shin TH, Vidal M et al. BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 2003; 425: 316\u2013321.", "journal-title": "Nature"}, {"key": "BFonc2016441_CR8", "doi-asserted-by": "publisher", "first-page": "311", "DOI": "10.1038/nature01959", "volume": "425", "author": "L Pintard", "year": "2003", "unstructured": "Pintard L, Willis JH, Willems A, Johnson JL, Srayko M, Kurz T et al. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature 2003; 425: 311\u2013316.", "journal-title": "Nature"}, {"key": "BFonc2016441_CR9", "doi-asserted-by": "publisher", "first-page": "1180", "DOI": "10.1105/tpc.105.031989", "volume": "17", "author": "P Figueroa", "year": "2005", "unstructured": "Figueroa P, Gusmaroli G, Serino G, Habashi J, Ma L, Shen Y et al. Arabidopsis has two redundant Cullin3 proteins that are essential for embryo development and that interact with RBX1 and BTB proteins to form multisubunit E3 ubiquitin ligase complexes in vivo. Plant Cell 2005; 17: 1180\u20131195.", "journal-title": "Plant Cell"}, {"key": "BFonc2016441_CR10", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1016/j.cell.2009.03.015", "volume": "137", "author": "Z Jin", "year": "2009", "unstructured": "Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR et al. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 2009; 137: 721\u2013735.", "journal-title": "Cell"}, {"key": "BFonc2016441_CR11", "doi-asserted-by": "publisher", "first-page": "791", "DOI": "10.1083/jcb.200906117", "volume": "187", "author": "S Maerki", "year": "2009", "unstructured": "Maerki S, Olma MH, Staubli T, Steigemann P, Gerlich DW, Quadroni M et al. The Cul3-KLHL21 E3 ubiquitin ligase targets aurora B to midzone microtubules in anaphase and is required for cytokinesis. J Cell Biol 2009; 187: 791\u2013800.", "journal-title": "J Cell Biol"}, {"key": "BFonc2016441_CR12", "doi-asserted-by": "publisher", "first-page": "841", "DOI": "10.1016/j.molcel.2009.09.004", "volume": "35", "author": "Y Chen", "year": "2009", "unstructured": "Chen Y, Yang Z, Meng M, Zhao Y, Dong N, Yan H et al. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol Cell 2009; 35: 841\u2013855.", "journal-title": "Mol Cell"}, {"key": "BFonc2016441_CR13", "doi-asserted-by": "publisher", "first-page": "719", "DOI": "10.1016/j.devcel.2006.05.004", "volume": "10", "author": "Q Zhang", "year": "2006", "unstructured": "Zhang Q, Zhang L, Wang B, Ou CY, Chien CT, Jiang J . A hedgehog-induced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription factor. Dev Cell 2006; 10: 719\u2013729.", "journal-title": "Dev Cell"}, {"key": "BFonc2016441_CR14", "doi-asserted-by": "publisher", "first-page": "7130", "DOI": "10.1128/MCB.24.16.7130-7139.2004", "volume": "24", "author": "A Kobayashi", "year": "2004", "unstructured": "Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004; 24: 7130\u20137139.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2016441_CR15", "doi-asserted-by": "publisher", "first-page": "856", "DOI": "10.1101/gad.1177904", "volume": "18", "author": "A Wilkins", "year": "2004", "unstructured": "Wilkins A, Ping Q, Carpenter CL . RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex. Genes Dev 2004; 18: 856\u2013861.", "journal-title": "Genes Dev"}, {"key": "BFonc2016441_CR16", "doi-asserted-by": "publisher", "first-page": "13647", "DOI": "10.1073/pnas.212516099", "volume": "99", "author": "M Hamaguchi", "year": "2002", "unstructured": "Hamaguchi M, Meth JL, von Klitzing C, Wei W, Esposito D, Rodgers L et al. DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci USA 2002; 99: 13647\u201313652.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2016441_CR17", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1016/j.canlet.2004.10.047", "volume": "225", "author": "MA Knowles", "year": "2005", "unstructured": "Knowles MA, Aveyard JS, Taylor CF, Harnden P, Bass S . Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer. Cancer Lett 2005; 225: 121\u2013130.", "journal-title": "Cancer Lett"}, {"key": "BFonc2016441_CR18", "doi-asserted-by": "publisher", "first-page": "1123", "DOI": "10.4161/cbt.10.11.13786", "volume": "10", "author": "SN Freeman", "year": "2010", "unstructured": "Freeman SN, Cress WD . RhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor. Cancer Biol Ther 2010; 10: 1123\u20131125.", "journal-title": "Cancer Biol Ther"}, {"key": "BFonc2016441_CR19", "doi-asserted-by": "publisher", "first-page": "1175", "DOI": "10.1007/s10529-013-1190-x", "volume": "35", "author": "L Han", "year": "2013", "unstructured": "Han L, Hou L, Song J, Lin D, Wu L, Ge Y et al. Decreased expression of the DBC2 gene and its clinicopathological significance in breast cancer: correlation with aberrant DNA methylation. Biotechnol Lett 2013; 35: 1175\u20131181.", "journal-title": "Biotechnol Lett"}, {"key": "BFonc2016441_CR20", "doi-asserted-by": "publisher", "first-page": "722", "DOI": "10.3892/ijmm.2013.1593", "volume": "33", "author": "W Tang", "year": "2014", "unstructured": "Tang W, Wang C, Fu F, Chen Q . RhoBTB2 gene in breast cancer is silenced by promoter methylation. Int J Mol Med 2014; 33: 722\u2013728.", "journal-title": "Int J Mol Med"}, {"key": "BFonc2016441_CR21", "first-page": "283", "volume": "49", "author": "H Mao", "year": "2010", "unstructured": "Mao H, Qu X, Yang Y, Zuo W, Bi Y, Zhou C et al. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer. Mol Carcinogen 2010; 49: 283\u2013289.", "journal-title": "Mol Carcinogen"}, {"key": "BFonc2016441_CR22", "doi-asserted-by": "publisher", "first-page": "74", "DOI": "10.1016/j.gene.2011.07.018", "volume": "486", "author": "H Mao", "year": "2011", "unstructured": "Mao H, Zhang L, Yang Y, Sun J, Deng B, Feng J et al. RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells. Gene 2011; 486: 74\u201380.", "journal-title": "Gene"}, {"key": "BFonc2016441_CR23", "doi-asserted-by": "publisher", "first-page": "2021", "DOI": "10.7314/APJCP.2012.13.5.2021", "volume": "13", "author": "W Dong", "year": "2012", "unstructured": "Dong W, Meng L, Shen HC, Du JJ . Loss of DBC2 expression is an early and progressive event in the development of lung adenocarcinoma. Asian Pac J Cancer Prev 2012; 13: 2021\u20132023.", "journal-title": "Asian Pac J Cancer Prev"}, {"key": "BFonc2016441_CR24", "doi-asserted-by": "publisher", "first-page": "366", "DOI": "10.1080/02841860701644094", "volume": "47", "author": "YG Cho", "year": "2008", "unstructured": "Cho YG, Choi BJ, Kim CJ, Song JH, Zhang C, Nam SW et al. Genetic analysis of the DBC2 gene in gastric cancer. Acta Oncol 2008; 47: 366\u2013371.", "journal-title": "Acta Oncol"}, {"key": "BFonc2016441_CR25", "doi-asserted-by": "publisher", "first-page": "709", "DOI": "10.1089/cbr.2012.1386", "volume": "28", "author": "Z Jin", "year": "2013", "unstructured": "Jin Z, Han YX, Han XR . Downregulated RhoBTB2 expression contributes to poor outcome in osteosarcoma patients. Cancer Biother Radiopharm 2013; 28: 709\u2013716.", "journal-title": "Cancer Biother Radiopharm"}, {"key": "BFonc2016441_CR26", "doi-asserted-by": "publisher", "first-page": "465", "DOI": "10.1016/j.urolonc.2007.08.009", "volume": "26", "author": "Y Shi", "year": "2008", "unstructured": "Shi Y, Chen JY, Yang J, Li B, Chen ZH, Xiao CG . DBC2 gene is silenced by promoter methylation in bladder cancer. Urol Oncol 2008; 26: 465\u2013469.", "journal-title": "Urol Oncol"}, {"key": "BFonc2016441_CR27", "doi-asserted-by": "publisher", "first-page": "873", "DOI": "10.1038/cr.2012.38", "volume": "22", "author": "S Bae", "year": "2012", "unstructured": "Bae S, Kim SY, Jung JH, Yoon Y, Cha HJ, Lee H et al. Akt is negatively regulated by the MULAN E3 ligase. Cell Res 2012; 22: 873\u2013885.", "journal-title": "Cell Res"}, {"key": "BFonc2016441_CR28", "doi-asserted-by": "publisher", "first-page": "1865", "DOI": "10.1038/cdd.2011.57", "volume": "18", "author": "JH Jung", "year": "2011", "unstructured": "Jung JH, Bae S, Lee JY, Woo SR, Cha HJ, Yoon Y et al. E3 ubiquitin ligase Hades negatively regulates the exonuclear function of p53. Cell Death Differ 2011; 18: 1865\u20131875.", "journal-title": "Cell Death Differ"}, {"key": "BFonc2016441_CR29", "first-page": "381", "volume": "21", "author": "S Bae", "year": "2008", "unstructured": "Bae S, Ha TS, Yoon Y, Lee J, Cha HJ, Yoo H et al. Genome-wide screening and identification of novel proteolytic cleavage targets of caspase-8 and -10 in vitro. Int J Mol Med 2008; 21: 381\u2013386.", "journal-title": "Int J Mol Med"}, {"key": "BFonc2016441_CR30", "doi-asserted-by": "publisher", "first-page": "1001", "DOI": "10.1038/ncb1056", "volume": "5", "author": "M Furukawa", "year": "2003", "unstructured": "Furukawa M, He YJ, Borchers C, Xiong Y . Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat Cell Biol 2003; 5: 1001\u20131007.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2016441_CR31", "doi-asserted-by": "publisher", "first-page": "903", "DOI": "10.1038/nm.2187", "volume": "16", "author": "MG Kharas", "year": "2010", "unstructured": "Kharas MG, Lengner CJ, Al-Shahrour F, Bullinger L, Ball B, Zaidi S et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med 2010; 16: 903\u2013908.", "journal-title": "Nat Med"}, {"key": "BFonc2016441_CR32", "doi-asserted-by": "publisher", "first-page": "6517", "DOI": "10.1038/ncomms7517", "volume": "6", "author": "S Wang", "year": "2015", "unstructured": "Wang S, Li N, Yousefi M, Nakauka-Ddamba A, Li F, Parada K et al. Transformation of the intestinal epithelium by the MSI2 RNA-binding protein. Nat Commun 2015; 6: 6517.", "journal-title": "Nat Commun"}, {"key": "BFonc2016441_CR33", "doi-asserted-by": "publisher", "first-page": "2440", "DOI": "10.1016/j.celrep.2015.11.022", "volume": "13", "author": "N Li", "year": "2015", "unstructured": "Li N, Yousefi M, Nakauka-Ddamba A, Li F, Vandivier L, Parada K et al. The Msi family of RNA-binding proteins function redundantly as intestinal oncoproteins. Cell Rep 2015; 13: 2440\u20132455.", "journal-title": "Cell Rep"}, {"key": "BFonc2016441_CR34", "first-page": "1089", "volume": "5", "author": "MH Wang", "year": "2015", "unstructured": "Wang MH, Qin SY, Zhang SG, Li GX, Yu ZH, Wang K et al. Musashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/beta-catenin pathway. Am J Cancer Res 2015; 5: 1089\u20131100.", "journal-title": "Am J Cancer Res"}, {"key": "BFonc2016441_CR35", "doi-asserted-by": "publisher", "first-page": "803", "DOI": "10.1016/j.jmb.2009.10.039", "volume": "395", "author": "D Fushman", "year": "2010", "unstructured": "Fushman D, Walker O . Exploring the linkage dependence of polyubiquitin conformations using molecular modeling. J Mol Biol 2010; 395: 803\u2013814.", "journal-title": "J Mol Biol"}, {"key": "BFonc2016441_CR36", "doi-asserted-by": "publisher", "first-page": "3453", "DOI": "10.1016/j.yexcr.2008.09.005", "volume": "314", "author": "J Berthold", "year": "2008", "unstructured": "Berthold J, Schenkova K, Ramos S, Miura Y, Furukawa M, Aspenstrom P et al. Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes\u2014evidence for an autoregulatory mechanism. Exp Cell Res 2008; 314: 3453\u20133465.", "journal-title": "Exp Cell Res"}, {"key": "BFonc2016441_CR37", "doi-asserted-by": "publisher", "first-page": "e90054", "DOI": "10.1371/journal.pone.0090054", "volume": "9", "author": "JR Manjarrez", "year": "2014", "unstructured": "Manjarrez JR, Sun L, Prince T, Matts RL . Hsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complex. PLoS One 2014; 9: e90054.", "journal-title": "PLoS One"}, {"key": "BFonc2016441_CR38", "doi-asserted-by": "publisher", "first-page": "e0136484", "DOI": "10.1371/journal.pone.0136484", "volume": "10", "author": "Y Han", "year": "2015", "unstructured": "Han Y, Ye A, Zhang Y, Cai Z, Wang W, Sun L et al. Musashi-2 silencing exerts potent activity against acute myeloid leukemia and enhances chemosensitivity to daunorubicin. PLoS One 2015; 10: e0136484.", "journal-title": "PLoS One"}, {"key": "BFonc2016441_CR39", "doi-asserted-by": "publisher", "first-page": "119", "DOI": "10.1016/j.yexcr.2013.09.009", "volume": "320", "author": "H Zhang", "year": "2014", "unstructured": "Zhang H, Tan S, Wang J, Chen S, Quan J, Xian J et al. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway. Exp Cell Res 2014; 320: 119\u2013127.", "journal-title": "Exp Cell Res"}, {"key": "BFonc2016441_CR40", "doi-asserted-by": "publisher", "first-page": "e03915", "DOI": "10.7554/eLife.03915", "volume": "3", "author": "Y Katz", "year": "2014", "unstructured": "Katz Y, Li F, Lambert NJ, Sokol ES, Tam WL, Cheng AW et al. Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state. Elife 2014; 3: e03915.", "journal-title": "Elife"}, {"key": "BFonc2016441_CR41", "first-page": "1202", "volume": "63", "author": "A Barbouti", "year": "2003", "unstructured": "Barbouti A, Hoglund M, Johansson B, Lassen C, Nilsson PG, Hagemeijer A et al. A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23). Cancer Res 2003; 63: 1202\u20131206.", "journal-title": "Cancer Res"}, {"key": "BFonc2016441_CR42", "doi-asserted-by": "publisher", "first-page": "2857", "DOI": "10.1182/blood-2011-04-346767", "volume": "118", "author": "RJ Byers", "year": "2011", "unstructured": "Byers RJ, Currie T, Tholouli E, Rodig SJ, Kutok JL . MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia. Blood 2011; 118: 2857\u20132867.", "journal-title": "Blood"}, {"key": "BFonc2016441_CR43", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1111/jcmm.12158", "volume": "18", "author": "L He", "year": "2014", "unstructured": "He L, Zhou X, Qu C, Hu L, Tang Y, Zhang Q et al. Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial\u2013mesenchymal transition. J Cell Mol Med 2014; 18: 49\u201358.", "journal-title": "J Cell Mol Med"}, {"key": "BFonc2016441_CR44", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1007/s00277-012-1637-5", "volume": "92", "author": "F Thol", "year": "2013", "unstructured": "Thol F, Winschel C, Sonntag AK, Damm F, Wagner K, Chaturvedi A et al. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia. Ann Hematol 2013; 92: 315\u2013323.", "journal-title": "Ann Hematol"}, {"key": "BFonc2016441_CR45", "doi-asserted-by": "publisher", "first-page": "10739", "DOI": "10.1038/ncomms10739", "volume": "7", "author": "J Taggart", "year": "2016", "unstructured": "Taggart J, Ho TC, Amin E, Xu H, Barlowe TS, Perez AR et al. MSI2 is required for maintaining activated myelodysplastic syndrome stem cells. Nat Commun 2016; 7: 10739.", "journal-title": "Nat Commun"}, {"key": "BFonc2016441_CR46", "doi-asserted-by": "publisher", "first-page": "e62857", "DOI": "10.1371/journal.pone.0062857", "volume": "8", "author": "JL Cox", "year": "2013", "unstructured": "Cox JL, Wilder PJ, Gilmore JM, Wuebben EL, Washburn MP, Rizzino A . The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells. PLoS One 2013; 8: e62857.", "journal-title": "PLoS One"}, {"key": "BFonc2016441_CR47", "doi-asserted-by": "publisher", "first-page": "1210", "DOI": "10.1111/j.1582-4934.2010.01090.x", "volume": "15", "author": "P Nikpour", "year": "2011", "unstructured": "Nikpour P, Baygi ME, Steinhoff C, Hader C, Luca AC, Mowla SJ et al. The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells. J Cell Mol Med 2011; 15: 1210\u20131224.", "journal-title": "J Cell Mol Med"}, {"key": "BFonc2016441_CR48", "doi-asserted-by": "publisher", "first-page": "732", "DOI": "10.3892/ijo.2014.2749", "volume": "46", "author": "C Gao", "year": "2015", "unstructured": "Gao C, Han C, Yu Q, Guan Y, Li N, Zhou J et al. Downregulation of Msi1 suppresses the growth of human colon cancer by targeting p21cip1. Int J Oncol 2015; 46: 732\u2013740.", "journal-title": "Int J Oncol"}, {"key": "BFonc2016441_CR49", "doi-asserted-by": "publisher", "first-page": "8091", "DOI": "10.1523/JNEUROSCI.21-20-08091.2001", "volume": "21", "author": "S Sakakibara", "year": "2001", "unstructured": "Sakakibara S, Nakamura Y, Satoh H, Okano H . RNA-binding protein Musashi2: developmentally regulated expression in neural precursor cells and subpopulations of neurons in mammalian CNS. J Neurosci 2001; 21: 8091\u20138107.", "journal-title": "J Neurosci"}, {"key": "BFonc2016441_CR50", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1016/j.ajpath.2012.03.019", "volume": "181", "author": "N Kagara", "year": "2012", "unstructured": "Kagara N, Huynh KT, Kuo C, Okano H, Sim MS, Elashoff D et al. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer. Am J Pathol 2012; 181: 257\u2013267.", "journal-title": "Am J Pathol"}, {"key": "BFonc2016441_CR51", "doi-asserted-by": "publisher", "first-page": "635", "DOI": "10.4149/neo_2013_082", "volume": "60", "author": "I Zmetakova", "year": "2013", "unstructured": "Zmetakova I, Danihel L, Smolkova B, Mego M, Kajabova V, Krivulcik T et al. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer. Neoplasma 2013; 60: 635\u2013646.", "journal-title": "Neoplasma"}, {"key": "BFonc2016441_CR52", "first-page": "616", "volume": "140", "author": "V Shilpa", "year": "2014", "unstructured": "Shilpa V, Bhagat R, Premalata CS, Pallavi VR, Ramesh G, Krishnamoorthy L . Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer. Indian J Med Res 2014; 140: 616\u2013623.", "journal-title": "Indian J Med Res"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc2016441.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2016441", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/doifinder/10.1038/onc.2016.441", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}, {"URL": "http://www.nature.com/articles/onc2016441.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 25]], "date-time": "2019-06-25T21:56:25Z", "timestamp": 1561499785000}, "score": 19.122135, "issued": {"date-parts": [[2016, 12, 12]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2017, 5]]}, "issue": "20"}, "alternative-id": ["BFonc2016441"], "URL": "http://dx.doi.org/10.1038/onc.2016.441", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}], "assertion": [{"value": "31 March 2016", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "10 September 2016", "order": 2, "name": "revised", "label": "Revised", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "20 October 2016", "order": 3, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "12 December 2016", "order": 4, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no conflict of interest.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:40:01Z", "timestamp": 1574113201442}, "reference-count": 51, "publisher": "Springer Science and Business Media LLC", "issue": "43", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2000, 10, 1]], "date-time": "2000-10-01T00:00:00Z", "timestamp": 970358400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2000, 10]]}, "DOI": "10.1038/sj.onc.1203865", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T19:50:34Z", "timestamp": 1031169034000}, "page": "5010-5019", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells"], "prefix": "10.1038", "volume": "19", "author": [{"given": "Susan E", "family": "Morgan", "sequence": "first", "affiliation": []}, {"given": "Ryungsa", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Pu Chen", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Uppoor G", "family": "Bhat", "sequence": "additional", "affiliation": []}, {"given": "Hiroki", "family": "Kusumoto", "sequence": "additional", "affiliation": []}, {"given": "Taihe", "family": "Lu", "sequence": "additional", "affiliation": []}, {"given": "William T", "family": "Beck", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2000, 10, 12]]}, "reference": [{"key": "BF1203865_CR1", "unstructured": "Alarcon R, Koumenis C, Geyer RK, Maki C and Giaccia AJ. . 1999 Cancer Res. 59: 6046\u20136051."}, {"key": "BF1203865_CR2", "unstructured": "Arriola EL, Lopez AR and Chresta CM. . 1999 Oncogene 18: 1081\u20131091."}, {"key": "BF1203865_CR3", "unstructured": "Barak Y, Juven T, Haffner R and Oren M. . 1993 EMBO J. 12: 461\u2013468."}, {"key": "BF1203865_CR4", "unstructured": "Boise LH, Gottschalk AR, Quintans J and Thompson CB. . 1995 Curr. Topics. Microbiol. Immunol. 200: 107\u2013121."}, {"key": "BF1203865_CR5", "unstructured": "Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B and Kaye SB. . 1993 Int. J. Cancer 55: 678\u2013684."}, {"key": "BF1203865_CR6", "unstructured": "Bugg BY, Danks MK, Beck WT and Suttle DP. . 1991 Proc. Natl. Acad. Sci. USA 88: 7654\u20137658."}, {"key": "BF1203865_CR7", "unstructured": "Chen M and Beck WT. . 1993 Cancer Res. 53: 5946\u20135953."}, {"key": "BF1203865_CR8", "unstructured": "Cheng EHJ, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K and Hardwick JM. . 1997 Science 278: 1966\u20131968."}, {"key": "BF1203865_CR9", "unstructured": "Cheng J and Haas M. . 1990 Mol. Cell. Biol. 10: 5502\u20135509."}, {"key": "BF1203865_CR10", "unstructured": "Craig RW. . 1995 Semin. Cancer Biol. 6: 35\u201343."}, {"key": "BF1203865_CR11", "unstructured": "Danks MK, Schmidt CA, Cirtain MC, Suttle DP and Beck WT. . 1988 Biochemistry 27: 8861\u20138869."}, {"key": "BF1203865_CR12", "unstructured": "Danks MK, Warmoth MR, Friche E, Granzen B, Bugg BY, Harker WG, Zwelling LA, Futshcer BW, Suttle DP and Beck WT. . 1993 Cancer Res. 53: 1373\u20131379."}, {"key": "BF1203865_CR13", "unstructured": "Danks MK, Yalowich J and Beck WT. . 1987 Cancer Res. 47: 1297\u20131301."}, {"key": "BF1203865_CR14", "unstructured": "Donehower LA and Bradley A. . 1993 Biochem. Biophys. Acta 1155: 181\u2013205."}, {"key": "BF1203865_CR15", "unstructured": "El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817\u2013825."}, {"key": "BF1203865_CR16", "unstructured": "Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O and Oren M. . 1989 Proc. Natl. Acad. Sci. USA 86: 8763\u20138767."}, {"key": "BF1203865_CR17", "unstructured": "Finlay CA, Hinds PW and Levine AJ. . 1989 Cell 57: 1083\u20131093."}, {"key": "BF1203865_CR18", "unstructured": "Foster BA, Coffey HA, Morin MJ and Rastinejad F. . 1999 Science 286: 2507\u20132510."}, {"key": "BF1203865_CR19", "unstructured": "Giaccia AJ and Kastan MB. . 1998 Genes. Dev. 12: 2973\u20132983."}, {"key": "BF1203865_CR20", "unstructured": "Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 805\u2013816."}, {"key": "BF1203865_CR21", "unstructured": "Hartwell LH and Kastan MB. . 1994 Science 266: 1821\u20131828."}, {"key": "BF1203865_CR22", "unstructured": "Haupt Y, Maya R, Kazaz A and Oren M. . 1997 Nature 387: 296\u2013299."}, {"key": "BF1203865_CR23", "unstructured": "Hollstein M, Sidransky D, Vogelstein B and Harris CC. . 1991 Science 253: 49\u201353."}, {"key": "BF1203865_CR24", "unstructured": "Honda R, Tanaka H and Yasuda H. . 1997 FEBS Lett. 420: 25\u201327."}, {"key": "BF1203865_CR25", "unstructured": "Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. . 1991 Cancer Res. 51: 6304\u20136311."}, {"key": "BF1203865_CR26", "unstructured": "Kastan MB, Zhan Q, El-Diery WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ. . 1992 Cell 71: 587\u2013597."}, {"key": "BF1203865_CR27", "unstructured": "Kim R and Beck WT. . 1994 Cancer Res. 54: 4958\u20134966."}, {"key": "BF1203865_CR28", "unstructured": "Kubbutat MHG, Jones SN and Vousden KH. . 1997 Nature 387: 299\u2013303."}, {"key": "BF1203865_CR29", "unstructured": "Kubbutat MHG, Ludwig RL, Levine AJ and Vousden KH. . 1999 Cell Growth Differ. 10: 87\u201392."}, {"key": "BF1203865_CR30", "unstructured": "Kwok TT, Mok CH and Menton-Brennan L. . 1994 Cancer Res. 54: 2834\u20132836."}, {"key": "BF1203865_CR31", "unstructured": "Laemmli UK. . 1970 Nature (Lond.) 227: 680\u2013685."}, {"key": "BF1203865_CR32", "unstructured": "Maki CG, Huibregtse JM and Howley PM. . 1996 Cancer Res. 56: 2649\u20132654."}, {"key": "BF1203865_CR33", "unstructured": "Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689\u20131694.", "DOI": "10.1128/MCB.4.9.1689", "doi-asserted-by": "crossref"}, {"key": "BF1203865_CR34", "unstructured": "Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC. . 1994 Oncogene 9: 1799\u20131805."}, {"key": "BF1203865_CR35", "unstructured": "Miyashita T and Reed JC. . 1995 Cell 80: 293\u2013299."}, {"key": "BF1203865_CR36", "unstructured": "Momand J, Zambetti GP, Olson DC, George DL and Levine AJ. . 1992 Cell 69: 1237\u20131245."}, {"key": "BF1203865_CR37", "unstructured": "Morgan SE and Kastan MB. . 1997 Adv. Cancer Res. 71: 1\u201325."}, {"key": "BF1203865_CR38", "unstructured": "Oltvai ZN, Milliman CL and Korsmeyer SJ. . 1993 Cell 74: 609\u2013619."}, {"key": "BF1203865_CR39", "unstructured": "Park DJ, Nakamura H, Chumakov AM, Said JW, Miller CW, Chen DL and Koeffler HP. . 1994 Oncogene 9: 1899\u20131906."}, {"key": "BF1203865_CR40", "unstructured": "Prives C. . 1998 Cell 95: 5\u20138."}, {"key": "BF1203865_CR41", "unstructured": "Reed JC. . 1994 J. Cell. Biol. 124: 1\u20136."}, {"key": "BF1203865_CR42", "unstructured": "Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB and Korsmeyer SJ. . 1995 Proc. Natl. Acad. Sci. USA 92: 7834\u20137838."}, {"key": "BF1203865_CR43", "unstructured": "Selvakumaran M, Lin H, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B and Liebermann D. . 1994 Oncogene 9: 1791\u20131798."}, {"key": "BF1203865_CR44", "unstructured": "Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E and Kastan MB. . 1997 Genes. Dev. 11: 3471\u20133481."}, {"key": "BF1203865_CR45", "unstructured": "Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, Gilmer TM, Kastan MB, O'Connor PM and Fornace Jr AJ. . 1994 Science 266: 1376\u20131380."}, {"key": "BF1203865_CR46", "unstructured": "Tishler RB, Calderwood SK, Coleman CN and Price BD. . 1993 Cancer Res. 53: 2212\u20132216."}, {"key": "BF1203865_CR47", "unstructured": "Ullrich SJ, Anderson CW, Mercer WE and Appella E. . 1992 J. Biol. Chem. 267: 15259\u201315262."}, {"key": "BF1203865_CR48", "unstructured": "Wang Q and Beck WT. . 1998 Cancer Res. 58: 5762\u20135769."}, {"key": "BF1203865_CR49", "unstructured": "Zambetti GP and Levine AJ. . 1993 FASEB J. 7: 855\u2013865."}, {"key": "BF1203865_CR50", "unstructured": "Zauberman A, Barak Y, Ragimov N, Levy N and Oren M. . 1993 EMBO J. 12: 2799\u20132808."}, {"key": "BF1203865_CR51", "unstructured": "Zhang W, Funk WD, Wright WE, Shay JW and Deisseroth AB. . 1993 Oncogene 8: 2555\u20132559."}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1203865.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1203865", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1203865.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T16:46:18Z", "timestamp": 1552841178000}, "score": 18.92229, "issued": {"date-parts": [[2000, 10]]}, "references-count": 51, "journal-issue": {"published-print": {"date-parts": [[2000, 10]]}, "issue": "43"}, "alternative-id": ["BF1203865"], "URL": "http://dx.doi.org/10.1038/sj.onc.1203865", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T00:25:15Z", "timestamp": 1575159915896}, "reference-count": 13, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1996, 11, 1]], "date-time": "1996-11-01T00:00:00Z", "timestamp": 846806400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Protein Chem"], "published-print": {"date-parts": [[1996, 11]]}, "DOI": "10.1007/bf01887146", "type": "journal-article", "created": {"date-parts": [[2005, 7, 5]], "date-time": "2005-07-05T07:21:46Z", "timestamp": 1120548106000}, "page": "731-736", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Stability and folding of a mutant ribose-binding protein ofEscherichia coli"], "prefix": "10.1007", "volume": "15", "author": [{"given": "Joon-Sik", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Hyoungman", "family": "Kim", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "BF01887146_CR1", "doi-asserted-by": "crossref", "first-page": "326", "DOI": "10.1006/bbrc.1994.2185", "volume": "203", "author": "T. Ahn", "year": "1994", "unstructured": "Ahn, T., and Kim, H. (1994).Biochem. Biophys. Res. Commun. 203, 326\u2013330.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "BF01887146_CR2", "doi-asserted-by": "crossref", "first-page": "12372", "DOI": "10.1074/jbc.271.21.12372", "volume": "271", "author": "T. Ahn", "year": "1996", "unstructured": "Ahn, T., and Kim, H. (1996).J. Biol. Chem. 271, 12372\u201312379.", "journal-title": "J. Biol. Chem."}, {"key": "BF01887146_CR3", "doi-asserted-by": "crossref", "first-page": "2703", "DOI": "10.1016/S0006-3495(95)80141-4", "volume": "69", "author": "S.-W. Chi", "year": "1995", "unstructured": "Chi, S.-W., Yi, G.-S., Suh, J.-Y., Choi, B.-S., and Kim, H. (1995).Biophys. J. 69, 2703\u20132709.", "journal-title": "Biophys. J."}, {"key": "BF01887146_CR4", "author": "C. Ghelis", "first-page": "348", "year": "1982", "unstructured": "Ghelis, C., and Yon, J. (1982). InProtein Folding, Academic Press, New York, pp. 348\u2013351.", "volume-title": "Protein Folding"}, {"key": "BF01887146_CR5", "doi-asserted-by": "crossref", "first-page": "1237", "DOI": "10.1006/bbrc.1993.2177", "volume": "195", "author": "D. Kim", "year": "1993", "unstructured": "Kim, D., and Park, C. (1993).Biochem. Biophys. Res. Commun. 195, 1237\u20131244.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "BF01887146_CR6", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1006/abbi.1996.0145", "volume": "328", "author": "H. Lee", "year": "1996", "unstructured": "Lee, H., Chi, S.-W., Kang, M., Baek, K., and Kim, H. (1996).Arch. Biochem. Biophys. 328, 78\u201384.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "BF01887146_CR7", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/0022-2836(92)91033-L", "volume": "225", "author": "S. L. Mowbray", "year": "1992", "unstructured": "Mowbray, S. L., and Cole, L. B. (1992).J. Mol. Biol. 225, 155\u2013175.", "journal-title": "J. Mol. Biol."}, {"key": "BF01887146_CR8", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/S0076-6879(72)26005-0", "volume": "26", "author": "Y. Nozaki", "year": "1972", "unstructured": "Nozaki, Y. (1972).Meth. Enzymol. 26, 43\u201350.", "journal-title": "Meth. Enzymol."}, {"key": "BF01887146_CR9", "doi-asserted-by": "crossref", "first-page": "1033", "DOI": "10.1126/science.3278378", "volume": "239", "author": "D. Park", "year": "1980", "unstructured": "Park, D., Liu, G., Topping, T. B., Cover, W. H., and Randall, L. J. (1980).Science 239, 1033\u20131035.", "journal-title": "Science"}, {"key": "BF01887146_CR10", "doi-asserted-by": "crossref", "first-page": "8063", "DOI": "10.1021/bi00421a014", "volume": "27", "author": "M. M. Santoro", "year": "1988", "unstructured": "Santoro, M. M., and Bolen, D. W. (1988).Biochemistry 27, 8063\u20138068.", "journal-title": "Biochemistry"}, {"key": "BF01887146_CR11", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1016/0003-2697(85)90442-7", "volume": "150", "author": "P. K. Smith", "year": "1985", "unstructured": "Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzono, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985).Anal. Biochem. 150, 76\u201385.", "journal-title": "Anal. Biochem."}, {"key": "BF01887146_CR12", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1016/0076-6879(86)30013-2", "volume": "130", "author": "J. T. Yang", "year": "1986", "unstructured": "Yang, J. T., Wu, C.-S. C., and Martinez, H. M. (1986).Meth. Enzymol. 130, 208\u2013269.", "journal-title": "Meth. Enzymol."}, {"key": "BF01887146_CR13", "doi-asserted-by": "crossref", "first-page": "1604", "DOI": "10.1016/S0006-3495(94)80952-X", "volume": "66", "author": "G.-S. Yi", "year": "1994", "unstructured": "Yi, G.-S., Choi, B.-S., and Kim, H. (1994).Biophys. J. 66, 1604\u20131611.", "journal-title": "Biophys. J."}], "container-title": ["Journal of Protein Chemistry"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF01887146.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF01887146/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF01887146", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T23:24:51Z", "timestamp": 1557444291000}, "score": 18.84974, "issued": {"date-parts": [[1996, 11]]}, "references-count": 13, "journal-issue": {"published-print": {"date-parts": [[1996, 11]]}, "issue": "8"}, "alternative-id": ["BF01887146"], "URL": "http://dx.doi.org/10.1007/bf01887146", "relation": {"cites": []}, "ISSN": ["0277-8033", "1573-4943"], "issn-type": [{"value": "0277-8033", "type": "print"}, {"value": "1573-4943", "type": "electronic"}], "subject": ["Biochemistry"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:09:51Z", "timestamp": 1574107791109}, "reference-count": 33, "publisher": "Springer Science and Business Media LLC", "issue": "9", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 12, 8]], "date-time": "2003-12-08T00:00:00Z", "timestamp": 1070841600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2004, 3]]}, "DOI": "10.1038/sj.onc.1207298", "type": "journal-article", "created": {"date-parts": [[2003, 12, 8]], "date-time": "2003-12-08T11:25:37Z", "timestamp": 1070882737000}, "page": "1645-1655", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation"], "prefix": "10.1038", "volume": "23", "author": [{"given": "Minsoo", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Tohru", "family": "Tezuka", "sequence": "additional", "affiliation": []}, {"given": "Keiji", "family": "Tanaka", "sequence": "additional", "affiliation": []}, {"given": "Tadashi", "family": "Yamamoto", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2003, 12, 8]]}, "reference": [{"key": "BF1207298_CR1", "unstructured": "Astarie-Dequeker C, Carreno S, Cougoule C and Maridonneau-Parini I . (2002). J. Cell Sci., 115, 81\u201389."}, {"key": "BF1207298_CR2", "unstructured": "Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, Oliveira-dos-Santos A, Mariathasan S, Bouchard D, Wakeham A, Itie A, Le J, Ohashi PS, Sarosi I, Nishina H, Lipkowitz S and Penninger JM . (2000). Nature, 403, 211\u2013216.", "DOI": "10.1038/35003228", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR3", "unstructured": "Bjorge JD, Jakymiw A and Fujita DJ . (2000). Oncogene, 19, 5620\u20135635.", "DOI": "10.1038/sj.onc.1203923", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR4", "unstructured": "Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, Hu RJ, Jang IK, Gutkind JS, Shevach E and Gu H . (2000). Nature, 403, 216\u2013220.", "DOI": "10.1038/35003235", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR5", "unstructured": "Honda R and Yasuda H . (1999). EMBO J., 18, 22\u201327.", "DOI": "10.1093/emboj/18.1.22", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR6", "unstructured": "Howlett CJ and Robbins SM . (2002). Oncogene, 21, 1707\u20131716.", "DOI": "10.1038/sj.onc.1205228", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR7", "unstructured": "Irby RB and Yeatman TJ . (2000). Oncogene, 19, 5636\u20135642.", "DOI": "10.1038/sj.onc.1203912", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR8", "unstructured": "Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T and Liu YC . (1999). Science, 286, 309\u2013312.", "DOI": "10.1126/science.286.5438.309", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR9", "unstructured": "Kaplan KB, Swedlow JR, Varmus HE and Morgan DO . (1992). J. Cell Biol., 118, 321\u2013333.", "DOI": "10.1083/jcb.118.2.321", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR10", "unstructured": "Kim M, Tezuka T, Suziki Y, Sugano S, Hirai M and Yamamoto T . (1999). Gene, 239, 145\u2013154.", "DOI": "10.1016/S0378-1119(99)00356-X", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR11", "unstructured": "Krawczyk C, Bachmaier K, Sasaki T, Jones GR, Snapper BS, Bouchard D, Kozieradzki I, Ohashi SP, Alt WF and Penninger MJ . (2000). Immunity, 13, 463\u2013473.", "DOI": "10.1016/S1074-7613(00)00046-7", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR12", "unstructured": "Langdon WY, Hartley JW, Klinken SP, Ruscetti SK and Morse Hd . (1989). Proc. Natl. Acad. Sci. USA, 86, 1168\u20131172.", "DOI": "10.1073/pnas.86.4.1168", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR13", "unstructured": "Lee PS, Wang Y, Dominguez MG, Yeung YG, Murphy MA, Bowtell DD and Stanley ER . (1999). EMBO J., 18, 3616\u20133628.", "DOI": "10.1093/emboj/18.13.3616", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR14", "unstructured": "Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S and Yarden Y . (1999). Mol. Cell, 4, 1029\u20131040.", "DOI": "10.1016/S1097-2765(00)80231-2", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR15", "unstructured": "Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B and Yarden Y . (1998). Genes Dev., 12, 3663\u20133674.", "DOI": "10.1101/gad.12.23.3663", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR16", "unstructured": "Lupher MJ, Songyang Z, Shoelson SE, Cantley LC and Band H . (1997). J. Biol. Chem., 272, 33140\u201333144.", "DOI": "10.1074/jbc.272.52.33140", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR17", "unstructured": "Meng F and Lowell CA . (1998). EMBO J., 17, 4391\u20134403.", "DOI": "10.1093/emboj/17.15.4391", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR18", "unstructured": "Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CB, Langdon WY and Bowtell DD . (1998). Mol. Cell. Biol., 18, 4872\u20134882.", "DOI": "10.1128/MCB.18.8.4872", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR19", "unstructured": "Nakazawa T, Komai S, Tezuka T, Hisatsune C, Umemori H, Semba K, Mishina M, Manabe T and Yamamoto T . (2001). J. Biol. Chem., 276, 693\u2013699.", "DOI": "10.1074/jbc.M008085200", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR20", "unstructured": "Odajima J, Matsumura II, Sonoyama J, Daino H, Kawasaki A, Tanaka H, Inohara N, Kitamura T, Downward J, Nakajima K, Hirano T and Kanakura Y . (2000). J. Biol. Chem., 11, 11."}, {"key": "BF1207298_CR21", "unstructured": "Panigada M, Porcellini S, Barbier E, Hoeflinger S, Cazenave PA, Gu H, Band H, von Boehmer H and Grassi F . (2002). J. Exp. Med., 195, 1585\u20131597.", "DOI": "10.1084/jem.20020047", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR22", "unstructured": "Paolini R, Molfetta R, Piccoli M, Frati L and Santoni A . (2001). Proc. Natl. Acad. Sci. USA, 98, 9611\u20139616.", "DOI": "10.1073/pnas.161298098", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR23", "unstructured": "Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N and Giordano S . (2002). Nature, 416, 187\u2013190.", "DOI": "10.1038/416187a", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR24", "unstructured": "Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A and Fotedar R . (1999). Oncogene, 18, 4313\u20134325.", "DOI": "10.1038/sj.onc.1202686", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR25", "unstructured": "Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC and Baron R . (2001). J. Cell. Biol., 152, 181\u2013195.", "DOI": "10.1083/jcb.152.1.181", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR26", "unstructured": "Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY and Dikic I . (2002). Nature, 416, 183\u2013187.", "DOI": "10.1038/416183a", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR27", "unstructured": "Suzuki T, K-Tsuzuku J, Ajima R, Nakamura T, Yoshida Y and Yamamoto T . (2002). Genes Dev., 16, 1356\u20131370."}, {"key": "BF1207298_CR28", "unstructured": "Tezuka T, Umemori H, Akiyama T, Nakanishi S and Yamamoto T . (1999). Proc. Natl. Acad. Sci. USA, 96, 435\u2013440.", "DOI": "10.1073/pnas.96.2.435", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR29", "unstructured": "Thien CB and Langdon WY . (2001). Nat. Rev. Mol. Cell Biol., 2, 294\u2013307.", "DOI": "10.1038/35067100", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR30", "unstructured": "Thien CB, Walker F and Langdon WY . (2001). Mol. Cell, 7, 355\u2013365.", "DOI": "10.1016/S1097-2765(01)00183-6", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR31", "unstructured": "Weissman AM . (2001). Nat. Rev. Mol. Cell Biol., 2, 169\u2013178.", "DOI": "10.1038/35056563", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR32", "unstructured": "Yasuda T, Tezuka T, Maeda A, Inazu T, Yamanashi Y, Gu H, Kurosaki T and Yamamoto T . (2002). J. Exp. Med., 196, 51\u201363.", "DOI": "10.1084/jem.20020068", "doi-asserted-by": "crossref"}, {"key": "BF1207298_CR33", "unstructured": "Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang H and Baron R . (2001). J. Biol. Chem., 276, 35185\u201335193.", "DOI": "10.1074/jbc.M102219200", "doi-asserted-by": "crossref"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1207298.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1207298", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1207298.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T15:54:07Z", "timestamp": 1552924447000}, "score": 18.76159, "issued": {"date-parts": [[2003, 12, 8]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2004, 3]]}, "issue": "9"}, "alternative-id": ["BF1207298"], "URL": "http://dx.doi.org/10.1038/sj.onc.1207298", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T05:23:28Z", "timestamp": 1574141008786}, "update-to": [{"updated": {"date-parts": [[2004, 10, 14]], "date-time": "2004-10-14T00:00:00Z", "timestamp": 1097712000000}, "DOI": "10.1038/sj.onc.1207298", "type": "erratum", "label": "Erratum"}], "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "47", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 10, 1]], "date-time": "2004-10-01T00:00:00Z", "timestamp": 1096588800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2004, 10]]}, "DOI": "10.1038/sj.onc.1207736", "type": "journal-article", "created": {"date-parts": [[2004, 10, 14]], "date-time": "2004-10-14T11:13:01Z", "timestamp": 1097752381000}, "page": "7903-7904", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Erratum: Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation"], "prefix": "10.1038", "volume": "23", "author": [{"given": "Minsoo", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Tohru", "family": "Tezuka", "sequence": "additional", "affiliation": []}, {"given": "Keiji", "family": "Tanaka", "sequence": "additional", "affiliation": []}, {"given": "Tadashi", "family": "Yamamoto", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2004, 10, 14]]}, "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1207736.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1207736", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1207736.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T12:11:38Z", "timestamp": 1552738298000}, "score": 18.76159, "issued": {"date-parts": [[2004, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 10]]}, "issue": "47"}, "alternative-id": ["BF1207736"], "URL": "http://dx.doi.org/10.1038/sj.onc.1207736", "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}], "assertion": [{"value": "14 October 2004", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T16:07:21Z", "timestamp": 1574698041889}, "reference-count": 56, "publisher": "Springer Science and Business Media LLC", "issue": "10", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2015, 6, 1]], "date-time": "2015-06-01T00:00:00Z", "timestamp": 1433116800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2016, 3]]}, "DOI": "10.1038/onc.2015.190", "type": "journal-article", "created": {"date-parts": [[2015, 6, 1]], "date-time": "2015-06-01T10:11:01Z", "timestamp": 1433153461000}, "page": "1314-1323", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 25, "title": ["The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation"], "prefix": "10.1038", "volume": "35", "author": [{"given": "C-C", "family": "Chen", "sequence": "first", "affiliation": []}, {"given": "K-H", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "L F", "family": "Lau", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 6, 1]]}, "reference": [{"key": "BFonc2015190_CR1", "doi-asserted-by": "publisher", "first-page": "448", "DOI": "10.1038/nrgastro.2010.100", "volume": "7", "author": "JD Yang", "year": "2010", "unstructured": "Yang JD, Roberts LR . Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 2010; 7: 448\u2013458.", "journal-title": "Nat Rev Gastroenterol Hepatol"}, {"key": "BFonc2015190_CR2", "first-page": "517", "volume": "59", "author": "Centers for Disease Control and Prevention (CDC)", "year": "2010", "unstructured": "Centers for Disease Control and Prevention (CDC). Hepatocellular carcinoma\u2014United States, 2001-2006. MMWR Morb Mortal Wkly Rep 2010; 59: 517\u2013520.", "journal-title": "MMWR Morb Mortal Wkly Rep"}, {"key": "BFonc2015190_CR3", "doi-asserted-by": "publisher", "first-page": "694", "DOI": "10.1038/ng.2256", "volume": "44", "author": "C Guichard", "year": "2012", "unstructured": "Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44: 694\u2013698.", "journal-title": "Nat Genet"}, {"key": "BFonc2015190_CR4", "doi-asserted-by": "publisher", "first-page": "1384", "DOI": "10.1016/j.jhep.2011.10.027", "volume": "56", "author": "G Baffy", "year": "2012", "unstructured": "Baffy G, Brunt EM, Caldwell SH . Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012; 56: 1384\u20131391.", "journal-title": "J Hepatol"}, {"key": "BFonc2015190_CR5", "doi-asserted-by": "publisher", "first-page": "945", "DOI": "10.1038/nrd3599", "volume": "10", "author": "JI Jun", "year": "2011", "unstructured": "Jun JI, Lau LF . Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 2011; 10: 945\u2013963.", "journal-title": "Nat Rev Drug Discov"}, {"key": "BFonc2015190_CR6", "doi-asserted-by": "publisher", "first-page": "8709", "DOI": "10.1128/MCB.22.24.8709-8720.2002", "volume": "22", "author": "FE Mo", "year": "2002", "unstructured": "Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF . CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 2002; 22: 8709\u20138720.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2015190_CR7", "doi-asserted-by": "publisher", "first-page": "961", "DOI": "10.1161/01.RES.0000248426.35019.89", "volume": "99", "author": "F-E Mo", "year": "2006", "unstructured": "Mo F-E, Lau LF . The matricellular protein CCN1 is essential for cardiac development. Circ Res 2006; 99: 961\u2013969.", "journal-title": "Circ Res"}, {"key": "BFonc2015190_CR8", "doi-asserted-by": "publisher", "first-page": "676", "DOI": "10.1038/ncb2070", "volume": "12", "author": "JI Jun", "year": "2010", "unstructured": "Jun JI, Lau LF . The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 2010; 12: 676\u2013685.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2015190_CR9", "unstructured": "Choi JS, Kim KH, Lau LF . The matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6. Mucosal Immunol e-pub ahead of print 25 March 2015.", "DOI": "10.1038/mi.2015.19", "doi-asserted-by": "crossref"}, {"key": "BFonc2015190_CR10", "doi-asserted-by": "publisher", "first-page": "2078", "DOI": "10.1128/MCB.00049-13", "volume": "33", "author": "KH Kim", "year": "2013", "unstructured": "Kim KH, Chen CC, Monzon RI, Lau LF . The matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 2013; 33: 2078\u20132090.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2015190_CR11", "doi-asserted-by": "publisher", "first-page": "1886", "DOI": "10.1172/JCI79327", "volume": "125", "author": "KH Kim", "year": "2015", "unstructured": "Kim KH, Chen C-C, Alpini G, Lau LF . CCN1 induces ductular reaction through integrin \u03b1v\u03b25-mediated NF\u03baB activation. J Clin Invest 2015; 125: 1886\u20131900.", "journal-title": "J Clin Invest"}, {"key": "BFonc2015190_CR12", "doi-asserted-by": "publisher", "first-page": "2728", "DOI": "10.1158/0008-5472.CAN-10-2711", "volume": "71", "author": "D Lai", "year": "2011", "unstructured": "Lai D, Ho KC, Hao Y, Yang X . Taxol resistance in breast cancer cells is mediated by the Hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res 2011; 71: 2728\u20132738.", "journal-title": "Cancer Res"}, {"key": "BFonc2015190_CR13", "doi-asserted-by": "publisher", "first-page": "8178", "DOI": "10.1038/sj.onc.1205682", "volume": "21", "author": "MS Tsai", "year": "2002", "unstructured": "Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R . Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 2002; 21: 8178\u20138185.", "journal-title": "Oncogene"}, {"key": "BFonc2015190_CR14", "doi-asserted-by": "publisher", "first-page": "7243", "DOI": "10.1158/1078-0432.CCR-05-0231", "volume": "11", "author": "S Gery", "year": "2005", "unstructured": "Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H et al. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 2005; 11: 7243\u20137254.", "journal-title": "Clin Cancer Res"}, {"key": "BFonc2015190_CR15", "doi-asserted-by": "publisher", "first-page": "8", "DOI": "10.1186/1476-4598-10-8", "volume": "10", "author": "I Haque", "year": "2011", "unstructured": "Haque I, Mehta S, Majumder M, Dhar K, De A, McGregor D et al. Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis. Mol Cancer 2011; 10: 8.", "journal-title": "Mol Cancer"}, {"key": "BFonc2015190_CR16", "doi-asserted-by": "publisher", "first-page": "1987", "DOI": "10.1158/0008-5472.CAN-03-0666", "volume": "64", "author": "D Xie", "year": "2004", "unstructured": "Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C et al. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res 2004; 64: 1987\u20131996.", "journal-title": "Cancer Res"}, {"key": "BFonc2015190_CR17", "doi-asserted-by": "publisher", "first-page": "47709", "DOI": "10.1074/jbc.M107878200", "volume": "276", "author": "X Tong", "year": "2001", "unstructured": "Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP . Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem 2001; 276: 47709\u201347714.", "journal-title": "J Biol Chem"}, {"key": "BFonc2015190_CR18", "doi-asserted-by": "publisher", "first-page": "53087", "DOI": "10.1074/jbc.M410254200", "volume": "279", "author": "W Chien", "year": "2004", "unstructured": "Chien W, Kumagai T, Miller CW, Desmond JC, Frank JM, Said JW et al. Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 2004; 279: 53087\u201353096.", "journal-title": "J Biol Chem"}, {"key": "BFonc2015190_CR19", "doi-asserted-by": "publisher", "first-page": "6355", "DOI": "10.1073/pnas.95.11.6355", "volume": "95", "author": "AM Babic", "year": "1998", "unstructured": "Babic AM, Kireeva ML, Kolesnikova TV, Lau LF . CYR61, product of a growth factor-inducible immediate-early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 1998; 95: 6355\u20136360.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2015190_CR20", "doi-asserted-by": "publisher", "first-page": "559", "DOI": "10.1083/jcb.200504015", "volume": "171", "author": "V Todorovic", "year": "2005", "unstructured": "Todorovic V, Chen C-C, Hay N, Lau LF . The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J Cell Biol 2005; 171: 559\u2013568.", "journal-title": "J Cell Biol"}, {"key": "BFonc2015190_CR21", "doi-asserted-by": "publisher", "first-page": "1257", "DOI": "10.1038/sj.emboj.7601596", "volume": "26", "author": "C-C Chen", "year": "2007", "unstructured": "Chen C-C, Young JL, Monzon RI, Chen N, Todorovic V, Lau LF . Cytotoxicity of TNF\u03b1 is regulated by Integrin-Mediated Matrix Signaling. EMBO J 2007; 26: 1257\u20131267.", "journal-title": "EMBO J"}, {"key": "BFonc2015190_CR22", "doi-asserted-by": "publisher", "first-page": "98", "DOI": "10.1016/j.biocel.2007.06.020", "volume": "40", "author": "P Feng", "year": "2008", "unstructured": "Feng P, Wang B, Ren EC . Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. Int J Biochem Cell Biol 2008; 40: 98\u2013109.", "journal-title": "Int J Biochem Cell Biol"}, {"key": "BFonc2015190_CR23", "doi-asserted-by": "publisher", "first-page": "e35754", "DOI": "10.1371/journal.pone.0035754", "volume": "7", "author": "ZQ Li", "year": "2012", "unstructured": "Li ZQ, Ding W, Sun SJ, Li J, Pan J, Zhao C et al. Cyr61/CCN1 is regulated by Wnt/beta-catenin signaling and plays an important role in the progression of hepatocellular carcinoma. PLoS ONE 2012; 7: e35754.", "journal-title": "PLoS ONE"}, {"key": "BFonc2015190_CR24", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1016/j.molonc.2013.01.005", "volume": "7", "author": "L Bakiri", "year": "2013", "unstructured": "Bakiri L, Wagner EF . Mouse models for liver cancer. Mol Oncol 2013; 7: 206\u2013223.", "journal-title": "Mol Oncol"}, {"key": "BFonc2015190_CR25", "doi-asserted-by": "publisher", "first-page": "1306", "DOI": "10.1038/ng1481", "volume": "36", "author": "JS Lee", "year": "2004", "unstructured": "Lee JS, Chu IS, Mikaelyan A, Calvisi DF, Heo J, Reddy JK et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 2004; 36: 1306\u20131311.", "journal-title": "Nat Genet"}, {"key": "BFonc2015190_CR26", "doi-asserted-by": "publisher", "first-page": "1118", "DOI": "10.1056/NEJMra1001683", "volume": "365", "author": "HB El-Serag", "year": "2011", "unstructured": "El-Serag HB . Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118\u20131127.", "journal-title": "N Engl J Med"}, {"key": "BFonc2015190_CR27", "doi-asserted-by": "publisher", "first-page": "64", "DOI": "10.1186/1471-230X-12-64", "volume": "12", "author": "SP Hiotis", "year": "2012", "unstructured": "Hiotis SP, Rahbari NN, Villanueva GA, Klegar E, Luan W, Wang Q et al. Hepatitis B vs hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma. BMC Gastroenterol 2012; 12: 64.", "journal-title": "BMC Gastroenterol"}, {"key": "BFonc2015190_CR28", "doi-asserted-by": "publisher", "first-page": "977", "DOI": "10.1016/j.cell.2005.04.014", "volume": "121", "author": "S Maeda", "year": "2005", "unstructured": "Maeda S, Kamata H, Luo JL, Leffert H, Karin M . IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005; 121: 977\u2013990.", "journal-title": "Cell"}, {"key": "BFonc2015190_CR29", "doi-asserted-by": "publisher", "first-page": "1929", "DOI": "10.1091/mbc.02-02-0023", "volume": "13", "author": "X Chen", "year": "2002", "unstructured": "Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002; 13: 1929\u20131939.", "journal-title": "Mol Biol Cell"}, {"key": "BFonc2015190_CR30", "doi-asserted-by": "publisher", "first-page": "938", "DOI": "10.1002/hep.21622", "volume": "45", "author": "E Wurmbach", "year": "2007", "unstructured": "Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 2007; 45: 938\u2013947.", "journal-title": "Hepatology"}, {"key": "BFonc2015190_CR31", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.2119/molmed.2008.00110", "volume": "15", "author": "VR Mas", "year": "2009", "unstructured": "Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med 2009; 15: 85\u201394.", "journal-title": "Mol Med"}, {"key": "BFonc2015190_CR32", "doi-asserted-by": "publisher", "first-page": "10202", "DOI": "10.1158/0008-5472.CAN-10-2607", "volume": "70", "author": "S Roessler", "year": "2010", "unstructured": "Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 2010; 70: 10202\u201310212.", "journal-title": "Cancer Res"}, {"key": "BFonc2015190_CR33", "doi-asserted-by": "publisher", "first-page": "11141", "DOI": "10.1158/0008-5472.CAN-07-1369", "volume": "67", "author": "JS Kang", "year": "2007", "unstructured": "Kang JS, Wanibuchi H, Morimura K, Gonzalez FJ, Fukushima S . Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res 2007; 67: 11141\u201311146.", "journal-title": "Cancer Res"}, {"key": "BFonc2015190_CR34", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/0163-7258(96)00062-9", "volume": "71", "author": "L Verna", "year": "1996", "unstructured": "Verna L, Whysner J, Williams GM . N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 1996; 71: 57\u201381.", "journal-title": "Pharmacol Ther"}, {"key": "BFonc2015190_CR35", "doi-asserted-by": "publisher", "first-page": "467", "DOI": "10.1016/j.immuni.2011.09.006", "volume": "35", "author": "A Kuraishy", "year": "2011", "unstructured": "Kuraishy A, Karin M, Grivennikov SI . Tumor promotion via injury- and death-induced inflammation. Immunity 2011; 35: 467\u2013477.", "journal-title": "Immunity"}, {"key": "BFonc2015190_CR36", "doi-asserted-by": "publisher", "first-page": "3266", "DOI": "10.1128/MCB.00064-09", "volume": "29", "author": "V Juric", "year": "2009", "unstructured": "Juric V, Chen CC, Lau LF . Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivo. Mol Cell Biol 2009; 29: 3266\u20133279.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2015190_CR37", "doi-asserted-by": "publisher", "first-page": "44166", "DOI": "10.1074/jbc.M406813200", "volume": "279", "author": "N Chen", "year": "2004", "unstructured": "Chen N, Leu S-J, Todorovic V, Lam SCT, Lau LF . Identification of a novel integrin \u03b1v\u03b23 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells. J Biol Chem 2004; 279: 44166\u201344176.", "journal-title": "J Biol Chem"}, {"key": "BFonc2015190_CR38", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1002/jcp.20689", "volume": "209", "author": "LE Giono", "year": "2006", "unstructured": "Giono LE, Manfredi JJ . The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 2006; 209: 13\u201320.", "journal-title": "J Cell Physiol"}, {"key": "BFonc2015190_CR39", "doi-asserted-by": "publisher", "first-page": "2306", "DOI": "10.1101/gad.390506", "volume": "20", "author": "E Stepniak", "year": "2006", "unstructured": "Stepniak E, Ricci R, Eferl R, Sumara G, Sumara I, Rath M et al. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev 2006; 20: 2306\u20132314.", "journal-title": "Genes Dev"}, {"key": "BFonc2015190_CR40", "doi-asserted-by": "publisher", "first-page": "7002", "DOI": "10.1093/emboj/18.24.7002", "volume": "18", "author": "N Dumaz", "year": "1999", "unstructured": "Dumaz N, Meek DW . Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 1999; 18: 7002\u20137010.", "journal-title": "EMBO J"}, {"key": "BFonc2015190_CR41", "doi-asserted-by": "publisher", "first-page": "20444", "DOI": "10.1074/jbc.M001020200", "volume": "275", "author": "QB She", "year": "2000", "unstructured": "She QB, Chen N, Dong Z . ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J Biol Chem 2000; 275: 20444\u201320449.", "journal-title": "J Biol Chem"}, {"key": "BFonc2015190_CR42", "doi-asserted-by": "publisher", "first-page": "1907", "DOI": "10.1016/S0140-6736(03)14964-1", "volume": "362", "author": "JM Llovet", "year": "2003", "unstructured": "Llovet JM, Burroughs A, Bruix J . Hepatocellular carcinoma. Lancet 2003; 362: 1907\u20131917.", "journal-title": "Lancet"}, {"key": "BFonc2015190_CR43", "doi-asserted-by": "publisher", "first-page": "242", "DOI": "10.1007/s11684-013-0256-4", "volume": "7", "author": "B Sun", "year": "2013", "unstructured": "Sun B, Karin M . Inflammation and liver tumorigenesis. Front Med 2013; 7: 242\u2013254.", "journal-title": "Front Med"}, {"key": "BFonc2015190_CR44", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.4161/cc.6.2.3789", "volume": "6", "author": "DA Liebermann", "year": "2007", "unstructured": "Liebermann DA, Hoffman B, Vesely D . p53 induced growth arrest versus apoptosis and its modulation by survival cytokines. Cell Cycle 2007; 6: 166\u2013170.", "journal-title": "Cell Cycle"}, {"key": "BFonc2015190_CR45", "doi-asserted-by": "publisher", "first-page": "1155", "DOI": "10.1053/j.gastro.2009.11.008", "volume": "138", "author": "N Teoh", "year": "2010", "unstructured": "Teoh N, Pyakurel P, Dan YY, Swisshelm K, Hou J, Mitchell C et al. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis. Gastroenterology 2010; 138: 1155\u20131165.", "journal-title": "Gastroenterology"}, {"key": "BFonc2015190_CR46", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.1158/0008-5472.CAN-12-1602", "volume": "73", "author": "T Sakurai", "year": "2013", "unstructured": "Sakurai T, Kudo M, Umemura A, He G, Elsharkawy AM, Seki E et al. p38alpha inhibits liver fibrogenesis and consequent hepatocarcinogenesis by curtailing accumulation of reactive oxygen species. Cancer Res 2013; 73: 215\u2013224.", "journal-title": "Cancer Res"}, {"key": "BFonc2015190_CR47", "doi-asserted-by": "publisher", "first-page": "1335", "DOI": "10.1016/j.celrep.2013.05.011", "volume": "3", "author": "H Mellert", "year": "2013", "unstructured": "Mellert H, Espinosa JM . Tumor suppression by p53: is apoptosis important or not? Cell Rep 2013; 3: 1335\u20131336.", "journal-title": "Cell Rep"}, {"key": "BFonc2015190_CR48", "doi-asserted-by": "publisher", "first-page": "150", "DOI": "10.1016/j.ejphar.2014.04.023", "volume": "735", "author": "S Kardeh", "year": "2014", "unstructured": "Kardeh S, Ashkani-Esfahani S, Alizadeh AM . Paradoxical action of reactive oxygen species in creation and therapy of cancer. Eur J Pharmacol 2014; 735: 150\u2013168.", "journal-title": "Eur J Pharmacol"}, {"key": "BFonc2015190_CR49", "doi-asserted-by": "publisher", "first-page": "3266", "DOI": "10.1128/MCB.00064-09", "volume": "29", "author": "V Juric", "year": "2009", "unstructured": "Juric V, Chen CC, Lau LF . Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivo. Mol Cell Biol 2009; 29: 3266\u20133279.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2015190_CR50", "doi-asserted-by": "publisher", "first-page": "4565", "DOI": "10.1038/onc.2012.451", "volume": "32", "author": "HX Yan", "year": "2013", "unstructured": "Yan HX, Wu HP, Zhang HL, Ashton C, Tong C, Wu J et al. DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats. Oncogene 2013; 32: 4565\u20134571.", "journal-title": "Oncogene"}, {"key": "BFonc2015190_CR51", "doi-asserted-by": "publisher", "first-page": "1160", "DOI": "10.1056/NEJMra0707704", "volume": "358", "author": "F Ciardiello", "year": "2008", "unstructured": "Ciardiello F, Tortora G . EGFR antagonists in cancer treatment. N Engl J Med 2008; 358: 1160\u20131174.", "journal-title": "N Engl J Med"}, {"key": "BFonc2015190_CR52", "doi-asserted-by": "publisher", "first-page": "1059", "DOI": "10.1002/cncr.22886", "volume": "110", "author": "MB Thomas", "year": "2007", "unstructured": "Thomas MB, Chadha R, Glover K, Wang X, Morris J, Brown T et al. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer 2007; 110: 1059\u20131067.", "journal-title": "Cancer"}, {"key": "BFonc2015190_CR53", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1002/hep.20538", "volume": "41", "author": "E Schiffer", "year": "2005", "unstructured": "Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 2005; 41: 307\u2013314.", "journal-title": "Hepatology"}, {"key": "BFonc2015190_CR54", "doi-asserted-by": "publisher", "first-page": "1577", "DOI": "10.1002/hep.26898", "volume": "59", "author": "BC Fuchs", "year": "2014", "unstructured": "Fuchs BC, Hoshida Y, Fujii T, Wei L, Yamada S, Lauwers GY et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology 2014; 59: 1577\u20131590.", "journal-title": "Hepatology"}, {"key": "BFonc2015190_CR55", "doi-asserted-by": "publisher", "first-page": "1630", "DOI": "10.1038/sj.bjc.6604353", "volume": "98", "author": "NF Smith", "year": "2008", "unstructured": "Smith NF, Baker SD, Gonzalez FJ, Harris JW, Figg WD, Sparreboom A . Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100. Br J Cancer 2008; 98: 1630\u20131632.", "journal-title": "Br J Cancer"}, {"key": "BFonc2015190_CR56", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1007/978-1-59745-019-5_13", "volume": "633", "author": "WC Li", "year": "2010", "unstructured": "Li WC, Ralphs KL, Tosh Ds . Isolation and culture of adult mouse hepatocytes. Methods Mol Biol 2010; 633: 185\u2013196.", "journal-title": "Methods Mol Biol"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc2015190.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2015190", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2015190.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T20:55:08Z", "timestamp": 1555620908000}, "score": 18.76159, "issued": {"date-parts": [[2015, 6, 1]]}, "references-count": 56, "journal-issue": {"published-print": {"date-parts": [[2016, 3]]}, "issue": "10"}, "alternative-id": ["BFonc2015190"], "URL": "http://dx.doi.org/10.1038/onc.2015.190", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}], "assertion": [{"value": "22 February 2015", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "23 April 2015", "order": 2, "name": "revised", "label": "Revised", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "1 May 2015", "order": 3, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "1 June 2015", "order": 4, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no conflict of interest.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}